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ABSTRACT OF DISSERTATION 
 
 
STUDIES ON DRUG SOLUBILIZATION MECHANISM 
IN SIMPLE MICELLE SYSTEMS 
 
        Poor aqueous solubilities of drug candidates limit the biopharmaceutical 
usefulness in either oral or parenteral dosage forms. Lipid assemblies, such as 
micelles, may provide a means of enhancing solubility. Despite their usefulness, 
little is known about the means by which micelles accomplish this result. The goal 
of the current dissertation is to provide the molecular level understanding of the 
mechanism by which simple micelle systems solubilize drugs. Specifically, the 
location, orientation and amount of the drug molecules in micelle systems are the 
focuses of the work.  
 
        Three series of model drugs, steroids, benzodiazepines and parabens, in three 
surfactant systems with anionic, cationic and neutral hydrophilic headgroups were 
studied. Solubilization power of each micelle system for each model drug was 
determined by equilibrium solubility. The observed strong surface activities of 
model drug at hydrocarbon/water interface and the ability of the drugs to compete 
with surfactants for the model oil/water interface lend support to the hypothesis 
that drug molecules are mainly solubilized in the interfacial region of the micelles. 
A surface-localized thermodynamic model that considered the surfactant-drug 
competition at micelle surface was successfully applied to predict the 
micelle/water partitioning coefficients. The predictions were made without the use 
of adjustable parameters in the case of both dilute and concentrated solutions. The 
orientation of drug at micelle surface was determined by matching calculated 
occupied areas by solutes at oil/water interface using molecular modeling method 
to the experimental values. To look into the micro-structure of micelles, two-
dimensional and diffusion (or PGSE) NMR techniques were employed to detect 
the specific drug-surfactant interactions and the micelle sizes influenced by model 
drugs and electrolytes. 
  
KEYWORDS: Simple Micelle Systems, Poorly Water-soluble 
Drugs, Solubilization, Thermodynamic Model, 
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Chapter 1 
Statement of Problem and Aims 
 
Poor water solubility is a major limiting factor to the development of many 
pharmacotherapeutic agents.  Micelles are well known to enhance the aqueous solubility 
of poorly-water soluble drugs and thus have the potential to enable drug delivery by the 
parenteral or oral routes.  At present, fundamental understanding of the solubilization 
mechanism by micelles is lacking.  As a consequence, the enhancement of drug delivery 
employing micelles has not reached its full potential. 
 
The goal of this dissertation is to provide a molecular-level understanding of the 
mechanism by which micelle systems solubilize drug molecules. Specifically, the 
location and orientation of the drug molecules in micelle systems will be determined; the 
amount of the solute molecules in specific micelle systems could be predicted based on 
the interactions between solutes and surfactants in micelles. The mechanistic 
understanding of which micelle system could best solubilize a specific drug candidate can 
provide a guideline for selecting the optimal solubilizing ingredients and greatly speed up 
the drug formulation process. 
 
The major hypothesis to be tested is: It is possible to predict micelle/water partitioning by 
accounting for solute-surfactant interactions that lead to localization at the micelle 
surface. 
 
The specific aims employed to test this hypothesis are as follows:  
1. Demonstrate that solubilization of model drugs in the core of the micelles is 
insufficient to predict micelle/water partitioning of the drugs. 
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2. Show experimentally that competition does occur between hydrophobic solutes and 
surfactants for a model oil/water interface. 
3. Evaluate the ability of a surface-localized thermodynamic model to account for 
experimentally-determined micelle/water partitioning. 
4. Determine the orientations of model drugs at the micelle surface by matching the 
calculated interfacial areas occupied by drugs at the oil/water interface to the 
experimental values.  
5. Employing NMR spectroscopic techniques, probe the nature of the solute-surfactant 
molecular interactions in the micelles with the goal of determining how interactions will 
govern molecular location/orientation and thus solubilization of drugs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Shaoxin Feng 2009 
 3 
 
Chapter 2 
Background and Literature Review 
 
2.1.   Introduction 
It has been estimated that 40 to 60 % of new drug candidates entering drug development 
programs possess poorly aqueous solubility.  Poor solubility presents a major challenge 
for pharmaceutical formulation of both oral and parenteral products. The formulation 
scientist is often faced with the difficult task of either increasing the dissolution rates or 
enhancing the aqueous solubility of those poorly soluble drug candidates.  
 
The importance of solubility has long been recognized by official compendia, such as the 
USP (USP, 2009). There are several ways to express absolute solubility of a solute, such 
as the number of parts of solvent required to dissolve one part of solute. For 
biopharmaceutical purposes, a solubility descriptor focusing on the clinical dose is 
appropriate. Based on biopharmaceutical classification system (BCS) (Amidon et al., 
1995), a drug candidate is considered to have adequate solubility when its highest dose 
could be dissolved in 250mL or less of buffer within pH 1~7.5. If more than 250mL is 
required the drug candidate is defined as poorly soluble. BCS classifies drug candidates 
into 4 categories in terms of their aqueous solubilities and permeabilities through 
biological membrane (Figure 2.1). Class I drugs are both highly soluble and highly 
permeable and tend to have good oral bioavailabilities, assuming no issues with first-pass 
metabolism or chemical stability. Class II drugs have bioavailabilities limited by poor 
solubility. Poor solubility is also one characteristic of Class IV drugs as well. Formulation 
methods that enhance solubility could “move” class II drug candidates (low solubility,  
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Figure 2.1 A schematic of biopharmaceutical classification system (BCS) (Adapted from 
Amidon et al. (Amidon et al., 1995)). Solubilization could shift BCS class II drug 
candidates into the BCS class I region. 
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high permeability) into class I (high solubility, high permeability) and enhance the 
corresponding bioavailabilities. 
 
2.2.   Means of Solubilization 
There are many techniques used to improve aqueous solubility, such as pH adjustment, 
salt formation, co-solvents, complexation, amorphous solids and lipid assemblies 
(Yalkowsky, 1999). The techniques could be employed individually or in combination to 
provide synergistic effect of solubility enhancement (Li et al., 1999a; Li et al., 1999b; Li 
et al., 1998; Tongeree et al., 1999; Viernstein et al., 2003; Kawakami et al., 2004). All 
these methods are successful to some extent or another, but all do have disadvantages for 
oral or parenteral administration. Altering pH or salt formation makes use of higher 
solubility of ionic form of solute which could be obtained by decreasing pH for weak 
bases or increasing pH for weak acids, but the methods has potential issues of chemical 
stability of drugs and biocompatibility of pH extremes. Co-solvents technique uses the 
mixture of water and physiologically-acceptable organic solvents, such as propylene 
glycol, ethanol, glycerin etc., to improve solubility, but has the issue of pharmacological 
effect of organic solvents and possible precipitation of drugs upon dilution. Complexation 
could shift monomer forms of drugs into complexes with complexing agents, usually 
cyclodextrin, and improve solubility.  The structure of drug must be such so as to 
interact strongly with the complexing agent. Slow releasing rate of drugs from the 
complexes is another potential limiting issue. Amorphous solids could be applied to 
enhance the “solubility”, as defined using free energy difference between amorphous and 
crystal form (Hancock and Parks, 2000), because of the higher free energy of the 
amorphous state.  On the other hand, the high free energy of amorphous solids exhibit 
poor long term physical/chemical stability.  Lipid assemblies make use of higher 
solubility of hydrophobic drugs in biocompatible lipid assemblies but excipient selection 
and drug releasing profiles are not yet well understood.  
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2.3.   Family of Lipid Assemblies 
One of the advantageous characteristics of the use of lipids to enhance the solubility of 
drugs in dosage forms is the wide variety of lipid assemblies that can be formed in an 
aqueous environment. The properties of lipid assemblies are modified by changing the 
composition of their components: water, surfactant, oil, and in some cases co-solvent. 
Figure 2.2 shows a general schematic phase diagram of lipid assemblies adapted from 
Bummer (Bummer, 2004). Lipid assemblies included here are micelles, mixed micelles, 
microemulsions, emulsions, liposomes, solid lipid nanoparticles, and self-dispersing 
systems. In all cases, the assemblies provide micro-environments that help solubilize 
drug molecules of varying properties. For example, micelles, as aggregations of 
surfactant molecules, may be treated as a separate phase when the surfactant 
concentration was above critical micelle concentration (CMC) in the absence of oil. 
Emulsions/microemulsions have oil-in-water or water-in-oil form depending on the 
surfactant properties and oil/water ratio. Liposomes use phospholipids bi-layer as the 
primary structure and may be classified as small unilamellar vesicles (SUV, size~50nm), 
large unilamellar vesicles (LUV, size 100~1000nm), multilamellar vesicles (MLV) and 
multivesicular liposomes (MVL) types. The drug molecules could be solubilized or 
loaded inside the liposomal vesicles or on lipid bi-layer membranes.  
 
As indicated in Figure 2.2, the surfactant is a critical component of any lipid assemblies. 
Surfactant, as an abbreviation of “surface active agent”, is an organic compound that is 
amphiphilic comprising both hydrophilic groups (commonly referred to as “heads”) and 
hydrophobic groups (“tails”). Based on the electron charges of the hydrophilic head 
groups, surfactant are classified into 4 categories: anionic surfactants, such as sodium 
dodecyl sulfate (SDS), cationic surfactants, such as cetyl trimethylammonium bromide 
(CTAB), nonionic surfactants, such as polysorbate 80, and amphoteric (zwitterionic)  
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Figure 2.2 A schematic of phase diagram of lipid based systems. Adapted from Bummer 
(Bummer, 2004) 
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surfactants, such as phospholipids that contain anionic phosphate groups and cationic 
ammonium groups. In pharmaceutical preparations, the surfactants or any other 
excipients selected are often limited to be generally regarded as safe (GRAS) materials 
by Food and Drug Administration (Smolinske, 1992). Especially the use of the cationic 
agents is limited to topical antimicrobial preservatives rather than solubilizing agents 
because organic cations can be adsorbed at cell membrane in a nonspecific manner 
resulting in cell lysis. Anionic agents generally result in less hemolysis and SDS has been 
widely used as wetting agent, emulsifier and solubilizer in oral solid dosage forms. 
Zwitterionic surfactants, such as phospholipids, usually exhibit good biocompatibility. 
Phospholipids are mainly used to form liposomes that are often effective drug delivery 
systems for poorly soluble drugs and have controlled releasing profile and targeting 
capability (Joguparthi, 2007). Nonionic surfactants generally have the least toxicity 
profile and thus are the major class of surfactants used in pharmaceutical system through 
both oral and parenteral routes. Most commonly used nonionic surfactants have 
polyethylene glycol (PEG) chains as parts of hydrophilic heads, e.g. trade-marked 
products Tween series, Brij series, Cremophor EL and RH, TPGS etc.. Besides the 
solubilization function of PEGylated head groups, the PEG brushes on particle surfaces 
are believed to prevent the phagocytosis by blocking opsonins binding and increase the 
lifetime of the drug delivery vehicles in systemic circulation when administered 
parenterally (Allen et al., 1991).  
 
Surfactants may also be classified in terms of technical applications. Each surfactant may 
be assigned a hydrophile-lipophile balance (HLB) value indicative of the relative polarity 
of parts of the molecules (Griffin, 1949; Griffin, 1954). The HLB value, as originally 
defined for nonionic surfactants, is weight percentage of hydrophilic groups (usually refer 
to polyethylene glycol) divided by 5 to narrow the range of values. Some ionic 
surfactants, such as SDS, could have greater HLB values than the theoretical maximum 
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number (20) because their hydrophilic behavior of the anionic head exceeds the 
polyethylene glycol group alone. HLB system is quite useful in assigning the major 
functions of surfactants: surfactants with HLB values between 3 and 6 are mainly used as 
water-in-oil emulsifiers; agents with HLB 8~18 are good oil-in-water emulsifiers; wetting 
agents usually have a HLB from 7 to 9; surfactants having HLB 15~20 can be used as 
solubilizers (Ansel et al., 1995).  
 
Again referring to Figure 2.2, the oil is also a critical component of many (but not all) 
lipid assembly dosage forms. The oil phase of lipid assemblies is often a glyceride 
derived from plant sources, purified and chemically modified, either by PEGylation or 
hydrogenation to decrease the degrees of unsaturation for protection from oxidation. 
Typically triglycerides could be classified into 3 categories: short chain (<5 carbons), 
medium chain (6~12 carbons) and long chain (>12 carbons) for fatty acid portion. In 
commercial application of lipid-based delivery systems, the most frequently used oils are 
medium-chain (e.g. coconut oil, palm seed oil, etc.) and long-chain (e.g. corn oil, soybean 
oil, olive oil, sesame oil etc.) triglycerides because those oils could provide desirable 
physical and drug absorption properties (Hauss, 2007). Typically, triglycerides are 
employed, but a wide variety of commercially-modifed di- and mono-glycerides are also 
available. 
 
2.4.   Examples in the Literature of Use of Lipid Assemblies in Drug Delivery 
Lipid-based drug delivery systems have received considerable interest in the recent years 
(Hauss, 2007; Pouton, 1997; Grove and Mullertz, 2007) because of their advantages in 
enhancing bioavailability of poorly-soluble hydrophobic drugs and possessing good 
biocompatibility. Besides the solubility improvement of poorly-soluble drugs by 
lipid-based system, there are several other factors that could help further increase the 
bioavailability and decrease the variability of absorption of poorly-soluble drugs: (1) 
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Some excipients such as Cremophor may increase absorption of drugs by inhibiting 
P-glycoprotein-mediated drug efflux and/or metabolism by GIT (GI tract) 
membrane-bind-cytochrome enzymes (Dintaman and Silverman, 1999; Chervinsky et al., 
1993; Wandel et al., 2003). (2) Lymphatic transport could be promoted by long chain 
triglyceride, which delivers drug into lymph before entering the systemic circulation 
while avoiding hepatic first-pass metabolism (Khoo et al., 2003; Holm et al., 2003). (3) 
Permeability of drug through GIT membrane can be enhanced by surfactants through 
interfering with epithelial cell membrane (Whitehead and Mitragotri, 2008; Kitagawa and 
Ikarashi, 2003). 
 
On the pharmaceutical market, there are already some commercially available 
formulations applying lipid based drug delivery systems through oral and parenteral 
routes (Strickley, 2004). For example, immunosuppressant cyclosporin A/Sandimmune® 
(Novartis) is formulated into oral soft gelatin capsules with Labrafil 
M-2125CS(surfactants) and corn oil; Anti-HIV drugs lopinavir & ritonavir/Kaletra® 
(Abbott) are formulated into oral soft gelatin capsules with oleic acid(oils) and 
Cremophor EL(surfactants); Antifungal antibiotics amphotericin B/Abelcet® (Enzon) 
employs liposomal formulations through IV injection using two kinds of phospholipids 
(dimyristoylphosphatidylcholine and dimyristoylphosphatidylglycol). Based on 
Strickley’s survey on three markets, lipid-based system has occupied 3% (27 out of 839 
products) of current drug market in the United States, 2% (21 out of 1254 products) in the 
United Kingdom, and 4% (8 out of 200 products) in Japan (Strickley, 2007).  
 
2.5.   Micelles as Drug Delivery Systems 
Micelles are among the oldest lipid-based drug delivery systems. The earliest 
pharmaceutical application of micelles as solubilization agents was using soap solutions 
to solubilize cresols in preparation of Saponated Solutions of Cresol, U.S.P. and Lysol, 
 11 
B.P. at the end of 19
th
 century (Sjoblom, 1967). Surfactants, as emulsifying agents, had 
been applied in pharmaceuticals even earlier (Fishbein, 1945). It was not until 1950s that 
the pharmaceutical applications of micellar solubilization had received systematic 
attention (Sjoblom, 1967) and became extensively studied afterwards. In the current 
pharmaceutical market, many products use micelles as the drug delivery systems. For 
examples: anti-cancer drug paclitaxel/Taxol® (Bristol-Myers Squibb) uses Cremorphor 
EL micelles as the major delivery vehicles through IV infusion; Dutasteride/Avodart® 
(Glaxo SmithKline) is formulated into gelatin capsule that could form mixed micelles of 
mono- and diglycerides of caprylic/capric acid upon oral administration. 
 
There are many advantages of micelles as a practical drug delivery system other than 
solubilization of poorly soluble drugs: micelles are thermodynamic stable (McBain and 
McBain, 1936); micelles may protect some unstable drugs from chemical degradation 
when the vulnerable functional groups of the drug are hided in the core region (Rodriguez 
et al., 2008); some polymeric micelles have tumor targeting function through enhanced 
permeation and retention (EPR) effect (Rangel-Yagui et al., 2005).  
 
Micelles could also play an important role in other lipid-based delivery systems, such as 
self-emulsifying drug delivery system (SEDDS). Emulsions or microemulsions are 
formed by diluting SEDDS with aqueous fluids in GI tract. The digestability of the lipid 
component is thought to be essential in the drug release and absorption because 
indigestible lipids, such as paraffin oil, often actually inhibit the drug absorption by 
keeping the drug within the lipophilic reservoir (Palin and Wilson, 1984). The lipid 
digestion, mainly through lipolysis, will hydrolyze triglycerides to mono- or diglycerides 
and fatty acids that form mixed micelles with phospholipids and bile salts (Zangenberg, 
2001a; Zangenberg, 2001b). The drugs solubilized in the mixed micelles are readily 
absorbed because of the large surface/volume ratio and fast exchange rate of the 
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monomers in and out of the micelles. The amount of the drug that could be solubilized in 
the mixed micelles would be critical in drug absorption.  
 
2.6.   Relevant Properties of Micelles 
2.6.1.   Physical and Chemical Properties of Micelles 
There are several physicochemical properties of micelles that are critical in understanding 
their thermodynamic and kinetic behaviors. Typically, micelles exhibit critical behavior, 
that is, they form only when the concentration of the surfactant exceeds a characteristic 
value. This critical micelle concentration (CMC) can be modified by temperature and by 
the presence of other solutes. Micelles have a small size, normally around 5 to 100 nm 
(Rangel-Yagui et al., 2005). Light-scattering (Anacker and Ghose, 1968), small angle 
X-ray scattering (SAXS) (Svens and Rosenholm, 1973), small angle neutron scattering 
(SANS) (Lin et al., 1990), pulse gradient spin-echo NMR (Soderman et al., 2004) and 
other methods have been used to measure the micellar size and shape. Yalkowsky and 
Zografi found most micelles likely assume a spherical shape when the aggregation 
number, the number of surfactant molecules in the assembly, is below 100 (Yalkowsky 
and Zografi, 1972). The aggregation number may be modified by changing surfactant 
concentration or by other solutes (Turro and Yekta, 1978). At high surfactant 
concentration corresponding to high aggregation number, micelles may be subjected to a 
transition from spherical shape to elongated ellipsoidal shape (Imae et al., 1985; 
Reiss-Husson and Luzzati, 1964; Lin et al., 1990). 
 
The kinetics of association and disassociation of surfactants forming a micelle are usually 
very rapid. The characteristic time for the surfactant monomers moving in and out of 
micelle is typically in the range of 10
-8
 to 10
-3
s (Lindman and Wennerstrom, 1980). These 
bring a practical issue of possible precipitation of solubilizate among dilution of 
surfactants to below CMC that could affect drug performance. One exception is some 
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polymeric micelle could have much longer lifetime, in the order of hours, in the 
circulation system even the surfactant concentration is below CMC (Lavasanifar et al., 
2002; Adams et al., 2003).  
 
The micellar surfaces are found to be highly hydrated based on both experiments 
(Lindman and Brun, 1973; Mukerjee, 1964) and theoretical molecular dynamic 
simulations (Tieleman et al., 2000). For example, the hydration numbers per surfactant 
molecule in micelle are on the order of 9 for SDS, 5 for dodecyl trimethylammonium 
chloride (Mukerjee, 1964) and 8.7 for sodium caprylate (Lindman and Brun, 1973).  
 
2.6.2.   Molecular Organization in Micelles 
The conventional representation of a micelle assumed the hydrocarbon chain was 
all-trans and directed radially inward shown in Figure 2.3. Apparently all the chain 
termini were located at the center of micelle which resulted in anomalously high density 
that was not physically appropriate. Dill et al. introduced an interphase model to describe 
the molecular arrangement in micelles that considered both chain continuity and steric 
constraint (Dill and Flory, 1981; Dill, 1982; Dill et al., 1984). The SANS and 
13
C and 
2
H 
NMR experiments supported the interphase model as opposed to the radial chain or oil 
droplet models. The interphase model inferred disordered alkyl chains near the micelle 
surface and much more ordered chains near the core of micelle. With rapid development 
in computational power, more explicit micellar structure was explored using molecular 
dynamic simulations (MacKerel, 1995; Bogusz et al., 2000; Moura and Freitas, 2005). 
The radial density distributions from micelle center for hydrocarbon chain, head group 
and water were clearly demonstrated. The interior of micelle was found to be less fluidic 
for hydrocarbon and be void of water that all agreed with Dill et al. (Dill et al., 1984). 
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Figure 2.3 Conventional representation of a micelle. The circles represent the hydrophilic 
head groups of micelles, and the zigzags are the hydrocarbon chains of micelles. 
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2.6.3.   Solubilization Capacity of Micelles 
The surfactant solutions, such as soaps and bile salts, had been observed to be able to 
increase the solubility of water insoluble substances in as early as 19
th
 century (Persoz, 
1846; Kuehne, 1868; Engler and Dierckhoff, 1892). It was until 1930s when the 
solubilization phenomena by surfactants were rationalized using the hypothesis of the 
formation of colloidal particles or micelles (Smith, 1932; Blitzinger and Beier, 1933; 
McBain and McBain, 1936; Verzar, 1933). Hartley observed that solubilization of 
trans-azobenzene in solutions of cetylpyridinium salts only occurred when the 
concentration of surfactant was above the CMC (Hartley, 1938). Many studies have been 
done on micellar solubilization of pharmaceuticals and there were many review 
articles/book chapters covering the subject (Mulley, 1964; Sjoblom, 1967; Elworthy et al., 
1968; Attwood and Florence, 1983; Rosen, 1989; Christian and Scamehorn, 1995; 
Yalkowsky, 1999). 
 
Many factors had been found to be able to affect solubilization capacities of micelles, 
such as hydrocarbon chain length and headgroup of surfactants, polarity and 
hydrophobicity of solubilizates, temperature, pH, ionic strength, etc. Longer hydrocarbon 
chain length of surfactant usually produces higher solubilization capacity. The more 
nonpolar the solute, the more significant the increase in solubilization. For example, a 
series of drugs was solubilized in polysorbate 20, 40, 60 and 80 and the solubilization 
powers all increased to some extent with increasing the alkyl chain length of surfactants 
(Sjoblom, 1967; Attwood and Florence, 1983; Ong and Tamoukian, 1988). The 
solubilization capacity ratio between polysorbate 80 and polysorbate 20 systems had the 
following ranking order: vitamin A palmitate (4.5) > estrone (1.9) > timobesome acetate 
(1.6) > indomethacin (1.4). Vitamin A palmitate was apparently most nonpolar of the 
tested solutes. Timobesome acetate and indomethacin, having more polar functional 
groups, were most polar. When the alkyl chain length of surfactants was fixed, the 
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hydrophilic head group could also affect the solubilization capacity and the trend 
depended on the solute properties. Tokiwa (Tokiwa, 1968) used a series of surfactants 
with same hydrocarbon chain length to solubilize hydrocarbon and nonpolar compounds. 
Although it was expected that these solutes localized in the core of the miclle, Tokiwa 
found the solubilizing powers of the surfactants in the order of anionic < cationic 
<nonionic. For polar solutes that were solubilized in the palisade layer of the micelles, the 
results were somewhat different. Shihab et al. (Shihab et al., 1979) solubilized 
furosemide, a diuretic, in anionic SDS micelles, nonionic polysorbate 80 micelles and 
PEG polymers and observed the ranking order of the solubilization capacity to be 
SDS>polysorbate 80>PEG. With elevated temperature the micellar solubilization capacity 
would usually increase (Lundberg, 1980; Saket, 1996) with some exceptions, e.g., 
benzocaine in polysorbate systems had lower solubilization power at higher temperature 
(Hamid and Parrott, 1971). The complicated behavior was due to the two factors of the 
solubilization power, intrinsic solubility and micelle-water partitioning, which may have 
different trend with rising temperature: intrinsic solubility would increase with increasing 
temperature while the micelle-water partitioning coefficient was usually decreased with 
elevated temperature (Barry and El Eini, 1976; Saket, 1996). The overall effect depended 
on the competition between the two factors. 
 
The above studies, although experimental, mainly observe some qualitative correlation 
between solubilization and varieties of micelle factors. Attempts to quantitatively predict 
the solubilization capacity are mainly of three approaches: linear free energy relationship 
(LFER), deconstruction method and thermodynamic modeling. Most commonly used 
LFER based methods utilize a correlation between micelle/water partitioning coefficient, 
Km/w, of the solubilizate with its octanol/water partitioning coefficient, Poct, in specific 
surfactant systems. The following linear equation is employed: 
oct/ loglog PBAK wm             (2.1) 
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where A, B are constants and have different values for different surfactants. This 
approach was applied to SDS (Valsaraj and Thibodeaux, 1990; Treiner and Mannebach, 
1987), DTAB/CTAB (Treiner and Mannebach, 1987), polysorbate 80 (Alvarez-Munez 
and Yalkowsky, 2000), bile salt (Wiedmann and Kamel, 2002) and bile salt/egg PC mixed 
micelle (Wiedmann and Kamel, 2002) systems. Abraham et al. (Abraham et al., 1995) 
extended the method to include the volume term of the solubilizate: 
xwm VCPBAK  oct/ loglog           (2.2) 
where A, B, C are constants; Vx is the McGowan characteristic volume (McGowan, 1978) 
of the solute. They also extended the LFER-based equation to express micelle/water 
partitioning coefficient in SDS using the linear combination of a few molecular 
descriptors of the solute, such as excess molar refraction, polarizability, hydrogen-bond 
acidity and basicity, in the absence of logPoct parameter. Some other LFER approaches to 
predict micelle/water partitioning considered the group contributions (Smith et al., 1987; 
Jafvert et al., 1994). Those correlation methods could be employed to predict the 
micelle/water partitioning of new compounds using their logP values and/or other solute 
properties. As with most LFER methods, the approach is semi-empirical and depends 
strongly on the training set of solubilizates.  
 
The second method of predicting solubilization capacity is a deconstruction approach 
(Malcolmson and Lawrence, 1993), where the micelle is broken down into component 
parts. Octadecene was used to simulate the inner core of the micelle; 
dimethoxytetraethylene glycol (DMTG) was employed to simulate the poly(ethylene 
oxide) mantle region of Brij 96 micelles. Solubilities in the component parts were 
combined by weight fraction to predict micelle solubilization. This method could roughly 
estimate the relative importance of two micellar regions, core and surface, in 
solubilization. The overall prediction was not accurate. In addition, it may be difficult to 
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identify suitable solvent counterparts for some micelle hydrophilic head groups, such as 
that of SDS and DTAB.  
 
The third method of predicting solubilization capacity is based on thermodynamic models 
(Mukerjee and Cardinal, 1978; Mukerjee, 1979; Gumkowski, 1986). In a two-location 
model, a micelle is divided into a core region that is hydrocarbon-like and a palisade 
region representing the surface of the micelle. The micelle/water partitioning coefficient 
of the solute could be expressed as the sum of two contributions from the two locations. 
Based on the Mukerjee model on bulk phase and surface adsorption phase, the 
micelle/water partitioning coefficient of solute could be expressed as: 
        AfRTPVKKKK whsurfacewmcorewmwm  exp/,/,//     (2.3) 
where Kh/w is the hydrocarbon/water partitioning coefficient; P is the Laplace pressure 
(Mukerjee, 1979); V is the molar volume of the solute; R the ideal gas constant; T the 
temperature. For the surface solubilization term,  is the surface excess of drugs on 
hydrocarbon/water interface; A is the area per surfactant molecular on micellar surface; f 
is a competition factor between surfactant and drug at hydrocarbon/water interface.  
 
The method had been applied to many organic molecules with simple structures, such as 
alkanols, ketones, amides and aromatics, in SDS and sodium decyl sulfate (SDeS) 
micelle systems and the predicted results showed good agreement with experimental 
values.  
 
2.6.4.   Location of Solutes in Micelles 
Micelles could solubilize water-insoluble drugs in a range of microenvironments, from 
the hydrophobic core to the amphiphilic surface (palisade). Certainly then, the micellar 
solubilization mechanism must be critically-related to the location of the drug in the 
assemblies. The small size of these aggregates results in a very large surface-to-volume 
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ratio, therefore, the surface region has to be considered in any mechanistic picture of 
micellar solubilization. Many spectroscopic techniques, including fluorescence 
quenching (Bromberg and Temchenko, 1999; Lebedeva et al., 2007) UV/visible 
spectroscopy (Sabate et al., 2001; Goldenberg et al., 1993; Ramachandran et al., 1982; 
Vermathen et al., 2000), small angle X-ray diffraction (Svens and Rosenholm, 1973;) 
NMR (Nagaonkar and Bhagwat, 2006; Kim et al., 2001; Suratkar and Mahapatra, 2000; 
Vermathen et al., 2000; Bratt et al., 1990), EPR (Yoshioka, 1979; Lebedeva et al., 2007), 
and indirect method based on thermodynamic analysis (Mukerjee and Ko, 1992; Croy 
and Kwon, 2005; Donbrow et al., 1967), had been employed to probe the locus of drug 
solubilization in micelles. The field is too voluminous to review comprehensively and we 
cover only some of the more important works below. 
 
Bromberg and Temchenko (Bromberg and Temchenko, 1999) used fluorescence 
spectroscopy combined with hydrophilic quenching (using Tl
+
 as quencher) technique to 
probe the location of pyrene and steroids in Pluronic-poly(acrylic acid) micelles. They 
concluded that pyrene was mainly solubilized in the micellar core while only 60% of 
17-estradiol was located in the core region. Lebedeva et al. (Lebedeva et al., 2007) 
applied EPR and time resolved fluorescence quenching techniques (using 5- and 
16-doxyl stearic acid methyl esters as quenchers) to study the location of pyrene in 
sodium dodecyl sulfate (SDS) micelles. At low aggregation number (N=53) of SDS 
micelles 33% of pyrene was found in the core region and the fraction decreased to 25% 
when the aggregation number was increased to 130. Sabate et al. (Sabate et al., 2001) 
employed UV/visible spectroscopy method to study the solubilization site of pinacyanol 
in DTAB, TTAB and HTAB micelles. They first built a correlation between ionization 
constant pKa of the solute and dielectric constant  of bulk solvent. By measuring the 
pKa of the solute in micelles using UV/vis method the effective dielectric constant of its 
microenvironment was determined to be that between water and hydrocarbon, which 
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indicated the solubilizate was on average located in an environment with characteristics 
between micellar core and outer aqueous solution. Svens and Rosenholm (Svens and 
Rosenholm, 1973) utilized small angle X-ray diffraction technique to examine the 
locations of N,N’-dimethylaniline, decanol and p-xylene in sodium octanoate micelles by 
measuring the radii of the core and polar (palisade) regions of the micelles. 
N,N’-dimethylaniline was found at the polar layer because the radius of the polar region 
increased in the presence of the solubilizate but the radius of the core was not affected by 
the solubilization process. Based on the same principle, p-xylene was mainly solubilized 
in the core region while the location of dodecanol was concentration-dependent.  
 
NMR is an important technique in studying the location of solutes in micelles. The 
technique includes approaches that focus on chemical shifts, spin-lattice /spin-spin 
relaxation times, and intermolecular interactions based on 2D NMR spectra. Nagaonkar 
and Bhagwat (Nagaonkar and Bhagwat, 2006) employed proton NMR spectroscopy to 
detect the solubilization site of isophorone in SDS micelles. By monitoring the change of 
chemical shifts of different protons in isophorone, part of the solute was not affected and 
believed to be located in aqueous environment while remainder of the solute was affected 
significantly indicating its location close to the micellar core. The NMR approach was 
also focused on the chemical shifts of surfactant molecule, which were measured in pure 
micelle system compared to those in micelle+solubilizate system. The largest change in 
chemical shift of hydrogen atoms of surfactant molecules corresponds to the closest 
contact to solute molecule. Using the position of those hydrogen atoms of the carbon 
chain, the depth of penetration of the drugs into micelle core could be determined 
(Suratkar and Mahapatra, 2000). 
1
H spin-lattice relaxation time (T1) and spin-spin 
relaxation time (T2) could also be used in molecular location determination (Ueno and 
Asano, 1997). In general, the relaxation rates depend on the motional behavior of 
functional groups in solution where restricting motion corresponds to shorter relaxation 
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time.  Ueno and Asano employed the relaxation time approach to study the orientation 
of bile salt sodium glycochenodeoxycholate (NaGCDC) at the NaGCDC/octaoxyethylene 
glycol mono n-decyl ether (C10E8) mixed micelle systems (Ueno and Asano, 1997). The 
increased T1 and T2 values of 19-methyl group at lower mole fraction of NaGCDC 
suggested 19-methyl group became free due to the hydrogen-bonding breakage between 
two NaGCDC molecules in the mixed micelle. In contrast, the motion of 18-methyl 
group was restricted at the lower mole fraction of NaGCDC. Those results suggested that 
-plane of the bile salt oriented toward the water phase and the -plane together with 
19-methyl group oriented toward the center of the core; the 18-methyl group was located 
near the boundary between ethylene oxide and hydrocarbon chain of the C10E8 molecule 
in mixed micelles. 2-Dimensional NMR, nuclear Overhauser effect spectroscopy 
(NOESY) and rotating-frame Overhauser effect spectroscopy (ROESY) were applied to 
detect inter-molecular interactions (Hawrylak and Marangoni, 1999; Matsuoka et al., 
2007; Heins et al., 2007; Bachofer et al., 1991). Hawrylak and Marangoni studied the 
solubilization sites of butanol and benzene in SDS and DTAB micelles using NOESY 
(Hawrylak and Marangoni, 1999). The cross peaks between -protons of the SDS and the 
1-butanol molecule indicated the hydroxyl group of butanol was close to the headgroup 
of SDS at the micelle surface. The cross peaks between the methyl protons of the butanol 
and the hydrocarbon chain protons of SDS suggested the hydrocarbon chain of butanol 
was pointed inwards towards the center of the micelle. 
 
2D NMR method is highly specific on the inter-molecular interactions that provide 
molecule level understanding of micellar solubilization. As of yet, the applications of the 
technique to micellar solubilization of pharmaceuticals are limited (Matsuoka et al., 2007; 
Heins et al., 2007). Applying 2D NOESY and ROESY NMR methods would be a 
powerful tool to study the solublization of model drugs in micelle systems in order to 
obtain microscopic information of micellar solubilization.  
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As shown earlier, the groups of Bromberg (Bromberg and Temchenko, 1999) and 
Lebedeva (Lebedeva et al., 2007) used fluorescence quenching method to determine the 
pyrene to be in the micellar core or part in hydrocarbon core and part at the surface of 
micelles. One reason for the controversies is the location of solutes has a subtle different 
definition for different experimental technique. For thermodynamics based technique the 
location is for the whole molecule: if one part of the molecule was at surface the whole 
molecule is considered to be at surface. But for UV/vis, fluorescence and NMR methods 
the location of drug is functional group specific: only the polar part or the fluorescent part 
of the molecules is focused in ultraviolet or fluorescence spectroscopy respectively. 
Hence, the conclusion about fractions of drug molecules located in different regions of 
micelles would be different using different experiments. Thermodynamics based method 
usually claim a larger fraction of solubilizates at the micellar surface compared to 
spectroscopy based methods.  
 
Mukerjee and Ko (Mukerjee and Ko, 1992) observed a significant discrepancy between 
micelle/water and hydrocarbon/water partitioning coefficients of ethyl o-, m- and 
p-aminobenzoates in a series of micelles (octyl glucoside, SDS, DM, zwig 3-12 and 
HTAC): the micelle/water partitioning coefficients were much higher than the 
hydrocarbon/water partitioning constants which indicated the core region was insufficient 
to solubilize the drugs, i.e. the first term in Eq. 2.3 was negligible, and micelle surface 
should be the major solubilization locus. Croy and Kwon (Croy and Kwon, 2005) studied 
the micelle/water partitioning of nystatin in polysorbate 80 and cremophor EL systems as 
a function of drug concentrations (solubilization isotherm). The results showed a good fit 
with the Langmuir adsorption isotherm indicating the drug was solubilized at the 
core-corona interface, in an adsorbed state.  
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Based on those studies on solubilization sites in micelles, attempts have been mad to 
correlate the locus of the solubilization and the chemical structures of the solubilizates: 
Saturated aliphatic and alicyclic hydrocarbons that were nonpolar molecules were 
solubilized in the inner core of the micelles (Rosen, 1989; Attwood and Florence, 1983; 
Lindblom et al., 1973). Semi-polar or polar solubilizates, such as alkanols, acids, and 
amines, were oriented radially in the micelle with the polar group at the micellar surface 
(Rosen, 1989; Attwood and Florence, 1983; Lee et al., 1990; Christian and Scamehorn, 
1995). For the aromatic hydrocarbons, such as benzene, naphthalene and pyrene, there is 
still no general agreement regarding their loci in micelle systems (Mukerjee and Cardinal, 
1978; Nakagawa, 1967; Eriksson and Gillberg, 1966; Bromberg and Temchenko, 1999; 
Lebedeva et al., 2007). For example, Mukerjee and Cardinal (Mukerjee and Cardinal, 
1978) showed a moderate surface activity of benzene at the heptane-water interface 
which provided an explanation of its location mainly at the micellar surface (in the 
“adsorbed” state). They also pointed out the hydrocarbon core could not provide 
sufficient solubilization power based on the micelle-water and hydrocarbon-water 
partitioning properties.  
 
2.7.   Unanswered Questions 
Controversy continues to surround the question s to the nature of the properties that 
promote solute localization in the core.  The weaker argument (covering narrow range 
of solubilizate) is that only nonpolar molecules reside in the core region (Rosen, 1989; 
Attwood and Florence, 1983). The stronger argument (covering a broader range of 
solubilizates) suggests that hydrophobic molecules have a tendency to reside in the core, 
in addition to other locations (Rangel-Yagui et al., 2005; Suratkar and Mahapatra, 2000). 
Hydrophobic molecules often possess larger nonpolar regions with fewer polar functional 
groups. Whether those small polar contributions would affect drug location in micelles 
would be important to rational application of the dosage form.  
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Mukerjee’s group have shown many organic molecules with simple chemical structures 
exhibit some surface activities at oil-water interface. It is unclear whether hydrophobic 
drug molecules with complicated chemical structures are surface active at oil/water 
interface although they do not possess surface activity at water-/air interface. If so, further 
studies of the strength of the surface activity, its correlation with chemical structures and 
the interaction/competition between the drugs and surfactants at the oil-water interface as 
a model micelle surface would provide deeper mechanistic understanding of micellar 
solubilization process.  
 
Mukerjee et al. had laid a solid foundation of applying thermodynamic model, especially 
the surface adsorption model, to micellar solubilization mechanism studies. There are still 
some questions to be clarified: 
  
1) Most of the test solutes were organic molecules with simple chemical structures. One 
exception was the solubilization studies on imaging probe molecules, OTEMPO and 
TEMPO in SDS micelles (Pyter et al., 1982). The surfactants chosen were limited to SDS 
and SDeS. It will be valuable to systematically study several series of drug molecules 
with complicated structures in micelle systems with different electron charges.  
2) One of the major assumptions in derivation of two-state model was the dilute condition 
of solute. In many of the solubilization isotherm studies, the micelle/water partitioning 
coefficient is significantly dependent upon solute concentration (Christian et al., 1986; 
Lee et al., 1990; Goto and Endo, 1978). To remove the assumption, the micelle/water 
partitioning at saturated concentration of drug would be important in pharmaceutical 
applications where solute concentration is often high.  
3) In the early two-state model studies, some controversial values for occupied areas at 
the oil/water interface by solute molecules were employed, e.g. 17.4Å² was used for both 
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benzene and pyrene molecules (Gumkowski, 1986). The area term is critical to predicting 
the amount and the orientation of solute at oil/water interface. As we illustrate in Chapter 
5, inaccuracies in the value of the occupied area can result in misinterpretation of the 
solubilization data and weaken the strength of the model. 
 
2.8.   Summary 
Micelle solution is a practical means of enhancing the solubility of poorly-soluble drugs 
and facilitating both administration and bioavailability. 
 
While several general rules have been developed, at present the mechanism of 
solubilization of poorly-soluble drugs by micelles is not understood. This lack of 
fundamental knowledge forces formulators to adopt an inefficient and labor-intensive 
search for the optimal combination of solubilizing ingredients. A mechanistic 
understanding of which micelle system could best solubilize a specific drug candidate 
would greatly speed up the drug formulation process. 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Shaoxin Feng 2009 
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Chapter 3 
Solubilization Capacity of Simple Micelle Systems and its Relation to the 
Partitioning of Model Drugs between Hydrocarbon and Water. 
 
3.1.   INTRODUCTION 
The application of micelles as drug delivery vehicles has become increasingly popular 
with growing number of commercially available products utilizing micelles in the 
formulations. Even for conventional oral delivery vehicles, such as tablets and capsules, 
when the formulations reach the gastrointestinal tract the bile salts/phospholipids mixed 
micelles produced by the human body serve as a natural delivery system to help carry and 
transport the drug molecules into systemic circulation. One of the important advantages 
of micelles as drug delivery vehicles is their ability to enhance the solubility of poorly 
water-soluble drugs which account for a significant fraction (>40%) of drug candidates. 
Although micellar solubilization of drug substances has been studied for some time, and 
many factors that influence the solubilization power of micelles have been identified, the 
mechanism of the solubilization by micelles is not fully understood. The most notable 
gap in our knowledge is the inability to predicting the amount of a drug solubilized in a 
specific micelle system. This current work is designed to probe the solubilization 
mechanism at the molecular level and in a quantitative manner. 
 
To understand the mechanism by which micelles solubilize poorly water-soluble drugs, 
one of the critical factors is the location of the drugs in micelles. It has been 
well-recognized that micelles present at least two regions for drug solubilization, a 
lipophilic “core” and an anisotropic “surface” region. The core is nonpolar and 
hydrocarbon-like. The surface, called palisade region, may be likened to an interface 
between oil (hydrocarbon) and aqueous phases. Many techniques, such as UV, NMR, 
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fluorescence, etc., had been employed to study the location of drug substances in 
difference micelle systems. In this study, a thermodynamics based model was employed 
so as to evaluate the location of the drug and to provide quantitative partitioning 
information of the drug in different regions.  
 
We started with an assumption that poorly-water soluble drug molecules were mainly 
solubilized in the core region of the micelle. The distribution of solutes between 
hydrocarbon and water could then serve as a simulation of partitioning between micellar 
core and aqueous phase. Experimentally, the hydrocarbon/water and the micelle/water 
partitioning coefficients were measured and compared to each other. If the assumption 
about micellar core as the solubilization region is true, the above two partitioning 
coefficient would be comparable.  
 
Related to the assumption of drugs solubilized in the core, another factor should be 
considered: the Laplace pressure effect (Mukerjee, 1979; Gumkowski, 1986). As a result 
of the presence of surface tension at the micelle surface and the small size of the micelle, 
the micellar interior is subject to a Laplace pressure which is expressed as following: 
        rP 2               (3.1) 
where P is the Laplace pressure;  is the surface tension at micelle surface and r is the 
micelle size. This equation is based on an assumption that the micelle has a spherical 
shape. Since the solute molecule has to create a spatial vacancy at micelle core, it must 
overcome a larger energy barrier under higher pressure. Therefore the presence of 
Laplace pressure will lower the solubilization capacity of micelle core region. To quantify 
the Laplace pressure effect, the following equation is applied: 
         RTPVKK whwm  exp//           (3.2) 
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where Km/w is the micelle/water partitioning coefficient; Kh/w is the hydrocarbon/water 
partitioning coefficient; V is the molar volume of the solute; R is the ideal gas constant 
and T is the temperature.  
 
Experiments on micelle/water and hydrocarbon/water partitioning were carried out to test 
the accuracy of Eq. (3.2) in order to clarify whether the core region is the major locus of 
the solubilization in micelles. In these studies, three independent series of drugs were 
chosen as model solutes. In each series, 3 or 4 compounds were selected in order to probe 
the effect of functional groups on solubilization phenomena. In sum total there were 11 
compounds: 4 steroids (progesterone, testosterone, 17-estradiol and 
11-hydroxyprogesterone), 4 benzodiazepines (diazepam, temazepam, oxazepam and 
prazepam) and 3 parabens (methylparaben, ethylparaben and butylparaben). The 
chemical structures of those molecules are shown in Figure 3.1.  So as to cover a broad 
range of micelle/water partitioning coefficient two series exhibit poor aqueous solubility 
and the third series exhibits relatively higher solubility were employed. Three micelle 
systems were employed as model simple micelle system: anonic sodium dodecyl sulfate 
(SDS), cationic dodecyltrimethylammonium bromide (DTAB) and nonionic dodecyl 
-D-maltoside (DM). All three surfactants have the same hydrocarbon chain length (12 
carbons) and differ only by the charge on the headgroups. The chemical structures of the 
surfactants are shown in Figure 3.2. An n-alkane, dodecane, was employed as a good 
model of hydrocarbon as a simulation of micellar core since dodecane have the same 
alkyl chain length with the hydrophobic tails of three model surfactants.  
 
3.2.   MATERIALS AND METHODS 
3.2.1.   Materials:  
Progesterone (>99%), testosterone (>98%), 17-estradiol (>98%), diazepam, temazepam, 
oxazepam, prazepam, methylparaben (>99%), ethylparaben (>99%), butylparaben  
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Progesterone       Testosterone 
 
17-estradiol        11-hydroxyprogesterone 
Figure 3.1a The chemical structures of model steroids. 
 30 
 
        
Diazepam        Temazepam 
           
Prazepam         Oxazepam 
Figure 3.1b The chemical structures of model benzodiazepines. 
 
 
 
    
Methylparaben  Ethylparaben     Butylparaben 
Figure 3.1c The chemical structures of model parabens. 
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Sodium dodecyl sulfate 
 
 
     
Dodecyltrimethylammonium bromide 
 
 
  
Dodecyl -D-maltoside 
 
Figure 3.2 The chemical structures of model surfactants. 
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(>99%), sodium dodecyl sulfate (>99%), dodecyltrimethylammonium bromide (>99%) 
and dodecyle -D-maltoside (>98%) were obtained from Sigma-Aldrich (St. Louis, MO). 
11-hydroxyprogesterone (>95%) was from Janssen Chimica (New Brunswick, NJ).  
 
3.2.2.   Solubility Measurements in Aqueous Solutions:  
The conventional shake-flask method was applied to measure the solubility of all model 
drugs in aqueous solutions in the presence and absence of surfactant: An extra amount of 
drugs was placed into aqueous solution with known concentration of surfactants and the 
system was rotated for 3~5 days at room temperature (24±1
o
C) to reach equilibrium. 
Solutions were filtered using 0.2m hydrophilic PTFE filter (Millipore Inc.) and the 
filtrates were diluted appropriately and assayed for drug concentration determinations by 
reverse phase HPLC methods (assays shown later in the chapter). 
 
3.2.3.   Solubility Determinations in Hydrocarbon Solutions:  
Dodecane was chosen as a model hydrocarbon medium. The conventional shake-flask 
method was employed to measure the solubility of model drugs in dodecane: An excess 
amount of drug was placed into dodecane and the system was rotated for 3~5 days at 
room temperature (24±1
o
C) to reach equilibrium. Solutions were filtered using 0.2m 
hydrophobic PTFE filter (Pall corp.) and the filtrates were diluted appropriately and 
assayed for drug concentrations by normal phase HPLC methods (assays shown later in 
the chapter). 
 
3.2.4.   Micelle/water Partitioning Coefficient Determinations: 
In a micelle-containing solution, drugs are dissolved both in the aqueous phase and in the 
micelle solutions. If it is assumed that solubility in the aqueous phase is independent of 
the presence of micelles, the total solubility of drug as a function of surfactant 
concentration has the following relationship: 
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*)( surfactant CMCCSS wtot            (3.3) 
where Stot and Sw are total and aqueous solubilities of drug (mole fraction based); 
Csurfactant and CMC are surfactant concentration and critical micelle concentration (CMC, 
mole fraction based);  is the slope of the ascending line and is defined as solubilization 
capacity (or solubilization power), in unit of moles of drug per mole of surfactant. 
 
Under the condition where the surfactant concentration is much greater than the CMC, Eq. 
(3.3) becomes: 
*surfactantCSS wtot             (3.4) 
 
If the micelle is considered as a “pseudo-phase”, a micelle/water partitioning coefficient, 
Km/w, can be defined as mole fraction of drugs in micelles divided by the mole fraction of 
drugs in aqueous phase. The relationship can be expressed as: 
 
w
wm
S
K
1
/



             (3.5) 
 
3.2.5.   Hydrocarbon/water Partitioning Coefficient Determination: 
In the literature, there are two methods that were used to determine the Kh/w, solubility 
ratio and direct partitioning. 
 
The solubility ratio (in mole fraction units) can be described by following equation: 
      
w
h
wh
S
S
K /               (3.6) 
where Sh is the solubility of drugs in model hydrocarbon, dodecane. The solubility ratio 
method assumes that both the aqueous phase and the oil phase act as near-ideal solutions 
of the drug. For instance, the drug is assumed not to self associate in either phase. The 
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method is also based on the assumption that saturated drugs have the same activities at 
different media. This assumption may not be true when the drug molecule could form 
different solvates in different media. One example is the testosterone crystal which has 
anhydrous form in dodecane but forms a hydrate in aqueous media. In those cases where 
the assumptions are not met, the direct partitioning method will be employed. 
 
3.2.6.   Direct Partitioning Coefficient Determinations  
A known amount of drug was placed into 1:1 (v/v) mixture of dodecane and water. The 
system was rotated for 2 days and all the solid material was dissolved. The drug 
concentrations in aqueous solutions and dodecane solutions were analyzed using reverse 
phase HPLC and normal phase HPLC methods respectively. In some instances it was 
necessary to dilute the sample prior to HPLC analysis. 
 
The partition coefficient (direct) would be determined: 
       
in water   conc.
n  hydrocarboin     conc.
whK       (3.7) 
 
3.2.7.   HPLC Methods 
Waters HPLC system including 717plus autosampler, 610 pump and 486 UV detector 
was employed in the reverse phase experiments. Waters LCMod1 HPLC system was 
employed to run the normal phase measurements. SRI PeakSimple V3.21 software was 
utilized to analyze the collected chromatograms. Column and samples were all held at 
room temperature (24±1
o
C). All mobile phases were pre-mixed and degassed before use. 
The assay protocols used in reverse phase and normal phase HPLC for all model drugs 
are listed in Table 3.1. In the table, the retention times and the response factors of the 
drugs are shown as well. All the assays were validated for precision and linearity test by 
standard protocols. The measured drug concentrations were all within the linear range of 
the respective calibration curves. No carry over was observed in any assays.  
 35 
 
The HPLC chromatograms for all the assays are shown in Figure 3.3~3.13. In a majority 
of the chromatograms the peaks of the interested compounds exhibit symmetric shapes. 
Only the normal phase HPLC assays for temazepam and oxazepam result in significant 
tailing. These assays were not optimized in terms of the peak shape because there was 
only one interested compound and no peak overlaps from other components.  
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Table 3.1 Reverse phase and normal phase HPLC assays for all model drugs 
Progesterone: 
 Reverse phase Normal phase  
Column  Supelcosil ABZ+plus C18 Alltech® Allsphere Silica 5u 
Mobile phase  50% acetonitrile/ 50% H2O 95% hexane/ 5% 2-propanol 
Injection volume  20L 20L 
Detection wavelength  240nm 240nm 
Flow rate  1.5mL/min 1.5mL/min 
Retention time 11.1min 7.2min 
Response factor  
(mV×min×mL/g) 
37.9±0.7 50.0±0.7 
 
Testosterone: 
 Reverse phase Normal phase  
Column  Supelcosil ABZ+plus C18 Alltech® Allsphere Silica 5u 
Mobile phase  50% acetonitrile/ 50% H2O 95% hexane/ 5% 2-propanol 
Injection volume  20L 20L 
Detection wavelength  240nm 240nm 
Flow rate  1.5mL/min 1.5mL/min 
Retention time 6.2min 9.1min 
Response factor  
(mV×min×mL/g) 
43.6±0.2 37.3±0.8 
 
17 -estradiol: 
 Reverse phase Normal phase  
Column  Alltech® Alltima C18 5u Alltech® Allsphere Silica 5u 
Mobile phase  50% acetonitrile/ 50% H2O 95% hexane/ 5% 2-propanol 
Injection volume  20L 40L 
Detection wavelength  280nm 280nm 
Flow rate  1.0mL/min 1.5mL/min 
Retention time 12.0min 3.4min 
Response factor  
(mV×min×mL/g) 
7.56±0.14 15.1±0.2 
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Table 3.1 (continued) Reverse phase and normal phase HPLC assays for all model drugs 
11-hydroxyprogesterone: 
 Reverse phase Normal phase  
Column  Supelcosil ABZ+plus C18 Alltech® Allsphere Silica 5u 
Mobile phase  50% acetonitrile/ 50% H2O 80% hexane/ 20% 2-propanol 
Injection volume  20L 20L 
Detection wavelength  240nm 240nm 
Flow rate  1.0mL/min 1.5mL/min 
Retention time 6.2min 6.4min 
Response factor 
(mV×min×mL/g) 
53.8±0.6 31.3±0.2 
 
Diazepam: 
 Reverse phase Normal phase  
Column  Supelcosil ABZ+plus C18 Alltech® Allsphere Silica 5u 
Mobile phase  50% acetonitrile/ 50% H2O 90% hexane/ 10% 2-propanol 
Injection volume  20L 20L 
Detection wavelength  240nm 240nm 
Flow rate  1.0mL/min 1.5mL/min 
Retention time 8.1min 3.9min 
Response factor 
(mV×min×mL/g) 
91.7±0.4 52.0±0.6 
 
Temazepam: 
 Reverse phase Normal phase  
Column  Supelcosil ABZ+plus C18 Alltech® Allsphere Silica 5u 
Mobile phase  50% acetonitrile/ 50% H2O 80% hexane/ 20% 2-propanol 
Injection volume  20L 20L 
Detection wavelength  240nm 240nm 
Flow rate  1.0mL/min 1.5mL/min 
Retention time 6.4min 4.2min 
Response factor 
(mV×min×mL/g) 
88.7±0.1 46.1±0.2 
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Table 3.1 (continued) Reverse phase and normal phase HPLC assays for all model drugs 
Prazepam: 
 Reverse phase Normal phase  
Column  Supelcosil ABZ+plus C18 Alltech® Allsphere Silica 5u 
Mobile phase  50% acetonitrile/ 50% H2O 90% hexane/ 10% 2-propanol 
Injection volume  20L 20L 
Detection wavelength  240nm 240nm 
Flow rate  1.0mL/min 1.5mL/min 
Retention time 12.8min 2.8min 
Response factor 
(mV×min×mL/g) 
77.7±0.9 44.6±0.5 
 
Oxazepam: 
 Reverse phase Normal phase  
Column  Supelcosil ABZ+plus C18 Alltech® Allsphere Silica 5u 
Mobile phase  50% acetonitrile/ 50% H2O 80% hexane/ 20% 2-propanol 
Injection volume  20L 200L 
Detection wavelength  240nm 240nm 
Flow rate  1.0mL/min 1.5mL/min 
Retention time 5.8min 3.3min 
Response factor 
(mV×min×mL/g) 
89.7±1.1 511±9 
 
Methylparaben: 
 Reverse phase Normal phase  
Column  Supelcosil ABZ+plus C18 Alltech® Allsphere Silica 5u 
Mobile phase  50% acetonitrile/ 50% H2O 97.5% hexane/2.5% 2-propanol 
Injection volume  20L 20L 
Detection wavelength  254nm 254nm 
Flow rate  1.5mL/min 1.5mL/min 
Retention time 3.4min 5.0min 
Response factor 
(mV×min×mL/g) 
78.1±0.3 68.9±1.0 
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Table 3.1 (continued) Reverse phase and normal phase HPLC assays for all model drugs 
Ethylparaben: 
 Reverse phase Normal phase  
Column  Supelcosil ABZ+plus C18 Alltech® Allsphere Silica 5u 
Mobile phase  50% acetonitrile/ 50% H2O 97.5% hexane/2.5% 2-propanol 
Injection volume  20L 20L 
Detection wavelength  254nm 254nm 
Flow rate  1.5mL/min 1.5mL/min 
Retention time 4.3min 4.5min 
Response factor 
(mV×min×mL/g) 
72.8±0.4 63.2±1.3 
 
Butylparaben: 
 Reverse phase Normal phase  
Column  Supelcosil ABZ+plus C18 Alltech® Allsphere Silica 5u 
Mobile phase  50% acetonitrile/ 50% H2O 97.5% hexane/2.5% 2-propanol 
Injection volume  20L 20L 
Detection wavelength  254nm 254nm 
Flow rate  1.5mL/min 1.5mL/min 
Retention time 8.8min 4.0min 
Response factor 
(mV×min×mL/g) 
63.4±0.3 54.8±0.7 
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Figure 3.3a, Reverse phase HPLC 
chromatograms of progesterone: the top 
chromatogram is the standard solution 
with drug concentration of 51ug/mL; the 
bottom curve represents 20-fold dilution 
of the saturated drug in 10mg/mL DTAB 
solution. 
Figure 3.3b, Normal phase HPLC 
chromatograms of progesterone: the top 
chromatogram is the standard solution 
with drug concentration of 105ug/mL; 
the bottom curve is 40-fold dilution of 
the saturated drug in dodecane. 
 
 
 
 
Figure 3.4a, Reverse phase HPLC 
chromatograms of testosterone: the top 
chromatogram is the standard solution 
with drug concentration of 81ug/mL; the 
bottom curve represents two-fold dilution 
of the saturated drug in 5mg/mL DTAB 
solution. 
Figure 3.4b, Normal phase HPLC 
chromatograms of testosterone: the top 
chromatogram is the standard solution 
with drug concentration of 104ug/mL; 
the bottom curve is 5-fold dilution of the 
saturated drug in dodecane. 
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Figure 3.5a, Reverse phase HPLC 
chromatograms of 17-estradiol: the top 
chromatogram is the standard solution 
with drug concentration of 40ug/mL; the 
bottom curve represents two-fold dilution 
of the saturated drug in 5mg/mL SDS 
solution. 
Figure 3.5b, Normal phase HPLC 
chromatograms of 17-estradiol: the top 
chromatogram is the standard solution 
with drug concentration of 10ug/mL; the 
bottom curve is the saturated drug in 
dodecane. 
 
 
 
 
Figure 3.6a, Reverse phase HPLC 
chromatograms of 11-hydroxy- 
progesterone: the top chromatogram is 
the standard solution with drug 
concentration of 84ug/mL; the bottom 
curve represents the saturated drug in 
1.0mg/mL DM solution. 
Figure 3.6b, Normal phase HPLC 
chromatograms of 11-hydroxy- 
progesterone: the top chromatogram is 
the standard solution with drug 
concentration of 67ug/mL; the bottom 
curve is the saturated drug in dodecane. 
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Figure 3.7a, Reverse phase HPLC 
chromatograms of diazepam: the top 
chromatogram is the standard solution 
with drug concentration of 88ug/mL; the 
bottom curve represents the saturated 
drug in 1.0mg/mL DM solution. 
Figure 3.7b, Normal phase HPLC 
chromatograms of diazepam: the top 
chromatogram is the standard solution 
with drug concentration of 119ug/mL; 
the bottom curve is 10-fold dilution of 
the saturated drug in dodecane. 
 
 
 
 
Figure 3.8a, Reverse phase HPLC 
chromatograms of temazepam: the top 
chromatogram is the standard solution 
with drug concentration of 82ug/mL; the 
bottom curve represents 20-fold dilution 
of the saturated drug in 2.5mg/mL SDS 
solution. 
Figure 3.8b, Normal phase HPLC 
chromatograms of temazepam: the top 
chromatogram is the standard solution 
with drug concentration of 57ug/mL; the 
bottom curve is 3-fold dilution of the 
saturated drug in dodecane. 
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Figure 3.9a, Reverse phase HPLC 
chromatograms of prazepam: the top 
chromatogram is the standard solution 
with drug concentration of 24ug/mL; the 
bottom curve represents the saturated 
drug in 5mg/mL DTAB solution. 
Figure 3.9b, Normal phase HPLC 
chromatograms of prazepam: the top 
chromatogram is the standard solution 
with drug concentration of 73ug/mL; the 
bottom curve is 40-fold dilution of the 
saturated drug in dodecane. 
 
 
 
 
Figure 3.10a, Reverse phase HPLC 
chromatograms of oxazepam: the top 
chromatogram is the standard solution 
with drug concentration of 81ug/mL; the 
bottom curve represents 5-fold dilution 
of the saturated drug in 2.5mg/mL SDS 
solution. 
Figure 3.10b, Normal phase HPLC 
chromatograms of oxazepam: the top 
chromatogram is the standard solution 
with drug concentration of 1.8ug/mL; the 
bottom curve is the saturated drug in 
dodecane. 
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Figure 3.11a, Reverse phase HPLC 
chromatograms of methylparaben: the 
top chromatogram is the standard 
solution with drug concentration of 
107ug/mL; the bottom curve represents 
40-fold dilution of the saturated drug in 
2.5mg/mL SDS solution. 
Figure 3.11b, Normal phase HPLC 
chromatograms of methylparaben: the 
top chromatogram is the standard 
solution with drug concentration of 
86ug/mL; the bottom curve is the 
saturated drug in dodecane. 
 
 
 
 
Figure 3.12a, Reverse phase HPLC 
chromatograms of ethylparaben: the top 
chromatogram is the standard solution 
with drug concentration of 91ug/mL; the 
bottom curve represents 20-fold dilution 
of the saturated drug in 2.5mg/mL SDS 
solution. 
Figure 3.12b, Normal phase HPLC 
chromatograms of ethylparaben: the top 
chromatogram is the standard solution 
with drug concentration of 87ug/mL; the 
bottom curve is the saturated drug in 
dodecane. 
 
 
 
 45 
 
 
 
 
Figure 3.13a, Reverse phase HPLC 
chromatograms of butylparaben: the top 
chromatogram is the standard solution 
with drug concentration of 87ug/mL; the 
bottom curve represents 15-fold dilution 
of the saturated drug in 2.5mg/mL SDS 
solution. 
Figure 3.13b, Normal phase HPLC 
chromatograms of butylparaben: the top 
chromatogram is the standard solution 
with drug concentration of 90ug/mL; the 
bottom curve is 3-fold dilution of the 
saturated drug in dodecane. 
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3.3.   RESULTS AND DISCUSSION 
3.3.1.   Solubilization of Model Drugs in Three Micelle Systems 
The aqueous solubility results for the steroids, benzodiazepines and parabens are shown 
in Tables 3.2~3.4. In all cases, the aqueous solubility results were in good agreement with 
those found in the literature (Yalkowski and He, 2003). The most water-soluble solute 
was methylparaben and the least soluble was 17-estradiol. 
 
The solubility results in dodecane for the three solute sets are also shown in Tables 
3.2~3.4. Dodecane solubility results in the literature are rare, so comparisons to results in 
Table 3.2 to 3.4 are difficult. None the less, the data presented in Tables 3.2 to 3.4 may be 
evaluated directly. For progesterone, testosterone, diazepam, prazepam and butylparaben 
solubility in dodecane is greater than in water. 17-estradiol and temazepam show 
approximately equal solubility in water and dodecane. All other compounds are less 
soluble in dodecane compared to water. The dodecane/water partitioning coefficients of 
model drugs are listed in Table 3.2~3.4. 
 
The solubilization capacities and associated micelle/water partitioning coefficients 
(calculated by Eq. (3.3) and (3.5), respectively) are also listed in Tables 3.2~3.4. For 
butylparaben,  and Km/w values in DTAB and DM were not determined because the 
solutions became cloudy that suggested there may be a phase transition. 
 
The experimental octanol/water partitioning property logPoct values from literatures 
(Johnson et al., 1995; Kamlet et al., 1988; Hansch et al., 1995) are also shown in those 
tables. From the logPoct values, most of the model compounds are quite hydrophobic.  
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Table 3.2, Critical parameters of model steroids: logPoct, aqueous solubility, solubility in 
dodecane, hydrocarbon/water partitioning coefficient (Kh/w), solubilization capacity () 
and micelle/water partitioning coefficients (Km/w) in SDS, DTAB and DM micelle 
systems. 
 Progesterone Testosterone 17-estradiol 11-hydroxyprogesterone 
logPoct (exp.) 3.77 3.31 3.86 2.36 
Aqueous 
solubility 
(M) 
(2.79±0.14)×10
-5 
(8.42±0.28)×10
-5 
(6.23±0.33)×10
-6 
(1.77±0.09)×10
-4 
Solubility in 
dodecane 
(M) 
(9.13±0.51)×10
-3 
(1.06±0.06)×10
-3 
(8.9±1.7)×10
-6 
(5.08±0.48)×10
-5 
Kh/w (3.80±0.10)×10
3 
51.2±2.9 10.6±0.6 3.62±0.39 
 (SDS) 0.227±0.008 0.209±0.006 0.0245±0.0003 0.276±0.010 
Km/w (SDS) (3.69±0.21)×10
5 
(1.14±0.05)×10
5 
(2.13±0.12)×10
5
 
 
(6.75±0.39)×10
4 
 (DTAB) 0.099±0.007 0.089±0.005 0.0479±0.0016 0.129±0.003 
Km/w (DTAB) (1.79±0.15)×10
5
 
 
(5.40±0.31)×10
4 
(4.07±0.25)×10
5
 
 
(3.57±0.19)×10
4 
 (DM) 0.0501±0.006 0.0491±0.0078 0.0157±0.0014 0.0441±0.0018 
Km/w (DM) (9.49±1.23)×10
4 
(3.09±0.48)×10
4 
(1.37±0.14)×10
5 
(1.32±0.09)×10
4 
Errors are based on 95% confidence intervals. 
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Table 3.3, Critical parameters of model benzodiazepines: logPoct, aqueous solubility, 
solubility in dodecane, hydrocarbon/water partitioning coefficient (Kh/w), solubilization 
capacity () and micelle/water partitioning coefficients (Km/w) in SDS, DTAB and DM 
micelle systems. 
 Diazepam Temazepam Oxazepam Prazepam 
logP (exp.) 2.99 2.19 2.24 3.73 
Aqueous 
solubility (M) 
(1.60±0.05)×10
-4 
(3.46±0.02)×10
-4 
(7.34±0.15)×10
-5 
(1.83±0.09)×10
-5 
Solubility in 
dodecane (M) 
(3.91±0.18)×10
-3 
(4.16±0.10)×10
-4 
(2.06±0.63)×10
-7 
(4.27±0.17)×10
-3 
Kh/w 308±17 15.1±0.4 0.0353±0.0108 (2.94±0.19)×10
3 
 (SDS) 0.349±0.014 0.416±0.014 0.166±0.003 0.154±0.007 
Km/w (SDS) (8.93±0.39)×10
4 
(4.70±0.11)×10
4 
(1.08±0.03)×10
5 
(4.03±0.26)×10
5 
 (DTAB) 0.0928±0.0016 0.116±0.003 0.0499±0.0023 0.0298±0.0013 
Km/w (DTAB) (2.94±0.10)×10
4 
(1.67±0.04)×10
4 
(3.58±0.18)×10
4 
(8.76±0.57)×10
4 
 (DM) 0.0647±0.0012 0.0640±0.0024 0.0267±0.0010 0.0220±0.0002 
Km/w (DM) (2.10±0.07)×10
4 
(9.63±0.35)×10
3 
(1.96±0.08)×10
4 
(6.51±0.33)×10
4 
Errors are based on 95% confidence intervals. 
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Table 3.4, Critical parameters of model parabens: logPoct, aqueous solubility, solubility in 
dodecane, hydrocarbon/water partitioning coefficient (Kh/w), solubilization capacity () 
and micelle/water partitioning coefficients (Km/w) in SDS, DTAB and DM micelle 
systems. 
 Methylparaben Ethylparaben Butylparaben 
logP (exp.) 1.96 2.47 3.57 
Aqueous 
solubility (M) 
(1.39±0.01)×10
-2 
(5.13±0.07)×10
-3 
(1.06±0.03)×10
-3 
Solubility in 
dodecane (M) 
(4.00±0.16)×10
-4 
(5.47±0.37)×10
-4 
(2.45±0.09)×10
-3 
Kh/w 0.362±0.015 1.34±0.09 29.0±1.3 
 (SDS) 0.559±0.035 0.475±0.015 0.643±0.009 
Km/w (SDS) (1.42±0.06)×10
3 
(3.48±0.09)×10
3 
(2.04±0.06)×10
4 
 (DTAB) 0.771±0.027 0.656±0.035 n.d. 
Km/w (DTAB) (1.73±0.04)×10
3 
(4.28±0.15)×10
3 
n.d. 
 (DM) 0.412±0.052 0.359±0.006 n.d. 
Km/w (DM) (1.16±0.10)×10
3 
(2.85±0.05)×10
3 
n.d. 
Errors are based on 95% confidence intervals. 
n.d.=not determined. 
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The detailed solubilization results of 11 model drugs in SDS, DTAB and DM surfactant 
systems at room temperature are shown in Figures 3.14~3.22. The typical solubilization 
profiles expected in the presence of surfactants were obtained: at low surfactant 
concentration the drug solubility was constant and equal to the aqueous solubility. At 
surfactant concentrations above the CMC (critical micelle concentration) the solubility 
increased linearly as a function of surfactant concentration. From the solubilization 
profiles, two critical parameters could be extracted: the aqueous solubility and the 
solublization capacity by the slope of the ascending line. Then the micelle/water 
partitioning coefficient could be calculated from the solubilization capacity and aqueous 
solubility based on Eq. (3.5).  
 
During the measurements of the hydrocarbon/water partitioning coefficients, two 
different techniques had been employed: solubility ratio and direct partitioning methods. 
For some compounds, such as testosterone and 17-estradiol, there was statistically 
significant discrepancy between the results from different methods. The likely reason for 
this difference is that both of the drugs can form different crystals in dodecane and 
aqueous media: they exhibit an anhydrous form in dodecane and hydrated (testosterone) 
or hemi-hydrated (17-estradiol) form in water. Therefore the saturated solutions in the 
two media are in equilibrium with different crystalline forms and the solubility ratio 
method becomes inappropriate. Other model compounds, such as progesterone, diazepam, 
temazepam, etc., have no reported solvate form and are expected to keep the same 
polymorph at the two media. 
 
To evaluate the micelle core as the locus of solubilization of model drugs, the 
hydrocarbon/water partitioning coefficients were compared to micelle/water partitioning 
coefficients. The data in Tables 3.2~3.4 clearly show that in all cases micelle/water 
partitioning coefficients, Km/w, are much larger than hydrocarbon/water partitioning  
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Figure 3.14, Solubilities of 4 model steroids as a function of SDS concentration.  
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Figure 3.15, Solubilities of 4 model steroids as a function of DTAB concentration. 
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Figure 3.16, Solubilities of four model steroids as a function of DM concentration. 
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Figure 3.17, Solubilities of four benzodiazepines as a function of SDS concentration. 
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Figure 3.18, Solubilities of four benzodiazepines as a function of DTAB concentration. 
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Figure 3.19, Solubilities of four benzodiazepines as a function of DM concentration. 
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Figure 3.20, Solubilities of three parabens as a function of SDS concentration. 
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Figure 3.21, Solubilities of two parabens as a function of DTAB concentration. 
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Figure 3.22, Solubilities of two parabens as a function of DM concentration. 
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coefficients, Kh/w. In most cases, Km/w is at least 2 orders of magnitude larger than Kh/w, 
which suggests there is less than 1% of the solutes are exclusively solubilized in the 
micellar core. The closest agreement between Kh/w and Km/w is when progesterone is 
solubilized in DM micelles with the ratio Km/w/Kh/w=25. When the Laplace pressure 
effect is taken into account the differences between Kh/w and Km/w are even greater. The 
factor  RTPVexp  in Eq. (3.2) is always less than 1 and ranges from 0.01 to 0.3 in 
our systems.  Detailed information on Laplace pressure is presented in Chapter 5. After 
considering the Laplace pressure effect, the ratio 
 
watermicelle
wh
K
RTPVK
/
/ exp   has a maximum 
of 0.4% for progesterone solubilized in DM micelles. The Eq. (3.2) will not hold in any 
of our studied systems, which indicates the assumption of micelle core as major 
solubilization locus is not true.  
 
If we relax the requirement that the Eq. (3.2) holds, the possible correlations between 
micelle/water partitioning coefficients and hydrocarbon/water partitioning constants can 
be examined. Using SDS micelle system as an example, the relationships between Kh/w 
and Km/w of 11 model drugs are shown in Figure 3.23. From the scattered pattern, there is 
no identifiable correlation between the two properties. The hydrocarbon/water 
partitioning coefficients cover 5 orders of magnitude from 0.04 (oxazepam) to 3.8×10
3
 
(progesterone) while micelle/water partitioning constants span only 2.5 orders of 
magnitude from 1.4×10
3
 (methylparaben) to 4.0×10
5
 (prazepam). 
 
Our results are consistent with reports that only completely nonpolar molecule may reside 
in the micellar core (Rosen, 1989; Attwood and Florence, 1983). High hydrophobicity is 
not the sufficient condition that makes hydrophobic solutes stay in the core region of the 
micelles. Although many hydrophobic molecules have the major part of the structure 
nonpolar and have only very small fraction of polar groups, those small polar fraction  
 57 
 
3
3.5
4
4.5
5
5.5
6
-2 0 2 4
logKh/w
lo
g
K
m
/w
 i
n
 S
D
S
Steroids
Benzodiazepines
Parabens
 
Figure 3.23, The relationships between hydrocarbon/water partition coefficient, Kh/w, and 
micelle/water partition coefficient, Km/w, in aqueous SDS solutions for three series of 
drugs, steroids, benzodiazepines and parabens. 
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would affect the location of the molecules and drive them away from the 
hydrocarbon-like core.  
 
This analysis had been applied to simple alkanols, ketones, amides and aromatics by 
Gumkowski (Gumkowski, 1986). Relatively complicated molecules, ethyl p- o- and m- 
aminobenzoates were also studied (Mukerjee and Ko, 1992). They found the micelle core 
is not the major locus of those compounds solubilized in the micelles. Our studies 
extended the objects to more pharmaceutical important molecules with complicated 
chemical structures and drew a similar conclusion: all of the model drugs are not mainly 
located at the micellar core region. 
 
Different methods may have different definition when they were applied to determine the 
location of solutes in the micelle systems. In the thermodynamics based method, a 
molecule that has part of it at the micelle surface will be defined as staying at surface. 
Our conclusion that majority of drug molecules are not in the micellar core does not 
mean any part of the drug molecules cannot be at the micelle core. The hydrophobic part 
of the solute is still likely buried in the core region. From this viewpoint there is actually 
no qualitative conflict between thermodynamics based method and spectroscopy 
methods. 
 
3.3.2.   Effect of Salts on the Micelle/water Partitioning Coefficients 
Three model drugs, progesterone, diazepam and methylparaben, each representing a 
series of solutes, were solubilized in SDS, DTAB and DM micelle systems in the 
presence of 0.15M NaCl to study the effect of the salts on the micelle/water partitioning 
coefficients. In Figures 3.24~3.27, the drug solubilities as a function of surfactant 
concentration in the presence and absence of 0.15M NaCl are shown. The quantitative 
results of aqueous solubility, solubilization power of micelles, and micelle/water 
 59 
partitioning coefficient for three model drugs are summarized in Table 3.5. The statistical 
analyses were carried out using Scientist® software to provide the 95% confidence 
intervals. For comparison, the results corresponding to the solubilization of the three 
model drugs in the absence of salts from Table 3.2~3.4 are included. 
 
In anionic SDS solutions, for all three model drugs, the solubilization power shows a 
significant decrease in the presence of salt compared to that in the absence of salt. The 
aqueous solubilities of progesterone and diazepam in 0.15M NaCl solutions were not 
significantly different from the measured solubilities in the absence of salt. On the other 
hand the aqueous solubility of methylparaben in 0.15M NaCl was decreased to 
13.0±0.1mM compared to the intrinsic aqueous solubility of 13.9±0.1mM without salts. 
The decreasing solubility could be attributed to salting out effect. The calculated 
micelle/water partitioning coefficients based on the solubilization power and aqueous 
solubility through Eq. (3.5) exhibited a significant decrease by 36% (progesterone), 19% 
(diazepam) and 24% (methylparaben) with the introduction of 0.15M NaCl.  
 
In cationic DTAB solutions, the solubilization power toward all three model drugs was 
significantly decreased by adding 0.15M NaCl. The micelle/water partition coefficients 
of progesterone and diazepam were reduced by 22% and 12% respectively in the 
presence of salts. The Km/w of methylparaben showed no statistically significant 
difference in the presence and absence of salt. This observation may be due to the 
nearly-saturated adsorption of methylparaben at DTAB micelle surface. The 
solubilization power of DTAB toward methylparaben was so large (>0.7) that the 
micelles consisted of a mole fraction of drugs nearly as much as that of surfactant. The 
effect of drug concentration on the solubilization isotherm will be further discussed in a 
later chapter. 
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Figure 3.24, Solubilities of progesterone and diazepam as a function of SDS 
concentration in the absence and presence of 0.15M NaCl. 
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Figure 3.25, Solubilities of progesterone and diazepam as a function of DTAB 
concentration in the absence and presence of 0.15M NaCl. 
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Figure 3.26, Solubilities of progesterone and diazepam as a function of DM concentration 
in the absence and presence of 0.15M NaCl. 
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Figure 3.27, Solubilization results of methylparaben in three surfactant systems, SDS 
(square), DTAB (triangle) and DM (circle), in the absence and presence of 0.15M NaCl. 
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Table 3.5, Aqueous solubility, solubilization capacity () and micelle/water partitioning 
coefficient (Km/w) of three model drugs in SDS, DTAB and DM micelle systems in the 
absence and presence of 0.15M NaCl. Experimental data in the absence of salts are from 
Table 3.2~3.4. 
 Progesterone Diazepam Methylparaben 
Aqueous solubility (M) (2.79±0.14)×10
-5 
(1.60±0.05)×10
-4 
(1.39±0.01)×10
-2 
Aqueous solubility 
w/0.15N NaCl (M) 
(3.09±0.22)×10
-5 
(1.59±0.03)×10
-4 
(1.30±0.01)×10
-2 
 (SDS) 0.227±0.008 0.349±0.014 0.559±0.035 
 (SDS) w/0.15N NaCl 0.151±0.002 0.261±0.003 0.341±0.008 
Km/w (SDS) (3.69±0.21)×10
5 
(8.93±0.39)×10
4 
(1.42±0.06)×10
3 
Km/w (SDS) w/0.15N NaCl (2.35±0.17)×10
5 
(7.21±0.15)×10
4
 (1.08±0.02)×10
3
 
 (DTAB) 0.099±0.007 0.093±0.002
 
0.771±0.027
 
 (DTAB) w/0.15N NaCl 0.084±0.003
 
0.080±0.002 0.714±0.023 
Km/w (DTAB) (1.79±0.15)×10
5
 
 
(2.94±0.10)×10
4 
(1.73±0.04)×10
3 
Km/w (DTAB) w/0.15N NaCl (1.39±0.11)×10
5 
(2.59±0.08)×10
4 
(1.78±0.04)×10
3 
 (DM) 0.050±0.006 0.065±0.001 0.412±0.052 
 (DM) w/0.15N NaCl 0.046±0.001
 
0.067±0.001
 
0.340±0.009
 
Km/w (DM) (9.49±1.23)×10
4 
(2.10±0.07)×10
4 
(1.16±0.10)×10
3 
Km/w (DM) w/0.15N NaCl (7.95±0.59)×10
4
 (2.19±0.05)×10
4
 (1.08±0.02)×10
3
 
Errors are based on 95% confidence intervals. 
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In nonionic DM solutions, the presence of salts had no statistically-significant effect on 
the micelle/water partition coefficients of all three model drugs. The results suggest that 
moderate concentrations of electrolytes have negligible influence on the solubilization 
behavior of nonionic micelles. 
 
To determine the location of model drugs in micelles in the presence of salts, the same 
approach introduced in section 3.3.1 was employed: the micelle/water partitioning 
coefficients, Km/w, was compared to hydrocarbon/water partitioning coefficient multiplied 
by a factor representing Laplace pressure effect, Kh/wexp(-PV/RT). The results in the 
absence of salts showed the term Km/w was at least 2 orders of magnitude greater than 
term Kh/wexp(-PV/RT) in all studied micelle systems. The minimum ratio between these 
two terms was 250 (when progesterone was solubilized in DM micelles). In the presence 
of salts, the greatest influence on Km/w was a 36% decrease. After taking salt effect into 
account, the micelle/water partitioning coefficient was still at least 2 orders of magnitude 
greater than term K h/wexp(-PV/RT) in all studied drug-surfactant systems. Therefore, the 
micelle surface or palisade region was the major location of model drugs when 
solubilized in the three micelle systems in the absence and presence of salts. 
 
3.4.   CONCLUSION 
The measured micelle/water partitioning coefficients were much larger than 
hydrocarbon/water partitioning constants, which indicated the core region of micelle was 
insufficient to solubilize the model hydrophobic drugs based on the thermodynamic 
model (Eq.(2.3)). This conclusion holds for 3 series of model drugs in 3 micelle systems 
in the absence and presence of salts. The model drugs have broad range in terms of 
hydrophobicity, as measured by logP, and aqueous solubility. In all the cases, partitioning 
solely into the micelle core seems insufficient to explain partitioning into a micelle.  
Copyright © Shaoxin Feng 2009 
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Chapter 4 
Oil/water Interface Activities of Hydrophobic Drugs in the Presence and Absence of 
Surfactants  
 
4.1.   INTRODUCTION 
Micellar solubilization has been shown to be important both in considering micelles as 
drug delivery vehicles of poorly water-soluble drugs and in understanding in vivo 
absorption of hydrophobic drug molecules. Currently, the physicochemical factors 
controlling the solubilization capacity of micelles are poorly understood. This work is 
designed to probe the mechanism of solubilization by micelle systems with the goal of 
quantitative prediction of the micellar solubilization for specific drug-surfactant mixtures. 
 
Location of the drugs in micelles is likely to be a critical factor in understanding the 
micellar solubilization phenomena. As a result of the small size of micelles, and the 
accompanying large surface/volume ratio, many studies have considered the surface 
region of micelles to be the major location of some solutes (Lebedeva et al., 2007; Sabate 
et al., 2001; Svens and Rosenholm, 1973; Nagaonkar and Bhagwat, 2006; Yoshioka, 
1979); Malcolmson and Lawrence, 1993; Mukerjee and Ko, 1992; Croy and Kwon, 2005; 
Donbrow et al., 1967). In the previous chapter, we employed a thermodynamics-based 
solubility method to show that solubilization in the micellar core alone is insufficient to 
explain our experimental data. The conclusion, drawn from 11 model drugs solubilized in 
3 micelle systems, indirectly suggests the micelle surface is the major location of the 
drugs solubilized in micelles. 
 
In this chapter, the characteristics of adsorption of model drugs to model interface are 
probed.  Here, we view the micelle surface as a hydrocarbon/water interface populated 
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by the surfactant molecules. For a drug to be solubilized at the micellar surface, it is 
expected to be surface active at the hydrocarbon/water interface even in the presence of 
surfactants. The surface activity of the model drugs will be measured at the water/air, 
oil/air and oil/water interfaces. The introduction of surfactants to the system will be used 
to observe the extent to which drugs and surfactants modulate the oil/water interfacial 
tension. Later a thermodynamic model will be utilized to quantitatively simulate the 
observed phenomena. 
 
Dodecane/water was chosen as the model hydrocarbon/water interface to mimic the 
hydrocarbon chain of the model surfactants. Poorly-soluble steroids were chosen to 
demonstrate the ability of drugs to adsorb to the model oil/water interface. Three 
surfactants, anionic sodium dodecyl sulfate (SDS), cationic dodecyl trimethyl ammonium 
bromide (DTAB) and nonionic dodceyl maltoside (DM), were used to detect their 
interactions with the drug molecules at oil/water interface. 
 
It should be kept in mind that many differences exist between a micelle surface and a flat 
hydrocarbon/water interface. Among the most obvious differences between the two is that 
the micelle surface is highly curved. In the current chapter, The curvature effect will be 
explored in the following chapter by invoking the Laplace pressure concept. 
 
4.2.   MATERIALS AND METHODS 
4.2.1.   Materials  
Progesterone (>99%), testosterone (>98%), 17-estradiol (>98%), sodium dodecyl 
sulfate (>99%), dodecyltrimethylammonium bromide (>99%) and dodecyl -D-maltoside 
(>98%) were obtained from Sigma-Aldrich (St. Louis, MO). Progesterone, testosterone, 
SDS and DTAB were purified before use while 17-estradiol and dodecyl -D-maltoside 
were used as received.  
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4.2.2.   Methods 
4.2.2.1.   Surface Tension Measurement 
DuNouy ring method was used to measure the liquid/air and liquid/liquid interfacial 
tension. The method was first developed by duNouy in 1919 (duNouy, 1919). In this 
method, the interfacial tension is measured with the aid of platinum-iridium ring pulled 
through the interface (Figure 4.1). The force necessary to detach the ring at the interface 
is proportional to the interfacial tension.  
 
The relationship between the interfacial tension and the applied force could be expressed 
using the formula: 


   
R4
F
 

              (4.1) 
F is the applied force pulling the ring; R is the radius of the metal ring and  is the 
correction factor that could be calculated using Zuidema and Waters‟s empirical equation 
(Zuidema and Waters, 1941): 
 
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F

     (4.2) 
Here, r is the radius of metal wire; C is the circumference of the metal ring which is equal 
to R2 ; 1 and 2 are the densities of lower and upper layers of liquid. The parameters 
of the above equation were obtained by fitting the formula to experimentally determined 
correction factors by Harkins and Jordan (Harkins and Jordan, 1930). 
 
Our experiments were carried out in a water-jacketed beaker where the temperature was 
controlled at 25.0±0.1
o
C. The parameters used were: circumference C=6.005cm; the ratio 
Rr =0.01859; 
3
1 997.0 cmg (water at 25
o
C) and 
3
2 748.0 cmg for dodecane 
or 0.001
3cmg  for air. 
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Figure 4.1, A schematic of the duNouy ring method. The ring is pulled up through the 
oil/water interface with a force F that is proportional to the interfacial tension. 
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When the drugs were present, an excess amount of drugs was added to water and 
hydrocarbon solvents (dodecane or octane) separately. Both systems were rotated for 3~5 
days at room temperature (24±1
o
C) to reach equilibrium. Aqueous solutions were filtered 
using 0.2m hydrophilic PTFE filter (Millipore Inc.) and the hydrocarbon solutions were 
filtered using 0.2m hydrophobic PTFE filter (Pall corp.). The filtrates were employed in 
water/air and hydrocarbon/air interfacial tension measurements respectively. The 
mixtures of the two filtered solutions (hydrocarbons at top layer and aqueous solutions at 
bottom layer) were used in hydrocarbon/water interfacial tension measurements.  
 
The surfactants were dissolved in aqueous phase to make solutions with known 
concentrations, e.g. 0.1, 1.0 and 10 mg/mL SDS solutions. Because of negligible 
solubility in hydrocarbons, the surfactants were not prepared in oil phase. The aqueous 
solutions containing surfactants were mixed with dodecane for dodecane/water interfacial 
tension determinations. When also present, an excess amount of the drug solid was placed 
into aqueous solutions with known concentration of surfactants. The aqueous solutions 
were rotated for 3~5 days to reach equilibrium before being filtered using 0.2m 
hydrophilic PTFE filter. The filtrate was mixed with drug-saturated dodecane prepared as 
shown above to measure the dodecane/water interfacial tensions. 
 
Since testosterone can form different crystal forms, an anhydrous form in oil and a 
hydrate in water, the saturated aqueous and dodecane solutions prepared separately could 
not keep the same activity of the drug in the two media. Therefore the oil/water 
interfacial tension measurement would have a starting point where the oil/water 
partitioning of the drug was far from equilibrium and the kinetics of partitioning could 
affect the interfacial tension determinations. To avoid the complexity, a direct partitioning 
method was used in sample preparations: the dodecane and aqueous solutions in the 
presence or absence of surfactants were pre-mixed and excess testosterone was placed 
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into the mixture. The system was rotated for 3~5 days at room temperature to reach 
equilibrium. The two liquid layers were filtered using 0.2m hydrophilic (for aqueous 
layer) and hydrophobic (for oil layer) PTFE filters separately and were mixed again for 
dodecane/water interfacial tension measurements. 
 
4.2.2.2.   Purification of Steroids and Surfactants:  
Solid state adsorption method reported by Rosen to purify SDS (Rosen, 1981) was 
employed. This method was also applied to the purification of DTAB and two model 
drugs (progesterone and testosterone).  
 
Purification of SDS and DTAB: About 1g SDS or DTAB was combined with 100mL 
deionized water and the solution was passed through a Sep-Pak® Plus C18 column 
(wetted with methanol and double distilled water before use). The first 15mL solution 
was discarded and the next 70 mL eluted solution was collected and freeze-dried using 
the following lyophilization cycle: 
1. Freeze to -40
o
C and maintain for 4h 
2. Apply vacuum (100mT) 
3. Increase temperature to -20
o
C and maintain for 2h 
4. Increase temperature to 0
o
C and maintain for 8h 
5. Increase temperature to 20
o
C and maintain for 10h 
After the purification, the surface tensions as a function of surfactant concentration were 
measured with the results shown in Figure 4.2 ad 4.3. For the purified surfactants, the 
figures clearly show the elimination of the local minimum near the CMC compared to the 
curves from unpurified surfactants. 
 
Surface tension versus surfactant concentration curve was also measured for dodecyl 
-D-maltoside with the results shown in Figure 4.4. The absence of local minimum in the 
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Figure 4.2, Surface tension vs. concentration of SDS in aqueous solutions before and 
after purification by solid adsorption method. Some error bars are smaller than the 
symbols. 
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Figure 4.3, Surface tension vs. concentration of DTAB in aqueous solutions before and 
after purification by solid adsorption method. 
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Figure 4.4. Surface tension vs. concentration of dodecyl -D-maltoside in aqueous 
solutions 
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curve indicates high purity of the materials received from the vendor. The purification 
step for DM was deemed unnecessary. 
 
Purification of progesterone and testosterone: The drugs were dissolved in hexane (20mL 
1.5mg/mL for progesterone and 200mL 0.125mg/mL for testosterone) and the solutions 
were passed through Sep-Pak® Plus C18 columns (wetted with methanol before use). 
The eluent solutions were dried under a stream of nitrogen gas. After the purification, the 
HPLC chromatograms (Figure 4.5 and 4.6) showed significant suppressions of two 
impurity peaks for progesterone and one impurity peak for testosterone. The putative 
impurities were found to exhibit be less than 0.1% of main peaks (based on AUC ratio).  
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Figure 4.5, HPLC chromatograms of progesterone before (upper curve) and after (lower 
curve) purification. The arrow shows the main progesterone elution band. 
 
 
Figure 4.6, HPLC chromatograms of testosterone before (upper curve) and after (lower 
curve) purification. The arrow shows the main testosterone elution band. 
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4.3.   RESULTS 
4.3.1.   Interfacial Studies in the Absence of Surfactants 
The surface tensions of the water/air, oil/air and oil/water interfaces were measured in the 
presence and absence of steroids. Saturated solutions of the drugs were employed for 
water and oil phases. The results are summarized in Table 4.1. At the air/water interface 
and at the air/oil interface, the presence of 17-estradiol showed no statistically 
significant effect on the surface tension. The presence of progesterone or testosterone 
showed only a weak effect on the surface tension at air/water interface and no effect at 
the air/oil interface. These results indicate that the model drugs are not significantly 
surface active at the water/air and oil/air interfaces. However, there was a dramatic 
change in the oil/water interfacial tension upon the addition of the drugs. In the absence 
of model drugs, the tension of the dodecane/water interface was 51.2 mN/m, a value 
close to that reported previously (Zeppieri et al., 2001; Gillap et al., 1968). In the 
presence of saturated solutions of progesterone (P), testosterone (T) or 17-estradiol (E) 
the oil/water interfacial tensions were reduced to 28.9, 33.5, and 44.6 mN/m, respectively. 
Clearly, the progesterone showed the greatest influence on the interfacial tension by 
almost a factor of 2 compared to that in the absence of the drug. Thus it seems that these 
steroids do possess an ability to accumulate at the oil/water interface. Shown in the last 
column of Table 4.1 are the effects of hydrocarbon chain length on the hydrocarbon/water 
interface properties. A similar trend was observed in octane/water interface system 
compared to dodecane/water interface. All model steroids show a strong surface activity 
at the octane/water interface. 
 
During the measurement of dodecane/water interfacial tension in the presence of the 
steroids, the direct partitioning was employed. The reason for this approach was that both 
testosterone and 17-estradiol form different crystalline forms in aqueous and dodecane 
environments (see Chapter 3, Section 3.3.1).  The direct partitioning method could 
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guarantee the same activity of the drugs in contacted phases. Despite the surface activity 
expressed by the steroids, no evidence of emulsification was observed. 
 
4.3.2.   Interfacial Studies in the Presence of Surfactants 
4.3.2.1   Sodium Dodecyl Sulfate (SDS) 
In Table 4.2, the interfacial tensions of the dodecane-water system in the presence of both 
SDS and steroids are listed. Addition of 0.1 mg/mL SDS to the control system (no drug) 
resulted in an interfacial tension of 40.1 mN/m. On the other hand, addition of 0.1 mg/mL 
SDS to the steroid-oil-water systems reduced the interfacial tensions to 24.2 (P), 30.4 (T) 
and 36.6 mN/m (E), respectively. The ability of the drugs to lower the interfacial tension, 
even in the presence of SDS, suggests that all three model drugs have some ability to 
compete with the surfactant for this interface. At the 1.0 mg/mL concentration of SDS, 
the interfacial tensions of the progesterone (12.9 mN/m) and testosterone (16.3 mN/m) 
systems were less than those of the SDS-oil-water system (19.4 mN/m) by about 6.5 and 
3.1 mN/m, respectively. The 17-estradiol exhibited no ability to make a statistically 
significant change in dodecane/water interfacial tension in the presence of 1mg/mL SDS. 
When the concentration of SDS was increased to 10 mg/mL, a value higher than the 
CMC of SDS (2.2mg/mL), the oil/water interfacial tension in the presence of 
17-estradiol was no different from control, indicating that the ability of the drug to 
effect interfacial tension was overwhelmed by higher surfactant concentration. On the 
other hand, saturated progesterone and testosterone were still able to compete with SDS 
for oil/water interface and further lower the interfacial tension from 7.86 (control, no 
drug) to 6.29 (P) and 7.68 mN/m (T). The surface tension of the air/water interface was 
only slightly decreased by progesterone or testosterone and unchanged by the presence of 
17-estradiol (shown in Table 4.1). The lack of effect at the air/water interface suggests  
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Table 4.1, Interfacial tensions in the absence and presence of model drugs 
 Interfacial tension (mN/m)
* 
Water/air Dodecane/air Dodecane/water Octane/water 
No drug 71.2±0.6 24.2±0.5 51.2±1.0 47.5 
Progesterone 65.2±1.8 23.8±1.1 28.9±0.8 23.7 
Testosterone 66.8±0.7 23.6±0.9 33.5±0.5 27.8 
-estradiol 69.9±1.3 24.8±0.2 44.6±0.4 42.7 
*
n=3, except for octane/water interface n=1. 
 
Table 4.2, Dodecane/water interfacial tensions in the absence and presence of saturated 
model steroids (progesterone, testosterone, 17-estradiol) and sodium dodecyl sulfate 
(SDS) solutions. Three concentrations of SDS were used: 0.1, 1.0 and 10.0mg/mL. 
Dodecane/water 
interfacial tension 
(mN/m)
* 
No surfactant 
0.1mg/mL 
SDS 
1.0mg/mL 
SDS 
10mg/mL 
SDS 
No drug 51.2±0.7 40.1±1.3 19.4±0.6 7.86±0.03 
Progesterone 28.9±0.8 24.2±0.2 12.9±0.3 6.29±0.03 
Testosterone 33.5±0.5 30.4±0.1 16.3±0.1 7.68±0.13 
-estradiol 44.6±0.4 36.6±2.0 18.8±0.6 7.84±0.19 
  
*
n=3. 
 77 
that the surface tension decrease observed at the oil/water interface is not due to highly 
surface-active impurities in the systems. 
 
4.3.2.2.   Dodecyltrimethylammonium Bromide (DTAB) 
In Table 4.3, the interfacial tensions of the dodecane-water system in the presence of both 
DTAB and steroids are listed. Addition of 0.1 mg/mL DTAB to the control system (no 
drug) resulted in an interfacial tension of 41.1 mN/m. On the other hand, addition of 0.1 
mg/mL DTAB to the steroid-oil-water system reduced the interfacial tensions to 21.1 (P), 
22.7 (T) and 32.2 mN/m (E), respectively. The ability of the drugs to lower the interfacial 
tension, even in the presence of DTAB, suggests that all three model drugs have some 
ability to compete with the surfactant for this interface. At the 1.0 mg/mL concentration 
of DTAB, the interfacial tensions of the progesterone (15.1 mN/m), testosterone (19.0 
mN/m) and 17-estradiol systems (20.9 mN/m) were less than those of the 
DTAB-oil-water system (25.8 mN/m) by about 10.7, 6.8 and 4.9 mN/m, respectively. 
When the concentration of DTAB was increased to 10 mg/mL, a value higher than the 
CMC of DTAB (4.9mg/mL), the ability of model drugs to compete for the interface was 
further weakened: the interfacial tensions of the steroid-DTAB-oil-water system dropped 
to 6.59 (P), 7.35 (T) and 7.43 mN/m (E) from 8.11 mN/m for control DTAB-oil-water 
system.  
 
4.3.2.3.   Dodecyl -D-Maltoside (DM) 
In Table 4.4, the interfacial tensions of the dodecane-water system in the presence of both 
DM and steroids are listed. Addition of 0.003mg/mL DM to the control system (no drug) 
resulted in an interfacial tension of 31.2 mN/m. On the other hand, addition of 
0.003mg/mL DM to the steroid-oil-water system reduced the interfacial tensions to 24.2 
(P), 26.9 (T), and 30.0 mN/m (E), respectively. The ability of the drugs to lower the 
interfacial tension, even in the presence of DM, suggests that all three model drugs have  
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Table 4.3, Dodecane/water interfacial tensions in the absence and presence of saturated 
model steroids (progesterone, testosterone, 17-estradiol) and dodecyl 
trimethylammonium bromide (DTAB) solutions. Three concentrations of DTAB were 
used: 0.1, 1.0 and 10.0mg/mL. 
Dodecane/water 
interfacial tension 
(mN/m)
*
 
No surfactant 
0.1mg/mL 
DTAB 
1.0mg/mL 
DTAB 
10mg/mL 
DTAB 
No drug 51.2±0.7 41.1±1.7 25.8±0.5 8.11±0.02 
Progesterone 28.9±0.8 21.1±0.5 15.1±0.4 6.59±0.17 
Testosterone 33.5±0.5 22.7±0.2 19.0±0.9 7.35±0.07 
-estradiol 44.6±0.4 32.2±1.7 20.9±0.9 7.43±0.03 
  
*
n=3 
 
Table 4.4, Dodecane/water interfacial tensions in the absence and presence of saturated 
model steroids (progesterone, testosterone, 17-estradiol) and dodecyl -D-maltoside 
(DM) solutions. Three concentrations of DM were used: 0.003, 0.03 and 0.3mg/mL. 
Dodecane/water 
interfacial tension 
(mN/m)
* 
No surfactant 
0.003mg/mL 
DM 
0.03mg/mL 
DM 
0.3mg/mL   
DM 
No drug 51.2±0.7 31.2±0.4 12.7±0.2 4.92±0.06 
Progesterone 28.9±0.8 24.2±0.6 11.3±0.3 4.22±0.16 
Testosterone 33.5±0.5 26.9±1.0 11.8±0.4 4.59±0.11 
-estradiol 44.6±0.4 30.0±0.4 12.7±0.2 4.89±0.06 
  
*
n=3 
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some ability to compete with the surfactant for this interface. At the 0.03mg/mL 
concentration of DM, the interfacial tensions of the progesterone (11.3 mN/m) and 
testosterone (11.8 mN/m) systems were less than those of the SDS-oil-water system (12.7 
mN/m) by about 1.4 and 0.9 mN/m. The 17-estradiol system exhibited no statistically 
significant change in dodecane/water interfacial tension in the presence of either 
0.03mg/mL or 0.3 mg/mL DM, indicating that the ability of the drugs to compete for the 
interface was overwhelmed by higher surfactant concentration. On the other hand, 
saturated progesterone and testosterone were still able to compete with DM for oil/water 
interface and further lower the interfacial tension from 4.92 (control, no drug) to 4.22 (P) 
and 4.59 mN/m (T).  
 
4.3.3.   Thermodynamic Model of Dodecane/water Interfacial Tension in the 
Presence of Drug and Surfactant 
The above experimental results clearly show competition between surfactants and model 
drugs in a concentration-dependent manner at the oil/water interface. As of yet, the 
molecular basis for this proposed competition is not known. In this section, we will 
subject interfacial tension data to a thermodynamic analysis to probe the energetics of the 
putative competition. We will focus attention on the free energy of transfer to the 
interface of the surfactants and of the model solutes and will attempt to predict interfacial 
tension of mixtures based on the Gtrans of the component members.  
 
4.3.3.1.   Introduction-Models for Surface Adsorption 
There are two main theoretical approaches to build the equilibrium relationship between 
adsorption and surface tension (Lucassen-Reynders, 1981). The two-dimensional gas 
model was first introduced by Langmuir (Langmuir, 1917) while a two-dimensional 
solution model was proposed by Butler (Butler, 1932). Both of the models employ a 
monolayer assumption for treatment of the interface. The 2-D gas model considers only 
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the surfactant at the interface, while the 2-D solution model explicitly includes the 
surfactants and the solvents at the interface. The 2-D gas approach works best for 
insoluble surfactants while the 2-D solution approach has advantages for soluble 
surface-active compounds (Lucassen-Reynders, 1981). In our studied systems, clearly the 
2-D solution approach would be more appropriate because the surfactants employed are 
quite soluble in the aqueous phase.  
 
Shown in Appendix 1 is the derivation, proposed by Butler, for relating bulk 
concentration, interfacial tension and surface transfer free energy. 
 
4.3.3.2.   Application of Butler Model to Single Solute Systems 
The goal of this section is to employ interfacial tension data to calculate both the free 
energy of transfer to interface from the bulk and the partial molar interfacial area 
occupied by solute (surfactant or drug).  
 
To determine the transfer free energies to interface for ionic surfactants (SDS and DTAB), 
the experimental dodecane-water interfacial tensions at three surfactant concentrations in 
Tables 4.2 and 4.3 were fitted to Eq. (A1.7). Several parameters required by the model 
could be obtained from the literature. The value employed for the occupied interfacial 
area of water was 7.62Å²/molecule taken from Gumkowski (Gumkowski, 1986) which 
was based on average hard sphere diameter of water ranging from 2.50~2.93 Å (Pierotti, 
1965). The area occupied per molecule by SDS and DTAB, two extensively studied 
surfactant systems, at oil/water interface were determined by fitting the experimental -A 
curves (Haydon and Taylor, 1960) using the -A relationship, Eq. (A1.13), derived from 
2-D solution model.  
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water aA
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a
RT 2
1ln          (A1.13) 
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where  is the surface pressure; A is the interfacial area per surfactant; awater is surface 
area occupied by water. Figures 4.7 and 4.8 show the experimental -A curves for three 
sodium alkyl sulfates and three alkyl trimethylammonium bromides in decane/water or 
petroleum ether/water interfacial systems from literatures (Haydon and Taylor, 1960). 
The SDS and DTAB data were collected employing petroleum ether whereas other 
systems, sodium octylsulfate (SOS), sodium decylsulfate (SDeS), 
octyltrimethylammonium bromide (OTAB) and decyltrimethylammonium bromide 
(DeTAB), were collected employing decane. Surprisingly the -A curves for three alkyl 
sulfate surfactants in two different oil/water interfaces were essentially indistinguishable 
indicating that the occupied areas of the surfactants were not sensitive to the chain length 
of the hydrophobic tail and the type of oil phase. For this reason, we extrapolated the 
results to SDS in dodecane/water interface. In Figure 4.7, the fitted -A curve using Eq. 
(A1.13) is also shown. Clearly the fitting was very good and the fitted occupied area by 
each SDS molecule was 32.0±0.6 Å². Similarly, in Figure 4.8, the -A curves for three 
alkyl trimethylammonium bromide surfactants in two different oil/water interfaces were 
overlapped with each other. The fitted -A curve applying Eq. (A1.13) is in good 
agreements with experiments. The estimated occupied area by DTAB at oil/water 
interface was 37.1±0.6 Å²/molecule.  
 
The activity coefficient lsurfactf  for ionized surfactants (SDS and DTAB) in Eq. (A1.7) 
could be calculated in terms of the ionic strength, I, using Debye-Huckel equation: 
1
509.0
log


I
I
f lsurfact           (4.3) 
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Figure 4.7, The experimental oil/water interfacial pressure in the presence of sodium 
alkyl sulfate surfactants as a function of area per surfactant molecule by Haydon and 
Taylor (Haydon and Taylor, 1960). The solid curve is fitted according to Eq. (A1.13). 
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Figure 4.8, The experimental oil/water interfacial pressure in the presence of alkyl 
trimethylammonium bromide surfactants as a function of area per surfactant molecule by 
Haydon and Taylor (Haydon and Taylor, 1960). The solid curve is fitted according to Eq. 
(A1.13). 
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At concentrations greater than CMC, the CMC was employed in the simulations because 
the concentration of surfactant monomers was critical in determining the surface 
properties. In addition, it is know that inclusion of hydrophobic solutes, such as dodecane, 
can significantly lower the CMC. To account for this effect, the CMCs of SDS and DTAB 
micelles in the presence of saturated dodecane (6.9mM for SDS, Bonfillon et al., 1994 
and 12.5mM for DTAB, Medrzycka and Zwierzykowski, 2000) were employed in the 
calculations. 
 
The fitted Gtrans values using Eq. (A1.7) and the parameters mentioned above were 
-23.5±0.8 for SDS and -22.8±1.2 kJ/mol for DTAB. These surfactants have the same free 
energy of transfer to the oil/water interface. 
 
For nonionic surfactant DM and neutral drugs, Eq. (A1.8) was employed to fit the 
experimental dodecane/water interfacial tension versus surfactant/drug concentration 
curves.  The experimental and fitted dodecane/water ~ C (concentration of either drug or 
surfactant) curves for DM, progesterone and testosterone are shown in Figures 4.9~4.11. 
The fitted parameters are listed in Table 4.5. Apparently the fitted curves coincide with 
the experimental data very well. Statistical analysis was applied using Scientist® 
software to provide the 95% confidence intervals for the fitted two parameters that are 
also shown in Table 4.5. When applied to 17-estradiol in dodecane/water interface 
system the fitting to the model was poor.  The lack of fit is likely the result of poor 
reproducibility in measuring interfacial tensions especially when the drug concentrations 
were very low (<1g/mL) (the results will be shown in Section 5.3.1, Figure 5.6). 
Therefore, in our simulation, the 17-estradiol results were not considered. 
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Table 4.5, Critical parameters used in simulations. The parameters are the results of 
fitting interfacial tension data to the Butler model. 
 
 a (Å
2
) Gtrans(kJ/mol) 
SDS 32.0±0.6
a 
-23.45±0.84
b 
DTAB 37.1±0.6
a 
-22.83±1.22
b 
DM 41.41±2.75
c 
-42.07±0.58
c 
Progesterone 61.3±4.8
c 
-42.12±0.48
c 
Testosterone 59.6±5.1
c 
-36.17±0.37
c 
a
Values from fitting Eq. (A1.13) 
b
Values from fitting Eq. (A1.7) 
c
Values from fitting Eq. (A1.8) 
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Figure 4.9, Dodecane/water interfacial tension as a function of dodecyl -D-maltoside 
concentration in water. The solid line is the fitted theoretical curve.  
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Figure 4.10, Dodecane/water interfacial tension as a function of progesterone 
concentration in water. The solid line is the fitted theoretical curve. 
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Figure 4.11, Dodecane/water interfacial tension as a function of testosterone 
concentration in water. The solid line is the fitted theoretical curve. 
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4.3.3.3.   Application of Butler Model to Two Solute (Surfactant and Drug) 
Systems 
The goal of the section is to predict surface tension by employing Gtrans and area 
occupied by each solute at the interface in the 2D solution model in the presence of drug 
and surfactant. These predicted values are then compared to experimental values (Tables 
4.2~4.4). 
 
For systems containing ionic surfactants SDS and DTAB and neutral molecules (steroids), 
Eq. (A1.9) was applied. For systems containing nonionic surfactant DM and steroids, Eq. 
(A1.10) was applied. Once the surface pressure, , at any given drug and surfactant 
concentrations was solved, the surface tension could be simply calculated using 
  0 . As mentioned in the previous section, the CMC of surfactant was employed 
in the simulations when the concentration of surfactant was higher than its CMC. The 
CMCs of SDS and DTAB in the presence of dodecane were taken from the literature 
(Bonfillon et al., 1994; Medrzycka and Zwierzykowski, 2000) with values shown in 
section 4.3.3.2. The CMC of DM in the presence of dodecane was determined by the 
point of intersection between the two segments of ~C curve (Fig. 4.9) above and below 
CMC. The determined CMC using this method was 0.14mM. The computation was 
divided into two groups. In the first group only three components, water, dodecane and 
either surfactant or drug were considered. The experimental data were used in fitting the 
parameters, Gtrans,drug/surfact and adrug/surfact, much like a training set. Eq. (A1.7) and (A1.8) 
were fitted with appropriate data to determine free energy of transfer and area occupied 
per molecule for the surfactant or the drug at the doecane/water interface. 
 
The second group of calculations considered all four components, water, dodecane, 
surfactant and drug. Eq. (A1.9) and (A1.10) were employed to predict the surface 
tensions for mixtures of surfactant and drug. The comparisons between calculated and 
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experimental surface tensions are shown in Figure 4.10 for part I and in Figure 4.11 for 
part II. 
 
It is not surprising that the prediction of surface tension in the first is very close to 
experimental results (see Figure 4.12). For the second group of calculations, where the 
surfactant and drug are both present, the overall predictions are overall good but with a 
few points that exhibited somewhat greater deviations (see Figure 4.13). To better 
illustrate the results, the quantitative data and their corresponding conditions are listed in 
Table 4.6. From the table, the calculated values for SDS and DM systems are quite close 
to measured surface tensions. Significant deviations of the model from experimental 
results are observed for DTAB at low concentration. The greatest differences between 
experiments and predictions are 10.2 mN/m for saturated testosterone in 0.1mg/mL 
DTAB. The other three data points that had large deviations are progesterone in 
0.1mg/mL DTAB (5.7 mN/m), progesterone (6.1 mN/m) and testosterone (5.1 mN/m) in 
1.0mg/mL DTAB. One possible reason for the deviations is the assumption used in the 
surface adsorption model, that there is no specific interactions between the drug and 
surfactant and the two solutes are ideally competing with each other for the oil/water 
interface.  In following chapters it will be shown that the assumption of no interaction 
between drug and surfactant may not hold. 
 
4.4.   DISCUSSION 
The experiments clearly showed, in all three surfactant systems differing in electronic 
charge, model steroids can successfully compete for the oil/water interface.  
 
In our studies, the ability of model drugs from saturated solution to compete with 
surfactants has the rank order: progesterone > testosterone > 17-estradiol. Therefore the 
progesterone has the greatest surface activity and 17-estradiol has the least surface  
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Figure 4.12, Comparison between experimental and theoretical fitted dodecane/water 
interfacial tensions in the presence of pure surfactants (SDS, DTAB or DM) or pure 
steroids (progesterone or testosterone). 
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Table 4.6, Comparison between experimental and predicted dodecane/water interfacial 
tensions in the presence of both surfactants and drugs. The predicted values were 
obtained using the Eq. (A1.9) and (A1.10). Experimental data are from Table 4.2 to 4.4. 
 
Interfacial tension 
(mN/m) 
Progesterone Testosterone 
Experimental Predicted Experimental Predicted 
0.1mg/mL 
SDS-dodecane 
24.2±0.2 26.5 30.4±0.1 32.4 
1.0mg/mL 
SDS-dodecane 
12.9±0.3 16.8 16.3±0.1 18.5 
10mg/mL 
SDS-dodecane 
6.29±0.03 7.13 7.68±0.13 7.51 
0.1mg/mL 
DTAB-dodecane 
21.1±0.5 26.8 22.7±0.2 32.9 
1.0mg/mL 
DTAB-dodecane 
15.1±0.4 21.2 19.0±0.9 24.1 
10.0mg/mL 
DTAB-dodecane 
6.59±0.17 6.61 7.35±0.07 6.93 
0.003mg/mL 
DM-dodecane 
24.2±0.6 24.3 26.9±1.0 27.8 
0.03mg/mL 
DM-dodecane 
11.3±0.3 11.9 11.8±0.4 12.3 
0.3mg/mL 
DM-dodecane 
4.22±0.16 4.75 4.59±0.11 4.87 
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Figure 4.13, Comparison between experimental and predicted dodecane/water interfacial 
tensions in the presence of both surfactants (SDS, DTAB or DM) and model steroids 
(progesterone or testosterone). 
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activity at oil/water interface. This rank order correlates well with the solubilization 
capacity of the model drugs in all three micelle systems. In those micelle systems, 
progesterone always has the greatest solubilization power and 17-estradiol has the least 
solubilization capacity. The correlation is consistent with the conclusion of Chapter 3 that 
the micellar solubilization is mainly localized to the micelle surface.  
 
When the three different surfactants are compared, the surface tensions at dodecane/water 
interface at concentrations near their CMCs are 7.86 (SDS), 8.11 (DTAB) and 4.92 (DM) 
mN/m. Therefore the surface activities of surfactants at their CMC have the following 
ranking order: DM > SDS  DTAB. This order has an inverse correlation with the 
solublization capacity of the micelle. DM micelle system always has the lowest 
solubilization power in the three micelle systems. For progesterone and testosterone, the 
solubilization power has the order SDS > DTAB > DM. For 17-estradiol, the ranking 
order of solubilization capacity becomes DTAB > SDS > DM. The correlation also 
supports the hypothesis that these drugs are mainly solubilized in the hydrocarbon/water 
interface of the micelle. 
 
The above correlations between solubilization in micelles and surface activity are only 
qualitative.  There is significant difference between flat oil/water interface we studied in 
this chapter and highly curved micelle surface. The high surface curvature could change 
the surface packing density of both surfactants and drugs.  The Laplace pressure, which 
likely offers molecule a greater energy barrier for entry onto the micelle surface  as 
compared to a flat interface, may be the physical basis of the effect of curvature. In the 
next chapter we will consider the curvature effect and apply the surfactant-drug 
co-adsorption model to predict the micelle/water partitioning properties. 
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It is likely that results obtained on flat oil/water interface will more closely correlate to 
real lipid assembly systems when the particle size of oil or water droplets is large. If so, 
the present work could be applicable to other lipid-based drug delivery system, such as 
emulsions and liposomes. The modification of oil/water interface properties can influence 
the emulsification efficiency or particle size of oil droplets in emulsions. In turn, it will 
affect the performance of lipid-based drug delivery systems (Malcolmson and Lawrence, 
1993; Craig et al., 1993). The studies on the behavior of drugs and surfactants on flat 
surface are important to provide intrinsic interface properties of drugs and surfactants and 
their interactions as a means of understanding lipid-based drug delivery systems. The 
larger the surface/volume ratio, the greater influences the drug-surfactant competition 
will make on solubilization.  
 
Besides the experimental studies of competition of drug-surfactant for the model 
oil/water interface, a thermodynamic model (2-D solution model) was applied to simulate 
the interface adsorption phenomena. The parameters used were obtained by fitting to 
dodecane/water interface properties in the presence of only one type of molecules, either 
the surfactants or the model drugs. When the surfactants and drugs were mixed together, 
the interfacial tension was calculated under an assumption that there is no specific 
interaction between drug and surfactant molecules. In another word, the drug and 
surfactant are ideally competing with each other at the oil/water interface without any 
synergistic or antagonistic effect. Overall the predictions were good with a few 
exceptions when the steroids were mixed with low concentration of DTAB. This 
suggested the simulation method and the assumption used are valid in most cases. For 
DTAB-drug mixtures, the measured surface tensions were lower than predicted values 
which indicated the steroids may have attractive interactions with DTAB molecules that 
make synergistic effect in lowering the surface tensions.   
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From the negative sign of the transfer free energies of surfactants and model steroids, the 
oil/water interface is always more energetically favorable than the bulk aqueous phase. 
The transfer free energy from water to interface and the partitioning coefficient between 
interface and water have the following relationship under dilute solution condition. 
 RTGK interfacewaterwaterinterface/  exp         (4.4) 
The lower the G value the more surface active the molecule (with constant low 
concentration). From Table 4.5, progesterone and dodecyl -D-maltoside have the largest 
surface activity, testosterone is the next, while SDS and DTAB have the lowest surface 
activity. The results are quite surprising because they show some hydrophobic molecules 
are very surface active at oil/water interface and are even more surface active than 
conventional surfactants. The total surface activity of the model drugs is probably limited 
by low aqueous solubility while the surfactants have much higher solubility and 
monomer concentrations.  
 
The study of 17-estradiol at dodecane/water interface was plagued by large variations in 
the surface tension results. The problem may be due to the slow adsorption to the 
oil/water interface when the drug concentrations in both oil and aqueous phases are quite 
low (<1g/mL). This slow adsorption kinetics may interfere with the effect of even small 
amount of impurities that could gradually lower the interfacial tension over long period 
of time up to hours (Mysels, 1986).  
 
The success of employing a thermodynamic model in simulating the competing 
adsorption at oil/water interface will encourage us to apply the model to micelle surface 
where the curvature effect is considered using Laplace pressure concept. 
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4.5.   CONCLUSION 
Hydrocarbon/water interfacial tension can be significantly decreased in the presence of 
hydrophobic drugs, while the model steroids exhibit little or no surface activity in 
hydrocarbon/air or water/air interface. The hydrophobic drugs can compete with 
surfactant molecules for the oil/water interface. The ability of saturated drugs to compete 
for oil/water interface depends on the concentrations of the surfactant. The competition 
phenomena can be quantitatively simulated using a thermodynamic model. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Shaoxin Feng 2009 
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Chapter 5 
Surface-localized Thermodynamic Model Used to Predict the Micelle/water 
Partitioning Coefficient 
 
5.1.   INTRODUCTION 
The capacity of micelle systems to solubilize poorly water-soluble drugs is one of the 
most important parameters when considering these lipid assemblies as drug delivery 
vehicles. The ability to quantitatively predict the micelle/water partitioning coefficients 
based on physicochemical properties of drug and surfactant would guide formulators to 
choose effective solubilizer and speed up the formulation process.  
 
Currently, the majority of the predictions of micelle/water partitioning coefficients are 
based on empirical linear free energy relationship (LFER). The most frequently used 
method is the linear relationship between logarithm of micelle/water partitioning 
constants and the logPoctanol/water values for a specific micelle system  (Valsaraj and 
Thibodeaux, 1990; Treiner and Mannebach, 1987; Alvarez-Munez and Yalkowsky, 2000; 
Wiedmann and Kamel, 2002).  While LFERs are successful in correlating solubility 
with molecular descriptors, the method is strongly dependent on the members of the 
“training set”. Both Valsaraj et al. (Valsaraj and Thibodeaux, 1990) and Treiner et al. 
(Treiner and Mannebach, 1987) have published successful correlation for solubilization 
of solutes in SDS micelles based on training sets of molecules of simple structure. If the 
Km/w data in Table 3.2~3.4 for steroids, benzodiazepines and parabens are plotted on 
those very same graphs, (Fig. 5.1), the correlation is much less successful, most likely 
because the structures of the drugs are significantly different than those of solutes of the 
training sets. 
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Figure 5.1. Correlation between logarithm of micelle/water partitioning coefficient for 
SDS, Km/w, and logPoctanol/water. The solid line is from Treiner and Mannebach (Treiner and 
Mannebach, 1987) and the dotted line is from Valsaraj and Thibodeaux (Valsaraj and 
Thibodeaux, 1990). The plotted points are experimental data taken from the present work 
in Tables 3.2~3.4. 
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Mukerjee et al. (Mukerjee and Cardinal, 1978; Mukerjee, 1979) first applied a two-state 
thermodynamic model to simulate the micelle/water partitioning by considering both 
surface and core regions as solubilization loci. The results showed the micelle surface 
played an important role in solubilization and the agreement between predictions and 
theory are quite good in the model anionic micelle systems. The limitations of the work 
include the simple molecular structures of model compounds, such as alkanols, ketones, 
amides and aromatics, as well as surfactant selection (only anionic). In this Chapter, we 
will use a surface-localized thermodynamic model adapted from Mukerjee‟s two-state 
model to predict the micelle/water partitioning coefficients of three series of model drugs 
in three micelle systems with different charges. Then we will extend the model beyond 
the dilute condition to simulate the micellar solubilization at high drug concentration, a 
condition of critical importance in pharmaceutical formulation work.  
 
5.2.   MATERIALS AND METHODS 
5.2.1.   Materials 
Progesterone (>99%), testosterone (>98%), 17 -estradiol (>98%), diazepam, temazepam, 
oxazepam, prazepam, methylparaben (>99%), ethylparaben (>99%), butylparaben 
(>99%), sodium dodecyl sulfate (>99%), dodecyltrimethylammonium bromide (>99%), 
dodecyle -D-maltoside (>98%) and dodecane (>99%) were obtained from 
Sigma-Aldrich (St. Louis, MO). 11-hydroxyprogesterone (>95%) was from Janssen 
Chimica (New Brunswick, NJ).  
 
5.2.2.   Purification of Dodecane: 
In order to remove surface active impurities dodecane was purified using a 
double-washing method. The dodecane was washed using methanol: about 40mL 
dodecane was mixed with 40mL methanol in separating funnel. The system was shaken 
for 1 minute and permitted to rest for 5 minutes. The liquid separated to form two layers. 
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The bottom layer containing methanol was removed. The top dodecane-rich layer was 
further washed 4 times with fresh methanol. The second washing step was carried out 
with deionized water. The washing was designed to remove impurities in dodecane that 
were soluble in methanol and the second step could remove methanol any water-soluble 
impurities. 
 
The dodecane/water interfacial tension was measured for unpurified and purified solvent 
as a function of time. The results are shown in Figure 5.2. Generally, with unpurified 
dodecane, the oil/water interfacial tension tended to decrease markedly as a function of 
time (Mysels, 1986). For purified dodecane, the drop of dodecane/water interfacial 
tension over 40 hours was only about 0.5 mN/m. 
 
5.2.3.   Surface-localized Thermodynamic Model 
A detailed derivation of the surface-localized thermodynamic model is included in 
Appendix 2. 
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Figure 5.2, Dodecane/water interfacial tension as a function of time before and after 
purification of dodecane. 
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5.3.   RESULTS AND DISCUSSION 
5.3.1.   Drug Solute-Specific Parameters of Solubilization in Micelles 
The molar volumes of the model drugs are required in evaluating the effect of Laplace 
pressure, e.g. Eq.(A2.4). The volumes were estimated based on the occupied volumes of 
the molecules in crystalline phases from the crystal structures found in Cambridge 
Structure Database (Allen, 2002). The volume of each model drugs is listed in Table 5.1. 
Based on the model there are two other key parameters related to the drug substances 
solubilized in micelles: the first is the transfer free energy from aqueous solution to 
hydrocarbon/water interface, interfacewaterG ; and the second is the area occupied by drug 
molecule at the oil/water interface, adrug. To determine these key parameters 
independently the dodecane/water interfacial tensions were measured as a function of 
drug concentration.  The ratio of drug concentrations between hydrocarbon and water 
phases were set to be equal to hydrocarbon/water partitioning coefficient determined in 
Chapter 3. From these data, adrug and interfacewaterG  could be determined by fitting the 
results to Eq. (A1.8) using Scientist® software. 
 
The measured dodecane/water interfacial tensions as a function of drug concentration in 
aqueous phase are shown in Figures 5.3 (for steroids), 5.4 (for benzodiazepines), 5.5 (for 
parabens) and 5.6 (17-estradiol and oxazepam). In those figures, the fitted curves based 
on surface adsorption model, Eq. (A1.8), are also shown as solid lines. The results in 
Figure 5.7 demonstrate the relationship between the ~C curve and the fitted parameters, 
interfacewaterG  and adrug. The initial slope of interfacial tension as a function of drug 
concentration (Fig. 5.7a) is related to the transfer free energy term (Eq. (A2.6)): 





 
 
RT
G
a
RT
slope
water
interfacewaterexp .  
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Table 5.1, Volumes of each molecules of model drugs based on reported crystal 
structures.  
 
Drug V(Å³) 
Progesterone 441.3 
Testosterone 406.9 
11-hydroxyprogesterone 450.7 
Diazepam 344.3 
Temazepam 356.7 
Prazepam 417.7 
Methylparaben 182.7 
Ethylparaben 213.8 
Butylparaben 259.2 
17-estradiol  370.2 
Oxazepam  330.5 
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Figure 5.3, Dodecane/water interfacial tensions as a function of drug concentration in 
aqueous phase for 3 model steroids. The markers are experimental data and the solid lines 
are fitted curves based on surface adsorption model, Eq.(A1.8). 
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Figure 5.4, Dodecane/water interfacial tensions as a function of drug concentration in 
aqueous phase for 3 model benzodiazepines. The markers are experimental data and the 
solid lines are fitted curves based on surface adsorption model, Eq.(A1.8). 
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Figure 5.5, Dodecane/water interfacial tensions as a function of drug concentration in 
aqueous phase for 3 model parabens. The markers are experimental data and the solid 
lines are fitted curves based on surface adsorption model, Eq.(A1.8). 
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Figure 5.6, Dodecane/water interfacial tensions as a function of drug concentration in 
aqueous phase for 17-estradiol and oxazepam. The markers are experimental data and 
the solid lines are fitted curves based on surface adsorption model, Eq.(A1.8). 
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Figure 5.7, A schematic of relationship between the two key parameters of drug 
substances, interfacewaterG , rugda  and the oil/water interfacial tension versus drug 
concentration (a) or logarithm of drug concentration (b). 
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In the ~logC plot (Fig. 5.7b), the linear limit is approached at high concentration. The 
slope of the line is related to the area occupied by the drug at the interface: 
druga
RT
slope  . The linear region will intersect the x-axis at a surface tension equal to 0. 
The intercept of the x-axis is equal to 




 
RT
G interfacewaterexp . It should be kept in mind that 
the concentration of the drug must be mole fraction which is unitless. From the 
relationship, the transfer free energy value depends on the position of the ~logC curve: a 
shift to the right of the curve corresponds to a larger transfer free energy.  
 
The fitting results in Fig 5.3~5.6 are very satisfactory for all cases except for 
17-estradiol and oxazepam. For these latter two drugs the measured interfacial tensions 
exhibited poor reproducibility which we believe contributed to the unsatisfactory nature 
of the fit. The fitted parameters are shown in Table 5.2. Scientist® software package was 
employed to carry out the statistical analysis and provide the 95% confidence intervals 
for those parameters. Not surprisingly, in all cases, the transfer free energies were 
negative. From the results in the table, progesterone has the largest negative transfer free 
energy from water to dodecane/water interface which indicates that the drug is 
energetically favored to reside at the interface. To further illustrate the comparison, the 
~C curves for 9 drugs are shown in Figure 5.8. In the figure, the curves have the rank 
order, from left to right, progesterone, prazepam, 11-hydroxyprogesterone, testosterone, 
diazepam, temazepam  butylparaben, ethylparaben and methylparaben. This rank order 
is the same as that of transfer free energies from low to high, as indicated in Fig. 5.7. 
Based on physical picture, the higher the surface activity, the lower transfer free energy 
and the smaller the concentration necessary to lower the dodecane/water interfacial 
tensions by the same amount.  
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Table 5.2, Fitted transfer free energy Gwater→interface and occupied area at oil/water 
interface for all model drugs.  Listed are average values +/- 95% confidence intervals. 
 
Drug Gwater→interface(kJ/mol) a(Å²) 
Progesterone -41.78±0.45 58.0±4.4 
Testosterone -36.18±0.34 59.8±4.9 
11-hydroxyprogesterone -37.05±0.17 64.8±1.9 
Diazepam -34.41±0.32 46.2±3.7 
Temazepam -31.94±0.33 41.3±3.7 
Prazepam -39.38±0.40 54.0±5.7 
Methylparaben -21.27±0.33 31.9±4.0 
Ethylparaben -24.21±0.43 31.8±4.6 
Butylparaben -31.41±0.16 34.1±1.2 
17-estradiol  -36.31±2.91 57.4±105.3 
Oxazepam  -31.34±0.74 42.1±17.5 
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Figure 5.8, Summary of dodecane/water interfacial tensions as a function of drug 
concentration in aqueous phase for 9 model drugs. All curves are experimental data in the 
absence of fitted theoretical lines. 
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If we compare the surface activities of the members of the same series of the model drugs 
(structures are shown in Chapter 3), the effect of some functional groups could be 
hypothesized. The addition of hydroxyl group to a molecule can significantly decrease its 
oil/water interfacial activities: For example, the transfer free energy of 
11-hydroxyprogesterone is less negative than that of progesterone and the interfacial 
activity of temazepam is much lower than that of diazepam. When testosterone is 
compared to progesterone the hydroxyl group appears to lower the interfacial activity to a 
greater extent than the acetyl group. The addition of hydrocarbon moiety to the molecule 
appears to increase the interfacial activity: For example, by adding a cyclopropyl group to 
diazepam, prazepam exhibits greater interfacial activity. Similarly, by lengthening the 
alkyl group, the surface activity of parabens exhibits the rank order methylparaben < 
ethylparaben < butylparaben.  
 
The negative sign of the transfer free energies listed in Table 5.2 suggests the 
dodecane/water interface is more energetically favorable than bulk aqueous phase for all 
the model drugs. The transfer free energy from hydrocarbon to oil/water interface can 
also be estimated from the following equation: 
      whater KRTGG /interfacewinterfacen  hy drocarbo ln       (5.1) 
The values of interfacen   hy drocarbo G  are shown in Table 5.3. When the structure ~ 
interfacen   hy drocarbo G  relationships are examined, it appears that the hydroxyl group has 
significant influence on decreasing the transfer free energy from oil to interface. On the 
other hand, the addition of hydrocarbon group surprisingly makes very small changes to 
the oil to interface transfer free energy. For example, interfacen   hy drocarbo G  of 
11-hydroxyprogesterone and temazepam are significantly lower than those of 
progesterone and diazepam, respectively. The interfacen   hy drocarbo G  values are relatively 
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Table 5.3, Estimated transfer free energy from hydrocarbon to oil/water interface, 
Ghydrocarbon→interface, for model drugs 
 
Drug Gdodecane→interface(kJ/mol) 
Progesterone -21.36±0.46 
Testosterone -26.43±0.37 
11-hydroxyprogesterone -33.86±0.32 
Diazepam -20.22±0.35 
Temazepam -25.21±0.34 
Prazepam -19.59±0.43 
Methylparaben -23.79±0.35 
Ethylparaben -23.48±0.46 
Butylparaben -23.07±0.19 
17-estradiol  -30.46±2.91 
Oxazepam  -39.62±1.06 
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constant when comparing diazepam with prazepam, or among the methyl-, ethyl- and 
butylparabens. Unsurprisingly, these results suggest the hydrocarbon regions of the model 
drugs likely remain in the hydrocarbon phase when the molecules are located at the 
hydrocarbon/water interface.  
 
5.3.2.   Surfactant-Specific Parameters Used in the Thermodynamic Model 
In this section, we discuss the rational behind the choice of surfactant-specific parameters 
employed in Equations (A2.13) and (A2.14). The parameters used for surfactants and 
micelles included minimum occupied area by surfactant molecules (a), radius (r) and 
aggregation number (Naggre) of the micelles, area per surfactant molecule (A) and surface 
pressure () at micelle surface, and Laplace pressure acting on the micelles (P). The first 
three parameters (a, r, and Naggre) are summarized in Table 5.4.  Parameters, A,  and P, 
can be calculated from a, r, and Naggre. 
 
The areas occupied by SDS or DTAB at the hydrocarbon/water interface were reported in 
Chapter 4 to be 32.0 (for SDS) and 37.1Å² (for DTAB) by fitting Eq. (A1.13) to 
experimental -A curves from literatures (Haydon and Taylor, 1960). The occupied area 
by DM at dodecane/water interface was determined by fitting Eq. (A1.8) to experimental 
~C curve, Fig. 4.9, with the fitted value of 41.4 Å².  
 
The aggregation number of SDS micelles was 51 from Thevenot et al. (Thevenot et al., 
2005) employing time-dependent static light scattering method. For cationic surfactant 
DTAB, the aggregation number was 56 from Rafati et al. (Rafati et al., 2003) using 
potentiometric technique. The aggregation number of nonionic surfactant DM was 113 by 
Bucci et al. (Bucci et al., 1991) using small angle neutron scattering method. 
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Table 5.4, The parameters of surfactants and the corresponding micelles used in the 
surface-localized model. The data with asterisk are independent and obtained from 
literatures (detail information is in main text). The other data are derivative from those 
independent parameters. 
 
 SDS DTAB DM 
asurfact (Å²) 32.0±0.6 37.1±0.6 41.4±2.7 
r (Å) 19.7* 18.4* 22.4* 
Naggr 51* 56* 113* 
A=4r2/Naggr (Å²) 95.6 76 55.8 
 (mN/m) 11.6 17.9 22.9 
P=2(0-)/r (atm) 405 366 257 
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The radii of the micelles were estimated as being equal to the length of single surfactant 
molecule. The radii of SDS, DTAB and DM micelles were 19.7, 18.4 and 22.4Å 
respectively. The molecular structures of SDS and DTAB were obtained from the 
corresponding crystal structure from Cambridge Structure Database (Allen, 2002). 
Unfortunately, there is no reported crystal structure for dodecyl -D-maltoside, but the 
molecular structure of methyl -maltoside was available and served as an analogue of 
head group of DM. The maximum inter-atomic distance of dodecyl sulfate molecule was 
18.4Å between one oxygen atom in sulfate group and one hydrogen atom in terminal 
methyl group. By considering the atomic radii of those atoms, the total length of the 
molecule was about 19.7Å. Using the same principle, the length of DTAB molecule was 
close to 18.4Å based on the maximum inter-atomic distance of 17.9Å between two 
hydrogen atoms in methyl group of head group and in terminal methyl group of 
hydrocarbon tail. For dodecyl -D-maltoside, the length of hydrocarbon chain was 14.6Å 
and the maximum inter-atomic distance of maltoside head group was 11.3Å. The head 
group and the alkyl tail were connected with each other through a carbon-oxygen bond 
that could rotate easily and the angle between the long axes of the head group and 
hydrocarbon chain varied from 95
o
 to 147
o
. The average angle was 119
o
 and the average 
value of the maximum inter-atomic distances of the DM molecule for different 
configurations was 22.4Å. The distance was chosen as the radius of DM micelles without 
considering the atomic radii because the DM micelles had a large hydrophilic head group 
that let us choose a slightly smaller length compared to the total length of the molecule 
without lose of accuracy.  
 
The areas occupied per surfactant molecule at the micelle surface were calculated based 
on geometry, A=4r2/Naggre. The surface pressure, =0-, at the micelle surface was 
determined by the -A relationship, Eq.(A1.13) for anionic surfactants (SDS or DTAB) or 
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Eq.(A1.15) for nonionic surfactants (DM). The parameters used in these equations were 
determined in Section 4.3.3.2. 
 
The Laplace pressure was calculated using equation: P=2/r=2(0-)/r based on 
assumption that the micelle has spherical shape.  
 
5.3.3.   Application of Surface-localized Model to Predict the Micelle/water 
Partitioning 
The micelle/water partitioning coefficients of dilute solutes can be predicted based on the 
surface-localized model described in Appendix 2. The model describes micellar 
solubilization as the co-localization of drug and surfactant at highly curved interface. The 
calculated micelle/water partitioning coefficients of 9 model drugs in 3 micelle systems 
are compared to experimental data (Chapter 3) with the results shown in Figure 5.9. 
Oxazepam and 17-estradiol were not included because there were poor estimations of 
their interfacial activities at hydrocarbon-water interface. When butylparaben was 
solubilized in DTAB and DM solutions, the solutions became cloudy, suggesting that the 
Krafft point had been exceeded. Therefore there is no experimental micelle/water 
partitioning coefficient for butylparaben in the two surfactant systems. It is clear that the 
predictions for the remaining 25 surfactant/drug combinations are in good agreement 
with the experimental result. It should be noted a broad range of the micelle/water 
partitioning constants that cover three orders of magnitude are included. There is no 
result that has a deviation greater than a factor of 2, and a majority of the data points (19 
out of 25) have deviations within a factor of 1.5. The R-square is equal to 0.959.  
 
Although the surface-localized model has a complicated final expression, e.g. Eq. (A2.13) 
or (A2.14), the calculated micelle/water partitioning coefficient can be analyzed by 
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Figure 5.9, Comparison between experimental and predicted micelle/water partitioning 
coefficients (Km/w) of 9 model drugs in 3 surfactant systems. 
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separating the expression into several components in terms of the basic relationship 
Eq.(A2.4): 
]exp[]exp[ // RTPVKRTPVfA
X
K wh
w
wm 

     (5.2) 
The values for terms, ]exp[  ,  ,  , RTPVfA
X w


 and ]exp[/ RTPVK wh  (also 
labeled as Km/w,core), are explicitly listed in Table 5.5 along with the predicted and 
experimental Km/w values. P=2/r.  Firstly, the contributions of the core region to the 
solubilization, ]exp[/ RTPVK wh  , are compared to the total micelle/water partitioning 
constants. The fraction of solubilization by micellar core (as determined by dividing 
]exp[/ RTPVK wh   by Km/w(calc.)) has a range from 6.9x10
-7
 
(11-hydroxyprogesterone in SDS micelles) to 2.6x10-3 (prazepam in DM micelles). The 
results clearly show that core-localized solubilization is insufficient to explain 
experimental results and that the micelle surface is likely the dominant solubilization site. 
 
The contributions of Laplace pressure on solubilization capacity, ]exp[ RTPV , vary 
from 0.011 (11-hydroxyprogesterone in SDS) to 0.32 (methylparaben in DM). 
Apparently the term exerts a significant influence on the total partitioning properties and 
can not be ignored. The Laplace pressure in the three micelle systems has the rank order: 
SDS > DTAB > DM, and correlates well with the differences in surface pressure at the 
micelle surface and the size of micelles. DM micelle has the greatest diameter and the 
largest surface pressure resulting in the lowest interfacial tension at micelle surface. 
Those two factors result in DM exhibiting the lowest Laplace pressure. For drug 
substances, the larger the molar volume, the more significant influence the Laplace 
pressure makes on solubilization capacity. Accordingly, 11-hydroxyprogesterone was 
most affected and methylparaben was least influenced by Laplace pressure.  
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Table 5.5, The predicted micelle/water partitioning coefficients, Km/w(calc.), their components, exp(-PV/RT), /Xw, A, f, Km/w, core 
(=Kh/wexp(-PV/RT)), and experimental micelle/water partitioning coefficients, Km/w(exp.), for 9 model drugs solubilized in 3 micelle 
systems. 
 
  exp(-PV/RT) /Xw (Å
-1
) A (Å) f Km/w, core  Km/w(calc.) Km/w(exp.) 
Progesterone SDS 0.01225 2.79E+06 95.6 0.1609 46.50 5.25E+05 (3.69±0.13)E+05 
Testosterone SDS 0.01726 2.90E+05 95.6 0.1529 0.88 7.33E+04 (1.14±0.05)E+05 
11OH-prog* SDS 0.01115 4.13E+05 95.6 0.1328 0.04 5.84E+04 (6.75±0.39)E+04 
Diazepam SDS 0.03224 1.42E+05 95.6 0.2245 9.92 9.84E+04 (8.93±0.39)E+04 
Prazepam SDS 0.0155 1.06E+06 95.6 0.1801 45.53 2.82E+05 (4.03±0.26)E+05 
Temazepam SDS 0.02849 5.24E+04 95.6 0.2575 0.43 3.68E+04 (4.70±0.11)E+04 
Methylparaben SDS 0.16159 7.05E+02 95.6 0.3357 0.06 3.66E+03 3.24E+03 
Ethylparaben SDS 0.11849 2.31E+03 95.6 0.3366 0.16 8.82E+03 8.51E+03 
Butylparaben SDS 0.07533 4.23E+04 95.6 0.3155 2.19 9.62E+04 7.24E+04 
Progesterone DTAB 0.01863 2.79E+06 76 0.0574 70.73 2.27E+05 (1.79±0.13)E+05 
Testosterone DTAB 0.02541 2.90E+05 76 0.0531 1.30 2.98E+04 (5.40±0.31)E+04 
11OH-prog* DTAB 0.01711 4.13E+05 76 0.0428 0.06 2.29E+04 (3.57±0.19)E+04 
Diazepam DTAB 0.04472 1.42E+05 76 0.096 13.76 4.64E+04 (2.94±0.10)E+04 
Prazepam DTAB 0.02305 1.06E+06 76 0.0683 67.72 1.27E+05 (8.76±0.57)E+04 
Temazepam DTAB 0.03999 5.24E+04 76 0.1185 0.61 1.89E+04 (1.67±0.04)E+04 
Methylparaben DTAB 0.19224 7.05E+02 76 0.1783 0.07 1.84E+03 (1.73±0.04)E+03 
Ethylparaben DTAB 0.14519 2.31E+03 76 0.1791 0.19 4.57E+03 (4.28±0.15)E+03 
*Abbreviation of 11-hydroxyprogesterone 
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Table 5.5 (cont.), The predicted micelle/water partitioning coefficients, Km/w(calc.), their components, exp(-PV/RT), /Xw, A, f, Km/w, 
core (=Kh/wexp(-PV/RT)), and experimental micelle/water partitioning coefficients, Km/w(exp.), for 9 model drugs solubilized in 3 
micelle systems. 
  exp(-PV/RT) /Xw (Å
-1
) A (Å) f Km/w, core  Km/w Km/w(exp.) 
Progesterone DM 0.06167 2.79E+06 55.8 0.0156 234.2 1.50E+05 (9.49±1.18)E+04 
Testosterone DM 0.07663 2.90E+05 55.8 0.0141 3.92 1.75E+04 (3.09±0.48)E+04 
11OH-prog* DM 0.05812 4.13E+05 55.8 0.0107 0.21 1.43E+04 (1.32±0.09)E+04 
Diazepam DM 0.1138 1.42E+05 55.8 0.0301 35.02 2.72E+04 (2.10±0.07)E+04 
Prazepam DM 0.07158 1.06E+06 55.8 0.0195 210.3 8.24E+04 (6.51±0.33)E+04 
Temazepam DM 0.10524 5.24E+04 55.8 0.0395 1.59 1.21E+04 (9.63±0.35)E+03 
Methylparaben DM 0.31556 7.05E+02 55.8 0.0667 0.11 8.28E+02 (1.16±0.10)E+03 
Ethylparaben DM 0.25931 2.31E+03 55.8 0.067 0.35 2.24E+03 (2.85±0.05)E+03 
*Abbreviation of 11-hydroxyprogesterone 
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The area per molecule term “A” can be best envisioned as the inverse of the density of 
surfactant molecules at the micelle surface. A larger value for “A” corresponds to a lower 
density of surfactants at the micellar surface. Since the drug is hypothesized to co-adsorb 
with surfactant for the oil/water interface, the lower surfactant density of surfactant will 
permit drug molecules to more easily adsorb to the micelle surface and thus increase the 
micelle/water partitioning coefficient.  
 
The term, /Xw, represents the surface activities of the solutes at an oil/water interface in 
the absence of surfactants. This term reflects the transfer free energy of the solute from 
water to hydrocarbon/water interface (Eq.(A2.7)). A broad range for the model drugs 
from 7x10
2
 (methylparaben) to 3x10
6
 Å
-1
 (progesterone) is evident.  
 
The relative adsorption potential, f, is defined as a ratio between surface density of drugs 
in the presence and absence of surfactant. The factor reflects the ability of the drug to 
co-adsorb with surfactants at the oil/water interface. Since the ability of the drug to get 
into oil/water interface in the absence of surfactants has been included in the /Xw term, 
the f factor takes into account the effect of the presence of the surfactants. The magnitude 
of the f factor is between 0.011 (11-hydroxyprogesterone in DM) and 0.34 (methyl- and 
ethylparabens in SDS). From Eq. (A2.11) and (A2.12), the f factor is affected mainly by 
two parameters: surface pressure of the surfactant at micelle surface and minimum 
occupied area by the drug.  High surface pressure, due to the stronger surface activity of 
the surfactant, will make adsorption of drug molecules onto the oil/water interface more 
difficult. When we compare the three surfactants, the f factor has the order of SDS > 
DTAB > DM because of the surface pressure has the reverse ranking order.  
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The second component of the adsorption potential is the occupied surface area by the 
drug molecule. When the drug must clear a larger area in order to move onto the oil/water 
interface, it has a weaker ability to compete with surface active agents for the interface. 
The rank order of relative adsorption factors in the same micelle system is reversely 
correlated to the occupied areas by the drug molecules: methylparaben ≈ ethylparaben > 
butylparaben > temazepam > diazepam > prazepam > progesterone > testosterone > 
11-hydroxyprogesterone. 
 
To assess the relative importance of those terms, the units must be identical. The /Xw 
term is combined with “A” term to form a unitless term /Xw to compare to the other 
two unitless terms, ]exp[ RTPV  and f. The /Xw term ranges from 3.9x10
4
 to 
2.7x10
8
 and thus makes the greatest contribution to total micelle/water partitioning 
coefficients. The Laplace pressure effect and the relative adsorption factor are within two 
orders of magnitude and make significant, but not the dominant, contributions to the 
micellar solubilization. 
 
5.3.4.   Sensitivity of Parameter Selections to the Prediction of Micelle/water 
Partition Coefficient 
As is evident in Table 5.4, there are a number of physical parameters that are critical to 
the application of the thermodynamic model outlined in Equation (A2.13) and (A2.14). 
Most notable of these critical parameters are size of the micelle, as defined by radius, 
aggregation number, and the interfacial areas occupied by water and drugs. In this section, 
the sensitivity of the thermodynamic model to the values selected for these critical 
parameters is evaluated. The strategy is to vary each parameter individually over a range 
of physically-relevant values and to observe the extent to which Km/w is influenced by the 
variation. It is important here to realize that the values of the parameters are not being 
“floated” to fit an optimal result, but rather are being systemically-varied to illustrate the 
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ultimate effect on Km/w by a range of possible values. The following table lists the 
“independent” parameters to be tested, parameters depending on the choice of those 
independents, and the corresponding section number. 
 
Independent 
parameter to be tested 
Parameters dependent on choice of 
independents 
Section 
number 
r (radius of micelle) A (micelle surface area per surfactant) 
 (surface pressure) 
P (Laplace pressure) 
5.3.4.1 
Naggre (aggregation 
number of micelle) 
r (radius of micelle) 
A (micelle surface area per surfactant) 
 (surface pressure) 
P (Laplace pressure) 
5.3.4.2 
awater (interfacial area 
occupied by water) 
asurfact (interfacial area occupied by 
surfactant) 
adrug (area occupied by drug) 
Gtrans (free energy of transfer for drug 
from water to oil/water interface) 
5.3.4.3 
adrug (interfacial area 
occupied by drug) 
Gtrans (free energy of transfer for drug 
from water to oil/water interface) 
5.3.4.4 
 
5.3.4.1.   Sensitivity of Predicted Km/w Values to the Radii of Micelles  
In evaluating the surface-localized model (see results in Table 5.4), radii of the micelles 
were based on the dividing oil/water interface at the micelle surface and were calculated 
from the lengths of those surfactant molecules including head groups (see Section 5.3.2). 
Although experimentally-determined micellar radii are available in the literature, these 
values were not employed in the model simulations. The experimental values are 
obtained by different detecting techniques, such as dynamic light scattering, small-angle 
X-ray diffraction, small-angel neutron scattering, gel filtration and diffusivity 
measurements (Anacker and Ghose, 1968; Svens and Rosenholm, 1973; Lin et al., 1990; 
Soderman et al., 2004). Typically, the results exhibit a broad range of values. More 
importantly, the experimental radii tend to include effects of bound water and electrolytes 
 122 
and are not defined solely at the dividing oil/water interface, as is defined in the 
thermodynamic model. 
 
The sensitivity of the thermodynamic model to the radii of micelles was tested by varying 
the parameter „r‟ without changing any other independent parameters. Some dependent 
parameter would surely be modified due to the changing micellar size, such as Laplace 
pressure, area per surfactant molecule at micelle surface and the surface pressure. The 
radii of SDS micelles were varied from 17 to 20.7Å. A small radius would correspond to 
more efficient packing of surfactant molecules in the micelles and a large radius would 
indicate looser structures of the micelles. Three model drugs, progesterone, diazepam and 
methylparaben, were chosen to run the sensitivity test with the results shown in Figure 
5.10. Here, the ratios of Km/w at the test radius to the Km/w at the radius of 19.7Å (Table 
5.4) were calculated. Clearly the Km/w value increases with larger micellar size because 
the looser micellar structure is expected to provide larger interfacial volume with which 
to solubilize drugs. The micelle/water partitioning constants are quite sensitive to the 
choice of the micellar radius. The calculated Km/w increases 28~50% with each 1Å 
increment of micellar radius. Solubilization of progesterone is most sensitive to the radii 
and methylparaben is the least sensitive among the three model drugs. Progesterone 
occupies the largest area at the micelle surface and has the largest molecular volume 
among the model drugs and it seems likely that progesterone is more sensitive to the 
available space in the micelle surface as compared to the other two drugs. 
 
Figures 5.11 and 5.12 show the sensitivities of predicted Km/w in DTAB and DM micelles 
to the radii of those micelles. The size ranges for DTAB and DM are 17~20Å and 
20.7~24Å respectively. Again, the micelle/water partitioning coefficient is sensitive to the 
choice of the micellar radius. For DTAB micelles, one angstrom increment could produce  
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Figure 5.10, The sensitivity of calculated micelle/water partitioning coefficient in SDS 
micelle systems to the radius of SDS micelles. The arrow marks the radius employed in 
the evaluation of the thermodynamic model, Table 5.4. 
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Figure 5.11, The sensitivity of calculated micelle/water partitioning coefficient in DTAB 
micelle systems to the radius of DTAB micelles. The arrow marks the radius employed in 
the evaluation of the thermodynamic model, Table 5.4. 
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Figure 5.12, The sensitivity of calculated micelle/water partitioning coefficient in DM 
micelle systems to the radius of DM micelles. The arrow marks the radius employed in 
the evaluation of the thermodynamic model, Table 5.4. 
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40~56% enhancement in Km/w value. For nonionic DM micelles, increasing 1Å of „r‟ 
would raise Km/w by 67~88%.  
 
When we compare the three micelle systems, the solubilization by DM micelle is the 
most sensitive to the micellar size and SDS micelle system is the least sensitive. One 
possible reason is the different packing efficiency of those micelles: The packing of 
nonionic surfactant is more compact than ionic surfactants due to the absence of 
repulsion forces due to the uncharged headgroup. When the two charged micelles are 
compared to each other, the positive charge of DTAB between head groups is screened to 
some extent by the methyl groups in the head, while the negative charges of SDS are on 
the surface of the head group and the repulsive interactions between head groups would 
be stronger. Therefore the DTAB micelles are more efficiently packed than SDS micelles. 
The more tightly packed micelles would be more sensitive to the space available for 
solubilization of model drugs. 
 
It is clear from the sensitivity analysis that the predicted Km/w is strongly dependent on 
the value of the „r‟ term and that the dividing oil/water interface of the micelles has to be 
selected carefully. 
 
5.3.4.2.   Sensitivity of Predicted Km/w Values to Aggregation Number of Micelles 
Many experimental studies on micelles have shown an increase in the aggregation 
number with increasing surfactant concentrations (Rafati et al., 2003; Bucci et al., 1991). 
There is experimental evidence for a relation between aggregation number and 
concentration of surfactant in our studied systems. For examples, SDS micelles have a 
aggregation number of 76 at 50mM and the number increases to 88 at 150mM (Bucci et 
al., 1991); the aggregation number of DTAB micelles is 56 at 15mM and rises to 62 at 
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92mM (Rafati et al., 2003); DM micelles have values of N=113 at 50mM and N=129 at 
150mM (Bucci et al., 1991). 
 
To test the sensitivity of Km/w on the aggregation number „N‟, an appropriate relationship 
between the radius of micelles and the „N‟ must be written. There are two approaches to 
deal with the effect of increasing surfactant concentration. One approach is to assume that 
micelles grow larger, while maintaining a spherical shape, as the total surfactant 
concentration in the system is increased. This approach assumes that the density of 
surfactant molecules in a micelle remains constant with increasing micelle size. The 
second approach assumes that the micelles take on the shape of a prolate ellipsoid. In this 
case, curvature restricts the size of the micelle. With a restriction on the size of the 
micelle, increasing the aggregation number of micelles must result in greater density of 
surfactant molecules in a micelle. 
 
Based on the growing-sphere approach, the r~N relationship can be simply expressed as: 
  3100 NNrr               (5.3) 
For an ellipsoidal shaped micelle, the additional surfactant molecules have more efficient 
packing as compared to spherical shaped micelle. One surfactant molecule in spherical 
micelles mainly occupies a cone shape with the volume equal to Sr
3
1
, where the S is the 
occupied surface area by each molecule and r is the length of the molecule. On the other 
hand, an additional surfactant molecule in an ellipsoid shaped micelle occupies a 
pie-shaped wedge with the volume equal to Sr
2
1
. Since the core region is limited by the 
packing of the hydrocarbon chain and had a constant density, the cone shape is not able to 
pack as efficiently on the surface compared with the pie-shape. The additional molecules 
were assumed to have a density of 1.5 times of the original density. The length of the 
three principle axes of the prolate ellipsoid is  
 127 
 
0
0
00
0
32
rcb
N
NNN
ra



           (5.4) 
The total surface area of a prolate ellipsoid is 
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The average curvature could use the following approximation: 
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The approximation had an error of <1.7% when the axial ratio of the ellipsoid was below 
2. The curvature was employed in estimating the Laplace pressure in prolate 
ellipsoid-shaped micelle.  
 
Listed in Table 5.6 are the predicted micelle/water partitioning constants as a function of 
aggregation number for SDS and DTAB and Table 5.7 for DM. Aggregation numbers 75 
and 100 were tested for ionic surfactants and N=120 and 130 were used for DM micelles. 
For purpose of comparison, the values of the Km/w calculated with the parameters listed in 
Table 5.4 are included. In the case of SDS micelles, the calculated Km/w of three steroids 
and three benzodiazepines increase significantly with large aggregation number under 
spherical shape condition. On the other hand, only a small variation in partition 
coefficients is observed with increasing aggregation number when the micelle assumes a 
prolate shape. The biggest deviations are 45% for spherical-shape micelles and 14% for 
prolate-shape micelles. When parabens are solubilized in SDS micelles, spherical shape 
micelles would produce smaller changes of Km/w with large aggregation number 
compared to those from ellipsoidal shape micelles. The deviations based on sphere shape 
are <12% compared to <30% based on prolate shape.  
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Table 5.6, Sensitivity of micelle/water partitioning coefficients in SDS and DTAB micelle 
systems to the aggregation number of the micelles  
  
Km/w 
Original 
Km/w spherical Km/w ellipsoidal 
Naggre=75 Naggre=100 Naggre=75 Naggre=100 
Progesterone SDS 5.25E+05 6.88E+05 7.62E+05 5.25E+05 5.12E+05 
Testosterone SDS 7.33E+04 8.97E+04 9.46E+04 6.81E+04 6.30E+04 
11OH-prog* SDS 5.84E+04 7.49E+04 8.11E+04 5.60E+04 5.27E+04 
Diazepam SDS 9.84E+04 1.17E+05 1.23E+05 9.27E+04 8.74E+04 
Prazepam SDS 2.82E+05 3.63E+05 3.99E+05 2.81E+05 2.74E+05 
Temazepam SDS 3.68E+04 4.58E+04 5.00E+04 3.69E+04 3.65E+04 
Methylparaben SDS 3.66E+03 3.57E+03 3.33E+03 2.97E+03 2.56E+03 
Ethylparaben SDS 8.82E+03 9.07E+03 8.79E+03 7.56E+03 6.75E+03 
Butylparaben SDS 9.62E+04 1.06E+05 1.07E+05 8.72E+04 8.09E+04 
Progesterone DTAB 2.27E+05 2.54E+05 2.46E+05 1.99E+05 1.61E+05 
Testosterone DTAB 2.98E+04 3.11E+04 2.80E+04 2.39E+04 1.75E+04 
11OH-prog* DTAB 2.29E+04 2.47E+04 2.27E+04 1.88E+04 1.39E+04 
Diazepam DTAB 4.64E+04 4.88E+04 4.57E+04 3.95E+04 3.16E+04 
Prazepam DTAB 1.27E+05 1.41E+05 1.37E+05 1.12E+05 9.19E+04 
Temazepam DTAB 1.89E+04 2.11E+04 2.11E+04 1.76E+04 1.55E+04 
Methylparaben DTAB 1.84E+03 1.67E+03 1.40E+03 1.38E+03 1.00E+03 
Ethylparaben DTAB 4.57E+03 4.36E+03 3.84E+03 3.65E+03 2.82E+03 
*Abbreviation of 11-hydroxyprogesterone 
 
Table 5.7, The sensitivity of micelle/water partitioning coefficients in DM micelle 
systems to the aggregation number of the micelles 
  
Km/w 
Original 
Km/w spherical Km/w ellipsoidal 
Naggre=120 Naggre=130 Naggre=120 Naggre=130 
Progesterone DM 1.50E+05 1.39E+05 1.24E+05 1.26E+05 9.68E+04 
Testosterone DM 1.75E+04 1.59E+04 1.37E+04 1.42E+04 1.04E+04 
11OH-prog* DM 1.43E+04 1.30E+04 1.12E+04 1.16E+04 8.36E+03 
Diazepam DM 2.72E+04 2.54E+04 2.27E+04 2.32E+04 1.82E+04 
Prazepam DM 8.24E+04 7.71E+04 6.92E+04 7.02E+04 5.49E+04 
Temazepam DM 1.21E+04 1.16E+04 1.07E+04 1.08E+04 8.99E+03 
Methylparaben DM 8.28E+02 7.57E+02 6.61E+02 6.97E+02 5.40E+02 
Ethylparaben DM 2.24E+03 2.08E+03 1.85E+03 1.93E+03 1.54E+03 
*Abbreviation of 11-hydroxyprogesterone 
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In DTAB micelle systems, for all model drugs, the effect of increasing aggregation 
number on predicted Km/w values is less under spherical-shape micelle condition 
compared to those from the ellipsoid shape. With spherical micelle shape, the deviations 
of Km/w are within 10% for steroids and benzodiazepines and are 24% and 16% for two 
parabens when aggregation number changed from 56 to 100. When the micelles are 
assumed to be in the prolate shape, the greatest deviations of Km/w are 41% for steroids 
and benzodiazepines and 46% for parabens. 
 
In DM micelle systems, the predicted Km/w decrease with increasing aggregation number 
no matter what the shape of the micelles. The spherical-shape micelles do exhibit smaller 
changes of Km/w compared to ellipsoidal micellar shape. The greatest deviations from 
original values are 22% for spherical shape and 42% for prolate shape.  
 
As has been seen in Figures 3.14~3.22, the experimental partition coefficients are 
insensitive to surfactant concentration and therefore the aggregation number. Under these 
conditions, it is likely the DTAB and DM micelles will maintain a sphere shape while 
SDS micelles will transform to prolate shape with increasing aggregation number. As an 
example, almost doubling the size of the micelles of SDS and DTAB only produces 
<30% change in Km/w values. For DM micelles, the sensitivity of Km/w to Naggre is a 
slightly larger: a 15% increase in aggregation number resulted in 22% decrease in 
micelle/water partition constants. For nonionic surfactant, the increasing of aggregation 
number with increasing surfactant concentration is less than that observed in ionic 
surfactant systems. Therefore, the sensitivity of Km/w to the surfactant concentration is 
small. 
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5.3.4.3.   Sensitivity of Predicted Km/w Values to Occupied Interfacial Areas by 
Water Molecules 
In the thermodynamic model being tested, the occupied areas by water molecules, awater, 
and by surfactant molecules, asurfact, are correlated. This can be seen by examining 
Figures 4.7 and 4.8 where Eq. (A1.13) was used to fit the two parameters to the 
experimental -A curves of SDS and DTAB. When two parameters are directly correlated 
to each other, testing one parameter is sufficient in evaluating model sensitivity. Here we 
have chosen to test the effect of the occupied area by water molecules. As with other 
studies, the choice of the parameter must be physically realistic and not be freely 
adjustable. The size of the water molecule was well known. The commonly employed 
value is about 10Å² (Lucassen-Reynders, 1981). Gumkowski‟s value, awater=7.62Å², 
(Gumkowski, 1986) had been used in our early studies. In this section, an area of 10Å² is 
employed to test the sensitivity of the predicted Km/w to the area occupied by water.  Due 
to the correlation between awater and asurfact, Eq. (A1.13) was fit to experimental -A 
curves for SDS and DTAB shown in Figures 4.7 and 4.8 using awater=10Å². The fitted 
values of asurfact were 33.8±0.6Å² for SDS and 38.9±0.6Å² for DTAB. For nonionic 
surfactant DM, Eq. (A1.8) was employed to fit to experimental -C curve for DM, Fig. 
4.9, using the test awater value and the fitted asurfact became 42.3±2.1Å². Compared to 
original values in Table 5.4, the changes were less than 2Å² indicating the parameter 
asurfact is not very sensitive to the occupied interfacial area of water molecules.  
 
The areas occupied by surfactants are not the only parameters that correlate with the area 
of water. The transfer free energy and interfacial area occupied by model drugs also 
correlate with awater. As mentioned in Section 5.3.1, these two parameters were 
determined by fitting to the experimental ~C curves, Fig.5.3~5.6, using Eq.(A1.8) where 
parameter awater was present. Table 5.8 shows the fitted transfer free energies and 
occupied interfacial areas of 9 model drugs using awater=10Å². Compared to parameter set 
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with awater=7.62Å², Table 5.2, the Gtrans drops by ~0.67kJ/mol while adrug increases by 
about 1.1Å². Applying the new parameter set corresponding to relatively large area of 
water molecules (10Å²), the predicted micelle/water partitioning coefficients for 9 model 
drugs in 3 surfactant systems are listed in Table 5.9. In the table, the calculated Km/w 
values using the initial parameter set with awater=7.62Å² are also listed for comparison. 
The last column of the table shows the ratios between the predictions using two different 
parameters sets. Clearly the ratios are very close to 1. The greatest deviation of these 
ratios from a value of 1 is only 1.1% indicating the model predictions of Km/w are not 
very sensitive to the choice of occupied interfacial areas by water molecules or surfactant 
molecules. 
 
5.3.4.4.   Sensitivity of Predicted Km/w Values to Interfacial Areas Occupied by 
Solubilized Drugs 
Once the awater term is fixed, the occupied interfacial area of drugs, adrug, and the transfer 
free energy of the model drugs, Gwater→interface, become a directly correlated parameter 
pair. In this section, only adrug will be adjusted to test the sensitivity of Km/w predictions. 
Just like the water molecules, molecular structures of drug substances limit their range of 
possible occupied areas at oil/water interface. In the following chapter, a molecular 
simulation technique will be used to calculate the theoretical maximum and minimum 
areas occupied by the drug molecules assuming the molecule could assume any 
orientation. The results are listed in Table 6.2. In the model sensitivity test, four areas 
were chosen for each model drug: the theoretical maximum area, the theoretical 
minimum area, an area 10% larger than experimental fitted value, and an area 10% 
smaller than experimental area. Using these areas, the transfer free energies, 
 Gwater→interface, were fitted using Eq.(A1.8). A Scientist® software was employed to run 
the statistical analysis. 
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Table 5.8, Fitted transfer free energies Gwater→interface and occupied areas at oil/water 
interface for the model drugs using awater=10Å² 
 
Drug Gwater→interface(kJ/mol) adrug(Å²) 
Progesterone -42.45±0.45 59.1±4.4 
Testosterone -36.85±0.34 60.9±4.9 
11-hydroxyprogesterone -37.72±0.17 65.9±1.9 
Diazepam -35.08±0.32 47.2±3.7 
Temazepam -32.61±0.33 42.4±3.7 
Prazepam -40.05±0.40 55.1±5.7 
Methylparaben -21.94±0.33 33.0±4.0 
Ethylparaben -24.88±0.43 32.9±4.6 
Butylparaben -32.08±0.16 35.1±1.2 
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Table 5.9, Calculated micelle/water partitioning coefficients using new parameter set 
(Table 5.8) corresponding to awater=10Å² compared to predictions using old parameters 
with awater=7.62Å². 
 
  
Km/w 
a=7.62Å² 
Km/w 
a=10Å² Ratio* 
Progesterone SDS 5.25E+05 5.29E+05 1.007  
Testosterone SDS 7.33E+04 7.39E+04 1.008  
11OH-prog^ SDS 5.84E+04 5.89E+04 1.008  
Diazepam SDS 9.84E+04 9.92E+04 1.008  
Prazepam SDS 2.82E+05 2.84E+05 1.007  
Temazepam SDS 3.68E+04 3.70E+04 1.006  
Methylparaben SDS 3.66E+03 3.68E+03 1.007  
Ethylparaben SDS 8.82E+03 8.87E+03 1.006  
Butylparaben SDS 9.62E+04 9.70E+04 1.009  
Progesterone DTAB 2.27E+05 2.28E+05 1.004  
Testosterone DTAB 2.99E+04 3.00E+04 1.005  
11OH-prog^ DTAB 2.30E+04 2.31E+04 1.005  
Diazepam DTAB 4.65E+04 4.68E+04 1.007  
Prazepam DTAB 1.27E+05 1.27E+05 1.004  
Temazepam DTAB 1.89E+04 1.90E+04 1.004  
Methylparaben DTAB 1.84E+03 1.85E+03 1.005  
Ethylparaben DTAB 4.58E+03 4.60E+03 1.004  
Progesterone DM 1.50E+05 1.51E+05 1.009  
Testosterone DM 1.75E+04 1.77E+04 1.010  
11OH-prog^ DM 1.43E+04 1.44E+04 1.010  
Diazepam DM 2.72E+04 2.75E+04 1.011  
Prazepam DM 8.24E+04 8.30E+04 1.008  
Temazepam DM 1.21E+04 1.22E+04 1.006  
Methylparaben DM 8.28E+02 8.34E+02 1.008  
Ethylparaben DM 2.24E+03 2.26E+03 1.007  
*
 Equal to Km.w at 10Å² divided by Km/w at 7.62Å² 
^ Abbreviation of 11-hydroxyprogesterone 
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The chosen occupied areas by drugs and the corresponding transfer free energies are 
shown in Table 5.10. The 95% confidence intervals of Gwater→interface are also listed. It is 
not surprising that the error of Gwater→interface  becomes larger when the chosen area 
deviates from the fitted areas. For example, the errors of the transfer free energies are 
about 0.20kJ/mol for progesterone areas within ±10% of fitted areas. The error increases 
to 1.02kJ/mol when the maximum area of progesterone molecules is chosen. Open cells 
Table 5.10 represent those physically-impossible conditions were the test areas are less 
than the theoretical lower limits. 
 
The micelle/water partition coefficients were calculated using the parameters in Table 
5.10 with the results shown in Table 5.11. When the areas of the drugs are within 10% of 
the fitted optimal areas, the calculated micelle/water partition coefficients exhibit small 
deviations, between -17% and 19%, from the original values. When the minimum areas 
of the drugs are employed, the calculated Km/w values have greater deviations, between 
-22% and 74%, from the original results. If the maximum areas of model drugs are 
chosen, the predicted Km/w values have the greatest deviations, between -70% and 106%, 
from the original values. Because the maximum areas of all model drugs are further away 
from the fitted values than are the minimum areas, it is not surprising that the Km/w 
predictions using maximum areas of the drugs result in greater deviations from the values 
based on fitted occupied areas of the drugs compared to the predictions using minimum 
areas. To demonstrate the effect of adrug term on the calculated Km/w, Figure 5.13a shows 
the distributions of the ratios Km/w/Km/w(adrug,exp) for four groups of interfacial areas 
occupied by drug substances. Clearly, employing maximum occupied areas of model 
drugs results in a broad distribution of results. In log units, the deviations range from -0.5 
log unit (factor of 3) to 0.3 log unit (factor of 2). The average of the ratios also shifts to 
-0.15 log unit corresponding to 30% decrease of the micelle/water partition coefficient. 
Both groups with ±10% from the experimental areas have very tight distribution and the  
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Table 5.10, The dependence of free energy of transfer for model drugs from water to 
oil/water interface on varying interfacial area occupied by the drugs at oil/water interface. 
In order to test the sensitivity of calculated Km/w on adrug, four interfacial areas were 
chosen: maximum area, minimum area and ±10% deviations from the experimental area.  
 
Drug Parameters amax aexp. 
+10% 
aexp. 
-10% 
amin 
Progesterone a(Å²) 104.4 63.8 52.2 39.6 
Gwater→interface 
(kJ/mol) 
-45.87 
±1.02 
-42.33 
±0.20 
-41.22 
±0.19 
-39.89 
±0.38 
Testosterone a(Å²) 95.8 65.8 53.8 39.5 
Gwater→interface 
(kJ/mol) 
-38.16 
±0.50 
-36.55 
±0.17 
-35.79 
±0.15 
-34.75 
±0.28 
11-hydroxy 
progesterone 
a(Å²) 104.8 71.3 58.3 40.2 
Gwater→interface 
(kJ/mol) 
-39.95 
±1.06 
-37.57 
±0.18 
-36.52 
±0.18 
-34.86 
±0.59 
Diazepam a(Å²) 86.2 50.8 - 42.7 
Gwater→interface 
(kJ/mol) 
-37.22 
±1.17 
-34.78 
±0.18 
- -34.13 
±0.15 
Temazepam a(Å²) 84.9 45.5 - - 
Gwater→interface 
(kJ/mol) 
-34.94 
±1.22 
-32.28 
±0.17 
- - 
Prazepam a(Å²) 86.4 59.4 - 50.9 
Gwater→interface 
(kJ/mol) 
-41.36 
±0.75 
-39.73 
±0.18 
- -39.17 
±0.14 
Methylparaben a(Å²) 62.0 35.1 28.7 24.5 
Gwater→interface 
(kJ/mol) 
-23.28 
±0.98 
-21.51 
±0.15 
-21.02 
±0.14 
-20.67 
±0.24 
Ethylparaben a(Å²) 70.6 35.0 28.6 25.6 
Gwater→interface 
(kJ/mol) 
-27.09 
±1.38 
-24.49 
±0.18 
-23.93 
±0.16 
-23.65 
±0.23 
Butylparaben a(Å²) 82.9 37.5 30.7 25.4 
Gwater→interface 
(kJ/mol) 
-36.60 
±2.35 
-31.82 
±0.17 
-30.99 
±0.16 
-30.30 
±0.39 
  Errors are based on 95% confidence intervals. 
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Table 5.11, Calculated micelle/water partitioning coefficients using new parameter set 
(Table 5.10) corresponding to varying interfacial areas occupied by drugs at oil/water 
interface. 
 
  
Km/w 
Original 
Km/w 
adrug,max 
Km/w 
adrug+10% 
Km/w 
adrug-10% 
Km/w 
adrug,min 
Progesterone SDS 5.25E+05 7.41E+05 5.57E+05 4.93E+05 4.11E+05 
Testosterone SDS 7.33E+04 5.91E+04 7.19E+04 7.42E+04 7.29E+04 
11OH-prog* SDS 5.84E+04 6.11E+04 6.00E+04 5.67E+04 4.83E+04 
Diazepam SDS 9.84E+04 9.91E+04 1.00E+05 - 9.69E+04 
Prazepam SDS 2.82E+05 2.52E+05 2.79E+05 - 2.83E+05 
Temazepam SDS 3.68E+04 3.62E+04 3.75E+04 - - 
Methylparaben SDS 3.66E+03 3.53E+03 3.68E+03 3.62E+03 3.54E+03 
Ethylparaben SDS 8.82E+03 9.45E+03 9.02E+03 8.62E+03 8.37E+03 
Butylparaben SDS 9.62E+04 1.98E+05 1.03E+05 8.93E+04 7.85E+04 
Progesterone DTAB 2.27E+05 1.58E+05 2.20E+05 2.33E+05 2.35E+05 
Testosterone DTAB 2.98E+04 1.39E+04 2.67E+04 3.30E+04 4.04E+04 
11OH-prog* DTAB 2.29E+04 1.30E+04 2.13E+04 2.46E+04 2.76E+04 
Diazepam DTAB 4.64E+04 2.54E+04 4.40E+04 - 4.81E+04 
Prazepam DTAB 1.27E+05 6.90E+04 1.15E+05 - 1.33E+05 
Temazepam DTAB 1.89E+04 9.56E+03 1.81E+04 - - 
Methylparaben DTAB 1.84E+03 1.12E+03 1.76E+03 1.91E+03 1.99E+03 
Ethylparaben DTAB 4.57E+03 2.71E+03 4.45E+03 4.69E+03 4.77E+03 
Progesterone DM 1.50E+05 5.89E+04 1.35E+05 1.65E+05 1.94E+05 
Testosterone DM 1.75E+04 5.23E+03 1.45E+04 2.09E+04 3.04E+04 
11OH-prog* DM 1.43E+04 4.95E+03 1.22E+04 1.65E+04 2.32E+04 
Diazepam DM 2.72E+04 9.11E+03 2.44E+04 - 2.95E+04 
Prazepam DM 8.24E+04 3.02E+04 7.02E+04 - 8.99E+04 
Temazepam DM 1.21E+04 3.59E+03 1.10E+04 - - 
Methylparaben DM 8.28E+02 3.48E+02 7.63E+02 8.95E+02 9.81E+02 
Ethylparaben DM 2.24E+03 8.25E+02 2.10E+03 2.39E+03 2.53E+03 
*Abbreviation of 11-hydroxyprogesterone 
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averages are within 5% from the unity. When minimum occupied areas are used, the 
ratios are between -0.11 and 0.24 log units. The average value is increased by 10%. In 
Figure 5.13b, the ratios Km/w/Km/w(adrug,exp.) were calculated by changing adrug term only 
without adjusting the transfer free energy term. When the maximum occupied areas of 
model drugs are employed, the predicted micelle/water partition coefficients are 
decreased dramatically. The average drop in the ratios is -0.7 log unit corresponding to 
80% decreases. If the minimum occupied areas of solutes are used, the predicted Km/w 
values are increased with the average increment of 64%. For ±10% variations in adrug the 
micelle/water partition coefficients are also significantly shifted: ~18% drop for 
adrug=1.1adrug,exp. and ~22% increase for adrug=0.9adrug,exp. 
 
Based on above analyses, if the correlations between two parameters, adrug and Gtrans are 
considered, the predicted micelle/water partition coefficients are not sensitive to the 
occupied areas of model drugs when those areas are within 10% of their experimental 
values. On the other hand, if the chosen areas are far removed from the fitted areas, such 
as the maximum occupied areas, the predictions result in significant deviations up to a 
factor of 2 or 3 from the original calculations. If we ignore the correlations between the 
interfacial areas occupied by model drugs and transfer free energies of the drugs and only 
adjust the area term, the calculated Km/w values are much more sensitive than those with 
consideration of the correlations: even ±10% variations in adrug term could produce ~ 
±20% changes in the micelle/water partition coefficients. 
 
Recalling that the determinations of Gtrans and adrug, and the sensitivity of Km/w to these 
two parameters the requirement for highly accurate experimental result of ~C is critical 
to the success of the prediction of Km/w. 
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Figure 5.13a,b, The ratio of calculated micelle/water partitioning coefficient (Km/w) using 
varying parameter, adrug, and the micelle/water partitioning coefficient (Km/w,0) using 
experimentally determined interfacial area occupied by drugs (adrug). Four groups of adrug 
values were chosen: the maximum and minimum interfacial areas, ±10% variations from 
adrug,exp. (a) Another parameter, Gtrans, was allowed to vary with changing adrug to best fit 
the oil/water interface adsorption experiment of drugs (Fig. 5.3~5.5); (b) The parameter 
Gtrans was fixed with changing adrug in the calculations of Km/w. 
 
(a) 
(b) 
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5.3.5.   Effect of Salt on the Micelle/water Partitioning Coefficients 
In section 3.3.2, the Km/w values of three model drugs, progesterone, diazepam and 
methylparaben, in ionic micelle systems (SDS and DTAB) were observed to decrease in 
the presence of 0.15N NaCl. The reduction of Km/w of model drugs in ionic micelles 
could be explained by the changes in micelle structure due to the added salt. Literature 
referneces (Hiemenz and Rajagopalan, 1997; Ueno and Asano, 1997) show the increase 
of aggregation number of ionic micelles by addition of NaCl. From our NMR studies on 
diffusivity of micelles in Chapter 7, the micelles show significant decreases in size. 
According to our surface-localized model, the increasing Naggre with decreased r will 
decrease the area per surfactant at micelle surface, A, and increase the surface pressure, . 
These changes indicate there is less space on the micelle surface to solubilize drug 
molecules.  The large surface density of surfactant molecules makes the adsorption of 
drug less favorable. Equations (A2.4) and (A2.14) clearly demonstrate that reducing A 
and increasing  will result in smaller values for Km/w.  
 
5.3.6.   Solubilization Isotherm Simulations - Moving Beyond the Dilute Solution 
Condition  
The above simulations were based on dilute condition of the solubilizates.  On the other 
hand, the solubilization capacity of a micelle system which was related to saturated 
condition of the solute was more relevant in practical design of drug delivery system. 
Indeed, the majority of measured micelle/water partition coefficients are carried out 
under saturated conditions. In this section, the Km/w values at finite solute concentrations 
will be studied. We extend the surface-localized model to finite solute concentrations. 
The detailed derivations are shown in Appendix 2.2.  Unlike the dilute condition where 
the final results of Km/w have a clear expression as Eq.(A2.13) and (A2.14), the calculated 
Km/w at finite solute concentration involve a numerical solving of Eq. (A2.20) and (A2.21) 
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for surface pressure, , at the micelle surface. The micelle/water partition coefficients are 
calculated using Eq. (A2.22) and (A2.23). 
 
There are limited experimental results of the solubilization isotherm for our interested 
systems in literature. Goto and Endo reported the experimental Km/w values of three 
parabens in SDS solutions as a function of drug concentration using gel filtration 
technique (Goto and Endo, 1978). We applied our extended surface-localized model to 
calculate the solubilization isotherms in these parabens-in-SDS systems in order to test 
the accuracy of the model.   The results of the simulations of three parabens in SDS 
solutions are shown in Figures 5.14~5.16, where the ratio of Km/w at finite drug 
concentration (experimental) to that predicted by applying the dilute condition is plotted 
as a function of mole fraction of drug in micelles. In general, the model successfully 
predicts the overall trend of the micelle/water partitioning, but the deviations from the 
model increase with drug concentration. The experimental slopes for three parabens 
solubilized in SDS solutions were -1.77 (methylparaben), -1.84 (ethylparaben) and -1.87 
(butylparaben) while the predicted slopes were -1.15 (methylparaben), -1.14 
(ethylparaben) and -1.15 (butylparaben). The deviations of the predictions were between 
35~39%. As has been experimentally observed in many other micelle solubilization 
systems (Christian et al., 1986; Lee et al., 1990; Goto and Endo, 1978; Croy and Kwon, 
2005), micelle/water partition coefficients tend to decrease with increasing concentration.  
The drop of Km/w (experimental) with increasing drug concentration is likely mainly due 
to the nature of surface adsorption of solutes.  As drug concentration in the system 
increases, it is likely that the density of solutes on the oil/water interface would approach 
a saturated state.  Saturating the surface would be expected to lower the partitioning 
coefficient between interface and bulk water at higher solute concentration. For example, 
under saturated condition of solutes, the maximum mole ratios of drug to surfactant were 
0.56 (methylparaben), 0.48 (ethylparaben) and 0.64 (butylparaben). The significant  
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Figure 5.14, Experimental and predicted solubilization isotherms for methylparaben in 
SDS micelles. Experimental data are from Goto and Endo (Goto and Endo, 1978). 
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Figure 5.15, Experimental and predicted solubilization isotherms for ethylparaben in SDS 
micelles. Experimental data are from Goto and Endo (Goto and Endo, 1978). 
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Figure 5.16, Experimental and predicted solubilization isotherms for butylparaben in SDS 
micelles. Experimental data are from Goto and Endo (Goto and Endo, 1978). 
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change in the composition of the micelle brought about by the high fraction of solute 
would induce an assembly that is far removed from that of a dilute solution. The 
assumption used in the model that micelle size was not affected by the solubilization of 
the drug would not be expected to be true given the dramatic changes in micelle structure. 
The model sensitivity test in section 5.3.4 showed even a small change in micelle size 
could produce significant changes in micelle/water partition coefficients. For instance, 
the deviation of 1Å in radius of SDS micelles could result in 28% changes in Km/w for 
methylparaben. The PGSE NMR studies in Chapter 7 will show there was no significant 
change in micelle size in the presence of solutes, but the conclusion only held within the 
experimental detection limit that was larger than 1Å.  Another assumption of the model 
was the small changes in Laplace pressure, due to the presence of the solubilizates, were 
not considered in the co-adsorption between drugs and surfactants at the micelle surface. 
The assumption would hold at low drug concentration but would induce larger errors at 
high drug concentration and would likely contribute to the deviations of the predictions 
from experiments.  
 
In addition to the parabens in SDS micelle systems, we also examined the micelle/water 
partition coefficients of all 9 model drugs in three surfactant systems at saturated 
condition.  The calculated Km/w values under dilute and saturated conditions as well as 
experimental micelle/water partition coefficients are listed in Table 5.12 for comparison. 
The ratios between Km/w (saturated) and Km/w (dilute) were calculated and shown in Table 
5.12. The ratios represented the effect of finite concentration of solute on the 
micelle/water partitioning.  Interestingly, the majority of the ratios were quite close to 1: 
16 out of 25 ratios were greater than 0.85 and another 4 ratios were between 0.7 and 0.85. 
For these systems, high drug concentration made little effect on the micelle/water 
partitioning coefficients. The predicted Km/w using dilute condition provided good 
estimations of the micelle/water partitioning at saturated drug concentrations. Only 5 out 
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of 25 ratios had smaller values than 0.7: 0.49 for methylparaben in SDS micelles, 0.52 for 
ethylparaben in SDS micelles, 0.32 for butylparaben in SDS micelles, 0.65 for 
methylparaben in DTAB micelles and 0.67 for ethylparaben in DTAB micelles. The 
influences of finite drug concentration on micelle/water partitioning were the greatest 
when the three parabens were solubilized in SDS solutions. The experimental ratios of 
Km/w between dilute and saturate conditions were 0.44 (methylparaben), 0.41 
(ethylparaben) and 0.28 (butlyparaben) that were quite close to our predicted ratios. 
Another two cases when finite solute concentration had significant effects on Km/w values 
were methylparaben and ethylparaben solubilized in DTAB micelles. For the 5 cases 
which had the lowest ratios, the corresponding solubilization capacities were the highest 
among all 25 systems with the minimum of 0.47. The 4 systems that had the medium 
ratios of Km/w(saturated)/Km/w(dilute) between 0.7 and 0.85 also had quite high 
solubilization capacities that were between 0.22 and 0.42. The only exceptions that high 
solubilization capacity resulted in low ratio of Km/w(saturated)/Km/w(dilute) were 
methylparaben and ethylparaben in DM micelle systems. The solubilization capacities of 
DM micelles were 0.42 (methylparaben) and 0.36 (ethylparaben) but the ratios were both 
0.85. Compared to ionic surfactants SDS and DTAB, the solubilization in nonionic DM 
micelles were less sensitive to the solute concentrations in micelles. 
 
Figure 5.17 illustrates the comparisons between experimental and predicted micelle/water 
partition coefficients at the saturated solute concentrations. The overall predictions were 
in good agreements with experiments. Predicted Km/w did not deviate by more than a 
factor of 2 from the experimental values. Most of the predictions (17 out of 25) were 
within factor of 1.5 from the experiments. The R-square was 0.953. The results strongly 
supported the applicability of the surface-localized model to micellar solubilization.  
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Table 5.12, Calculated micelle/water partitioning coefficients under dilute condition 
(shown early in section 5.3.3 Table 5.5) and non-dilute condition (saturated solution) 
compared to experimental micelle/water partitioning coefficients (mainly under saturated 
condition). The ratios of Km/w(saturated solution) and Km/w(dilute condition) are listed. 
 
  
Km/w 
dilute 
Km/w 
saturated Ratio 
Km/w 
exp. 
Progesterone SDS 5.25E+05 3.83E+05 0.73 3.69E+05 
Testosterone SDS 7.33E+04 6.31E+04 0.86 1.14E+05 
11OH-prog* SDS 5.84E+04 4.58E+04 0.78 6.75E+04 
Diazepam SDS 9.84E+04 7.19E+04 0.73 8.93E+04 
Prazepam SDS 2.82E+05 2.50E+05 0.89 4.03E+05 
Temazepam SDS 3.68E+04 2.86E+04 0.78 4.70E+04 
Methylparaben SDS 3.66E+03 1.78E+03 0.49 
3.24E+03 (dilute) 
1.42E+03 (saturat.) 
Ethylparaben SDS 8.82E+03 4.56E+03 0.52 
8.51E+03 (dilute) 
3.48E+03 (saturat.) 
Butylparaben SDS 9.62E+04 3.09E+04 0.32 
7.24E+04 (dilute) 
2.04E+04 (saturat.) 
Progesterone DTAB 2.27E+05 1.94E+05 0.85 1.79E+05 
Testosterone DTAB 2.98E+04 2.79E+04 0.94 5.40E+04 
11OH-prog* DTAB 2.29E+04 2.06E+04 0.90 3.57E+04 
Diazepam DTAB 4.64E+04 3.93E+04 0.85 2.94E+04 
Prazepam DTAB 1.27E+05 1.19E+05 0.94 8.76E+04 
Temazepam DTAB 1.89E+04 1.64E+04 0.87 1.67E+04 
Methylparaben DTAB 1.84E+03 1.20E+03 0.65 1.73E+03 
Ethylparaben DTAB 4.57E+03 3.06E+03 0.67 4.28E+03 
Progesterone DM 1.50E+05 1.36E+05 0.91 9.49E+04 
Testosterone DM 1.75E+04 1.69E+04 0.97 3.09E+04 
11OH-prog* DM 1.43E+04 1.34E+04 0.94 1.32E+04 
Diazepam DM 2.72E+04 2.50E+04 0.92 2.10E+04 
Prazepam DM 8.24E+04 7.96E+04 0.97 6.51E+04 
Temazepam DM 1.21E+04 1.13E+04 0.93 9.63E+03 
Methylparaben DM 8.28E+02 7.05E+02 0.85 1.16E+03 
Ethylparaben DM 2.24E+03 1.91E+03 0.85 2.85E+03 
*Abbreviation of 11-hydroxyprogesterone 
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5.3.7.   Effect of Solutes on CMC of Micelles – Influence of Laplace Pressure 
A very interesting phenomenon observed commonly during micelle studies is the 
reduction of critical micelle concentration (CMC) upon solubilization of drug. Goto and 
Endo systematically studied the CMC of SDS micelles as a function of aqueous 
concentrations of three parabens (Goto and Endo, 1978).  In this section, we apply the 
Laplace pressure effect to quantitatively predict the decline of CMC with increasing drug 
concentrations. The detailed derivations of the model are shown in Appendix 2.3. The 
development of the theory can be divided into 2 steps: the first step is the introduction of 
solutes to micelle surface lowers the surface pressure and thus decreases the Laplace 
pressure; the second step is the surfactant molecules, subject to Laplace pressure, will 
have a lower transfer free energy from bulk water to micelle surface and thereby 
decreasing the CMC. 
 
Figure 5.18 compares the predicted and experimental CMCs of SDS micelles as a 
function of aqueous concentrations of three parabens. The overall predictions are quite 
good. The model successfully predictes the decreasing trend of CMC with increasing 
drug concentration and also the slope of the CMC reduction with respective to drug 
concentration. Under the condition of equal solute concentration, butylparaben produced 
the greatest drop of CMC because that solute is the most surface active at oil/water 
interface. According to Eq. (A2.25) and (A2.26), the greatest negative transfer free 
energy of butylparaben (Gtrans=-31.4kJ/mol) could increase the surface pressure and 
lower the Laplace pressure to the greatest extent, resulting in the greatest drop in the 
CMC. 
 
The successful predictions of the CMC~Conc. curves support the existence and 
importance of the Laplace pressure in micelle systems. The predictions are based on two 
assumptions: (1) the micelle size is not significantly affected by the addition of solutes; 
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Figure 5.17, Comparison between experimental and predicted micelle/water partitioning 
coefficients (Km/w) of 9 model drugs in 3 surfactant systems under saturated condition of 
drugs. 
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(2) The activity (free energy level) of surfactant at micelle surface is not changed with 
increasing solute concentration. The second assumption is important because it will 
change the monomer concentration of surfactant (CMC) and not the micelle structure as a 
consequence of the change of transfer free energy from bulk water to micelle surface.  
 
5.4.   CONCLUSION 
A surface-localized thermodynamic model was successfully applied to predict the 
micelle/water partitioning coefficients of 9 model drugs in 3 micelle systems. The 
thermodynamic model was employed to calculate (1) the transfer free energies of model 
drugs from aqueous solution to oil/water interface; (2) the occupied areas of drugs at the 
oil/water interface. The greater the negative transfer free energy and the smaller the 
occupied interfacial areas by the drug molecules, the greater the  micelle/water partition 
coefficients. For three model surfactants, the larger surface pressure at micelle surface 
correlated to lower solubilization capacity of the micelles. The successful predictions of 
micelle/water partitioning coefficients using surface-localized model support the 
following conclusions: (1) the model hydrophobic drugs are predominantly located at the 
surface region of the micelles; (2) the co-adsorption to the micelle surface by drugs and 
surfactants is the main mechanism of micellar solubilization; (3) the 2-D solution 
adsorption model is successfully applied to the hydrocarbon-water interface system and 
the relationship between drugs and surfactants is mainly pure competition without their 
specific interactions; (4) Laplace pressure exhibits a significant effect on micelle/water 
partitioning of the model drugs and can not be ignored. 
 
The sensitivities of the predicted micelle/water partition coefficients to the chosen 
parameters were tested. The Km/w values were sensitive to the radius of the micelles with 
constant aggregation number of the micelles. Many parameter pairs were strongly 
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Figure 5.18, Predicted and experimental CMCs of SDS as a function of drug 
concentration in aqueous solutions. The experimental data are from Goto and Endo (Goto 
and Endo, 1978). 
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correlated with each other, for examples, aggregation number and radius of micelles, 
interfacial area occupied by drug molecules and transfer free energy of drug substance 
from water to oil/water interface. If the correlations of those parameter pairs were 
considered, the predicted micelle/water partitioning coefficients were not sensitive to the 
aggregation number of the micelles (50s~100 for SDS and DTAB, 113~130 for DM), 
interfacial area occupied by water molecules (7.6~10Å²) and the interfacial area occupied 
by drug molecules (<10% variation). The insensitivity of the predictions to those chosen 
parameter reflected the robustness of the surface-localized model.  
 
The model was extended to study some other micellar solubilization properties: salt effect, 
solubilization isotherm, CMC depression effect by solutes. The addition of salts to the 
surfactant solutions resulted in a decreased micelle/water partition coefficient for ionic 
micelle systems. This phenomenon could be explained by increasing aggregation number 
of micelles due to the screening of electrostatic forces between charged headgroups in the 
presence of salt while the micelle size was decreased. The model clearly showed the 
above changes could cause decrease in the micelle/water partition coefficients. 
 
The surface-localized model was extended to finite solute concentration. The simulated 
solubilization isotherms for parabens solubilized in SDS micelles were compared to 
experiments from literature. The model successfully simulated the trend of Km/w~Cdrug 
curves but could not predict the slope of the curves accurately. The micelle/water 
partition coefficients of 9 model drugs in 3 micelle systems at saturated condition of 
model drugs were calculated and the results were in good agreements with experimental 
values.  
 
The CMC of SDS micelles were observed to decrease with increasing concentration of 
parabens. The Laplace pressure acting on surfactant molecules were considered in the 
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thermodynamic model simulations. The quantitative predictions of CMC~Cdrug curves 
coincided with experiments very well. 
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Chapter 6 
Molecular Simulation Studies on the Orientations of Model Drugs at Oil/water 
Interface 
 
6.1.   INTRODUCTION 
To understand the solubilization mechanism of hydrophobic drugs in micelle system, the 
location, orientation and amount of hydrophobic drugs solubilized in the lipid assembly 
are important factors to be considered. The three factors are interdependent. For instance, 
the maximum amount of drugs in micelles is dependent on the location and orientation of 
the model drugs in micelles.  
 
The location and amount of model hydrophobic drugs in micelle systems have been 
extensively studied in last three chapters based on a framework of a thermodynamic 
model. A surface-localized thermodynamic model considering the co-adsorption of drug 
and surfactant molecules for micelle surface successfully predicted the micelle/water 
partition coefficients.  Sensitivity analysis of the model illustrated that the areas 
occupied by model drugs at micelle surface could influence the micelle/water partitioning 
(Section 5.3.4.4). The larger occupied interfacial areas are correlated with less solubilized 
drugs in micelles. For example, a 10% increase in the area could decrease the 
micelle/water partition coefficient by 20% under assumption that other parameters, such 
as interfacewaterG , remain constant. The interfacial areas occupied by model drugs are 
dependent on the size and orientation of the drugs. Since the size of a specific drug is 
fixed, the orientation of the drug localized at the micelle surface would be important to 
the solubilization capacity. Understanding the orientation of drug substances in micelles 
may also be critical to the chemical stability of solubilized drugs because of the 
anisotropic local environment that may protect chemically-vulnerable functional groups. 
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So far, little is known about the orientation of model drugs at the micelle surface. In the 
literature, NMR technique was employed to detect the intermolecular interactions as well 
as microenvironment of different functional groups in order to infer the orientation of 
solubilizates in micelles (Hawrylak and Marangoni, 1999; Heins et al., 2007; Gjerde et al., 
1998; Ueno and Asano, 1997; Nagaonkar and Bhagwat, 2006; Suratkar and Mahapatra, 
2000;). These studies have advantages in probing selective regions of the solute molecule 
in aqueous or oil phases. The methods do not give detailed information such as the angles 
between the long axes of solutes with the oil/water interface. The angles would affect the 
interfacial areas occupied by model drugs and the micelle/water partition coefficients. 
 
In this chapter, the experimental interfacial areas occupied by model drugs from the 
adsorption studies at dodecane/water interface (Section 5.3.1) were used to infer the 
orientation of the drugs at oil/water interface. A molecular simulation method was 
employed to calculate the possible cross-section areas of the drug molecules along any 
defined directions. By matching the calculated areas with experimental values and 
applying chemical intuition (considerations on hydrophilic/hydrophobic interactions and 
surface energies), the orientations of the drug molecules at oil/water interface, 
specifically the angles between the drug and interface, could be determined.  
 
6.2.   METHODS 
6.2.1.   Molecular Structures of Isolated Drug Molecules 
There were three ways of obtaining three-dimensional molecular structures of single drug 
molecule. The following methods were taken in order: 
(1) If the crystal structures of model drugs were reported in literature and the complete 
molecular structure information including the fractional coordinates of all atoms was 
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available, the molecular structures of the single drug molecule were extracted from the 
reported crystal structure data.  
 
(2) If the crystal structures of model drugs were reported in literature and the partial 
molecular structures including only the fractional coordinates of heavy atoms were 
available, the partial molecular structures of the single drug molecule were extracted 
from the reported crystal structure data and hydrogen atoms were added afterwards 
employing Hyperchem® software (Hyperchem, 2001).  
 
(3) If there was no reported crystal structure of model drugs that included the molecular 
details, the molecular structure was built and optimized using quantum chemistry 
software. In our studies, GaussView® software (Frisch et al., 2000) was employed to 
build the molecule according to its chemical structure and Gaussian03® software (Frisch 
et al., 2003) was used to optimize the structure based on minimum-energy principle. The 
calculation technique used in structure optimization was Hartree-Fock method combined 
with Pople‟s 6-31G** basis set.  
 
6.2.2.   Defining the Boundary of Isolated Molecules 
To calculate the cross-section area of a molecule, the boundary of the molecule was 
defined as the “molecular shell”. In our studies, an isosurface of electron densities of the 
molecule was used as the molecular boundary. The electronic structure of drug molecules 
was calculated using Hartree-Fock method with 6-31G** basis set. The calculations were 
carried out using Gaussian 2003 software. A three dimensional grid of electron densities 
for the drug molecules was generated from the electronic structures described as wave 
functions of electrons solved from Hartree-Fock equation. The resolutions of the grid 
were 10 points/Å along all three directions.  
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To define the molecular boundary, the isovalue of the isosurface of electron densities was 
chosen so as to match the enclosed volume of the isosurface to experimental partial molar 
volume of the drugs. The isovalue for electron densities was kept constant for all model 
drugs. The generation of isosurface from the 3-D grid of electron densities and the 
calculations of the enclosed volume by the isosurface were performed using self-written 
computer program with C language.  
 
6.2.3.   Calculation of Cross-section Areas along All Possible Directions 
To make the calculation more convenient, the Cartesian coordinates of drug molecules 
were fixed while the orientations of oil/water interface were varied. The normal of the 
interface was used to describe the orientation of the plane and a pair of angles () was 
sufficient to represent all possible directions of the normal. The vector of the normal with 
angles () was (sincos, sinsin, cos) (0<<, 0<<2). Once the orientation of 
the interface was defined, a series of planes parallel to the orientation would cut through 
the body of the molecular shell. For each plane, the cross-section area was calculated 
based on the intersection between the plane and the molecular shell. Among those 
cross-section areas corresponding to the parallel planes, the maximum area was chosen 
for the specific orientation. The above calculations were carried out for all possible 
orientations chosen as follows: 
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The orientations shown in above equation only covered half of a sphere. Because the 
calculations had an inversion symmetry: the area calculated for orientation with normal 
(x, y, z) was same with the area for orientation (-x, -y, -z). Therefore half sphere is 
sufficient to represent all possible directions. The parameter n determined the resolution 
 156 
of the orientations that was approximately 90
o
/n. The larger n corresponded to higher 
resolution. In our studies, a value of 18 was chosen for n with the resolution of the 
orientations equal to 5
o
. The simulations were carried out using self-written C program. 
 
6.2.4.   Visualizations of the Molecules, Isosurfaces of Electron Densities, and 
Cutting Planes 
The visualizations of the drug molecules, molecular shells, and the cutting planes that 
represented the oil/water interface were realized using OpenDX® software (OpenDX). A 
ball-and-stick model was used to show the molecular structure. Different atoms were 
color coded and had different radii. The molecular shells that represented the molecular 
boundaries were made half-transparent in order to illustrate the molecular structures 
inside. The intersection between the molecular boundary and the cutting plane was 
clearly demonstrated. The cutting plane was also mapped with electron densities. Areas 
with red color had highest electron density while areas with blue color had lowest 
electron density. The axes of 3-D Cartesian coordinates were shown beside the molecules 
with the gridlines. The scales had a unit of Å. 
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6.3.   RESULTS AND DISCUSSION 
6.3.1.   Molecular Structures of Model Drugs 
Of the model compounds, progesterone, testosterone, 17-estradiol, 
11-hydroxyprogesterone, diazepam, temazepam and methylparaben had reported crystal 
structures that included complete molecular structures (Allen, 2002). The molecular 
structures could be extracted from those reported structure data. Another three drugs, 
oxazepam, prazepam and ethylparaben, had reported crystal structures that included 
partial molecular structures that only had coordinates of heavy atoms (Allen, 2002; Lin, 
1986). These molecular structures were completed by adding hydrogen atoms using 
Hyperchem® software. Figure 6.1 uses prazepam as an example to illustrate the 
molecular structure extracted from literature without hydrogen atoms, Fig. 6.1a, and 
molecular structure with added hydrogen atoms using Hyperchem® program, Fig. 6.1b. 
Butylparaben has no reported crystal structure containing detailed molecular structure. 
The molecular structure of butylparaben was built according to its chemical structure 
using GaussView® program. One advantage of using GaussView to draw molecular 
structures was the program provided initial bond lengths and bond angles that were close 
to true values so that the following structure optimization calculations were more 
efficient. The molecular structure was optimized using Hartree-Fock/6-31G** method 
and the calculations were carried out using Gaussian03® software. The optimized 
structure of butylparaben is shown in Figure 6.2.  
 
6.3.2.   Determination of Molecular Boundaries 
The molecular boundary was defined using an isosurface of electron densities of the 
molecules. The cut-off electron density, or the isovalue of the isosurface, was chosen so 
as to match the enclosed volume by the isosurface to the experimental occupied 
molecular volume. The experimental occupied volumes of model drugs were estimated  
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a 
b 
Figure 6.1, (a) The molecular structure of prazepam extracted from reported crystal 
structure (Allen, 2002) without coordinates of hydrogen atoms; (b) The molecular 
structure in (a) was added with hydrogen atoms using Hyperchem® software. 
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Figure 6.2, The optimized molecular structure of butylparaben using Hartree-Fock 
/6-31G** method with the aid of Gaussian03® program (Frisch et al., 2003). 
 160 
using the reported crystal structures and the results shown in Table 5.1. In Table 6.1, the 
enclosed volumes by the isosurface of electron densities using different isovalues were 
calculated and compared with experimental occupied molecular volumes. Using least 
square fitting, the isovalue =0.00065e/bohr3 gave the best matches between calculations 
and experiments. The comparisons between calculated and experimental occupied 
volumes by isolated model drugs are shown in Figure 6.3. The predictions coincide well 
with the experimental results. 
 
6.3.3.   Determining Orientation of Model Drugs by Matching Calculated 
Interfacial Areas Occupied by Model Drugs to Experimental Areas  
The theoretical areas occupied by model drugs at oil/water interface could be calculated 
as the cross-section areas of the molecular shells with a cutting plane representing the 
oil/water interface. Since the actual orientations of the model drugs at oil/water interface 
were unknown, exhaustive searches were carried out for all possible orientations. For 
each orientation, a cross-section area could be calculated and compared to the 
experimental value (see section 5.3.1). The matching between the calculations and 
experiments could indicate the possible orientations of the drugs at oil/water interface.   
 
In our simulations, a fixed molecule with changing cutting planes was more convenient in 
calculating the cross-section areas than a fixed cutting plane with changing molecular 
positions and orientations. From the computational point of view, the above two cases 
were equivalent to each other.  
 
The orientations of the cutting planes were described using two angles,  and (0<<, 
0<<2). A total number of 685 “molecular slices” with the resolution of 5o were 
considered to calculate the corresponding cross-section areas. In Table 6.2, the 
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Table 6.1, The calculated occupied volumes of isolated molecules using different 
isovalues of the isosurfaces of electron densities compared to experimental occupied 
volumes for all model drugs. 
 
Model drugs 
The calculated occupied volumes of isolated molecules (Å³)  
using the following isovalue of electron density (e/bohr
3
) 
Experimental 
occupied 
volume(Å³) 0.0005 0.00055 0.0006 0.00065 0.0007 0.0008 
progesterone 444.7  436.9  429.9  423.3  417.3  406.4  441.3 
testosterone 416.9  408.9  402.3  396.3  390.7  380.6  406.9 
17 -estradiol 389.7  382.7  376.4  370.6  365.2  355.6  370.2 
11OHprog* 457.8  450.0  442.9  436.4  430.3  419.4  450.7 
diazepam 371.5  364.6  358.3  352.5  347.1  337.5  344.3 
oxazepam 365.0  358.3  352.2  346.6  341.5  332.2  330.5 
prazepam 447.6  439.5  432.1  425.4  419.1  407.7  417.7 
temazepam 380.1  375.1  368.7  362.8  357.4  347.7  356.7 
methylparaben 203.3  199.3  195.6  192.3  189.2  183.7  182.7 
ethylparaben 238.1  233.4  229.1  225.1  221.5  215.0  213.8 
butylparaben 289.9  284.2  279.0  274.2  269.9  262.0  259.2 
*Abbreviation of 11-hydroxyprogesterone 
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Figure 6.3, The comparisons between calculated and experimental occupied volumes by 
isolated model drug molecules. The calculated occupied volumes were based on a cut-off 
electron density of 0.00065e/bohr
3
. 
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experimental areas are listed for comparisons. Figures 6.4~6.14 illustrate the orientations 
of model drugs at the oil/water interface (shown as the blue plane in the graph) when they 
are occupying maximum and minimum areas at the interface. Those calculated maximum 
and minimum cross-section areas are shown in Table 6.2. There were significant 
differences between the maximum and minimum areas with the ratio of amax/amin ranging 
from 1.7 (prazepam) to 3.3 (butylparaben) suggesting that the molecules would not be 
accurately described by simple spherical geometry.  
 
When the data in Table 6.2 are examined, two trends are immediately apparent. All 
molecules in a single class tend to exhibit similar orientations. Each class of model 
solutes tends to exhibit characteristic orientation angles. For three benzodiazepines 
(oxazepam is not included because of the lack of accurate experimental areas occupied by 
oxazepam molecules), the experimental occupied areas by isolated molecules are not 
significantly different from the theoretical minimum occupied areas. Thus, it is concluded 
that benzodiazepines are likely orientated vertical to the oil/water interface. For three 
parabens, the experimental occupied areas are significantly larger than the minimum 
areas by 6~9Å² which suggests the long axes of paraben molecules deviate from the 
vertical orientation and form angles with the normal of the oil/water interface.  
 
The estimated angles deviated from the normal are shown in the last column of Table 6.2. 
The angles were calculated between the long axis of the fixed molecule and all normals 
of the cutting planes that could produce the calculated cross-section areas within 1Å² 
from the experimental area. For the three parabens, the average angles are around 42
o
. 
When steroids were studied, the experimental occupied areas are significantly larger than 
theoretical minimum areas by 18~25Å², corresponding to angle of about 54
o
 between the 
long axes of steroid molecules and the normal of the oil/water interface. 
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a b 
Figure 6.4, The orientations of progesterone when it occupies the maximum (a) and 
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane. 
The maximum projected area is 104.4Å² and the minimum projected area is 39.6 Å². The 
scales of axes have a unit of Å. 
 
 
 
a b 
Figure 6.5, The orientations of testosterone when it occupies the maximum (a) and 
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane. 
The maximum projected area is 95.8Å² and the minimum projected area is 39.5Å². The 
scales of axes have a unit of Å. 
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a b 
Figure 6.6, The orientations of 11-hydroxyprogesterone when it occupies the maximum 
(a) and minimum (b) areas at the oil-water interface which is illustrated using a blue color 
plane. The maximum projected area is 104.8Å² and the minimum projected area is 40.2Å². 
The scales of axes have a unit of Å. 
 
 
a b 
Figure 6.7, The orientations of 17-estradiol when it occupies the maximum (a) and 
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane. 
The maximum projected area is 95.8Å² and the minimum projected area is 38.3Å². The 
scales of axes have a unit of Å. 
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a b 
Figure 6.8, The orientations of diazepam when it occupies the maximum (a) and 
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane. 
The maximum projected area is 86.2Å² and the minimum projected area is 42.7Å². The 
scales of axes have a unit of Å. 
 
 
a b 
 
Figure 6.9, The orientations of temazepam when it occupies the maximum (a) and 
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane. 
The maximum projected area is 84.9Å² and the minimum projected area is 45.5Å². The 
scales of axes have a unit of Å. 
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a b 
Figure 6.10, The orientations of prazepam when it occupies the maximum (a) and 
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane. 
The maximum projected area is 86.4Å² and the minimum projected area is 50.9Å². The 
scales of axes have a unit of Å. 
 
 
a b 
Figure 6.11, The orientations of oxazepam when it occupies the maximum (a) and 
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane. 
The maximum projected area is 83.7Å² and the minimum projected area is 44.8Å². The 
scales of axes have a unit of Å. 
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a b 
Figure 6.12, The orientations of methylparaben when it occupies the maximum (a) and 
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane. 
The maximum projected area is 62.0Å² and the minimum projected area is 24.5Å². The 
scales of axes have a unit of Å. 
 
 
 
 
a b 
Figure 6.13, The orientations of ethylparaben when it occupies the maximum (a) and 
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane. 
The maximum projected area is 70.6Å² and the minimum projected area is 25.6Å². The 
scales of axes have a unit of Å. 
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a b 
Figure 6.14, The orientations of butylparaben when it occupies the maximum (a) and 
minimum (b) areas at the oil-water interface which is illustrated using a blue color plane. 
The maximum projected area is 82.9Å² and the minimum projected area is 25.4Å². The 
scales of axes have a unit of Å. 
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Table 6.2, The calculated maximum and minimum cross-section areas occupied by drug 
molecules at oil/water interface, amax and amin, compared to the experimental 
cross-section areas of molecules at oil/water interface, aexp, reported in Table 5.2 (section 
5.3.1); the estimated angles between long axes of model drugs and the normal of the 
oil/water interface and the calculated time-average interfacial areas occupied by drug 
molecules when the molecules are permitted to rotate freely at oil/water interface, aaverage. 
 
Drug amax(Å²) amin(Å²) aexp.(Å²) Angles (
o
) aaverage(Å²) 
Progesterone 104.4 39.6 58.0±4.4 49.5±3.9 64.8 
Testosterone 95.8 39.5 59.8±4.9 55.8±5.4 62.5 
11prog* 104.8 40.2 64.8±1.9 56.8±4.9 66.2 
Diazepam 86.2 42.7 46.2±4.7 29.1±12.9 59.7 
Temazepam 84.9 45.5 41.3±3.7 N/A 61.2 
Prazepam 86.4 50.9 54.0±5.7 16.9±7.3 69.7 
Methylparaben 62.0 24.5 31.9±4.0 47.3±3.1 38.0 
Ethylparaben 70.6 25.6 31.8±4.6 38.4±3.0 42.0 
Butylparaben 82.9 25.4 34.1±1.2 41.2±3.9 46.7 
17-estradiol  95.8 38.3 57.4±105.3 n.d. 59.5 
Oxazepam  83.7 44.8 42.1±17.5 n.d. 59.3 
*
Abbreviation for 11-hydroxyprogesterone 
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The estimated orientation angles could be rationalized by chemical intuition using the 
distribution of hydrophilic functional groups in the molecule of interest. Figure 6.15 
shows a schematic of orientations of 3 series of model drugs at oil/water interface. 
Molecules of model drugs are illustrated using ellipsoids which have long and short axes. 
The small circles in the figure represent hydrophilic functional groups. The determining 
factor for the orientation of a molecule at oil/water interface is its free energy state; the 
molecule will choose an orientation that has the minimum free energy. There are two 
factors affecting the total free energy of a molecule at the oil/water interface. One 
modulating factor is the occupied area of the molecule. The larger occupied area of the 
molecule at oil/water interface, the larger the surface energy based on Eq. (A1.1). For 
other factors being equal, the molecule tends to take the minimum surface area to lower 
its surface energy. A second factor that influences the molecular orientation at oil/water 
interface is the distribution of hydrophilic functional groups of the molecule. 
Sequestering a polar (hydrophilic) functional group in a non-polar (hydrophobic) 
environment can be rather costly in terms of free energy. Molecular orientations that 
maximize the interactions of the polar functional groups with water tend to minimize the 
free energy. The two orientation factors may or may not conflict with each other. 
Obviously, when considered together, the effects of the two factors result in an 
orientation that will result in a minimum system free energy. In our studied system, 
benzodiazepines seem to have no conflict between the two factors. There are one or two 
hydrophilic functional groups (hydroxyl or carbonyl group) in each molecule that are 
adjacent to each other. As shown in Fig. 6.15a, the benzodiazepine molecules can take the 
minimum occupied interfacial area and, at the same time, maintain the hydrophilic 
functional groups in aqueous phase. For parabens, the two hydrophilic groups are far 
from each other as shown in Fig. 6.15b. It is not possible for the molecule to occupy a 
minimum surface area while simultaneously maintaining contact of the two hydrophilic 
groups with water. It seems reasonable to expect that the molecule will rotate from the 
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             (a)                  (b)                 (c) 
Figure 6.15, A schematic of orientations of three series of model drugs at oil/water 
interface. The molecules of model drugs are illustrated using ellipsoids that have long and 
short axes reflecting molecular shapes. The small circles represent the hydrophilic 
functional groups. 
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vertical orientation until the two hydrophilic groups are near/in the water phase. As a 
consequence, the long axes of parabens form an angle (~42
o
) with the normal of the 
oil/water interface. For steroids, the two hydrophilic groups are at opposite ends of long 
axis of each molecule. Similar to parabens, the conflict between the two factors, 
maintaining the minimum surface area and keeping hydrophilic groups in water, will 
drive the molecules to deviate from the vertical orientation. Because the hydrophilic 
groups are more distantly separated in steroid molecules compared to the paraben 
molecules, the angles between long axes of drug molecules and the normal of oil/water 
interface are larger for steroids (~54
o
) than those for parabens (~42
o
).  
 
In the above analysis, we considered the solute to occupy an area of the interface while in 
a static fixed orientation. In reality, the drug adsorption is a dynamic partitioning 
phenomenon. As a consequence, the orientation of drug molecules at the oil/water 
interface is unlikely fixed and would represent a time-average over different orientations. 
Solubilization of drug in micelle systems is known to be a dynamic partitioning 
phenomenon. The high exchange rate of molecules between the micelles and water 
(10
3
~10
8
/s (Lindman and Wennerstrom, 1980)) suggests the estimated orientations are 
time averages over possible orientations. The estimated angles between long axes of 
drugs and the normal of oil/water interface, e.g. 42
o
 for parabens and 54
o
 for steroids, are 
time average angles over their possible orientations. In the extreme case, the solute may 
freely rotate within the plane of the surface. The last column of Table 6.2 presents the 
average areas occupied by the solutes when allowed to freely rotate. When the average 
occupied areas are compared to experimental values, the experimental areas occupied by 
benzodiazepines and parabens are significantly smaller than the calculated average. For 
steroids the experimental areas occupied are close to the overall average when permitted 
to freely rotate. The results suggest steroids may have larger rotating degree of freedom at 
oil/water interface as compared to benzodiazepines and parabens. 
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The experimental studies on the occupied interfacial areas were carried out on a flat 
dodecane/water interface (Section 5.3.1). When attempting to correlate these findings to 
results at a micelle surface we must assume that the micelle surface curvature has no 
effect on the occupied area.  
 
In these studies, rigid molecular structures (extracted from crystal structure) were 
employed, while, in solution state, the molecules had less restriction and could be flexible. 
For our model drugs, steroids molecules are all rigid and benzodiazepines are mainly 
rigid with a benzene ring at C5 position having limited rotating ranges due to the steric 
hindrance. Parabens have flexible hydrocarbon chains but the determining factor of 
occupied surface areas is the rigid bulky resonance structure of the molecules. Therefore, 
the simplifications using rigid molecular structure will not introduce significant errors on 
the calculations of the areas occupied by drugs at the oil/water interface.  
 
6.4.   CONCLUSION 
The orientations of model drugs at oil/water interface were estimated by comparing the 
experimental occupied areas of model drugs to the theoretical areas when model drugs 
were taking any possible orientations at oil/water interface. The theoretical occupied 
interfacial areas were carried out using molecular simulation methods: (1) the molecular 
boundary was defined using an isosurface of electron density; (2) the cross-section area 
of the molecule cut by a plane representing the oil/water interface was used as the 
occupied area corresponding to the specific orientation.  
 
The orientations of model drugs at oil/water interface are different for different drug 
series but are similar within one series of model drugs. All three benzodiazepines are 
believed to take the vertical orientation at oil/water interface because the experimental 
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occupied areas are not significantly different from theoretical minimum areas. For 
parabens, the long axis of each drug molecule form an angle about 42
o
 with the normal of 
oil/water interface. For steroids, the angles between long axes of drug molecules and the 
normal of oil/water interface aere about 54
o
. 
 
The molecular orientations at oil/water interface are related to the distribution of 
hydrophilic functional groups of model drugs. If the hydrophilic groups are congregated 
at one end of molecular long axis, such as benzodiazepines, the molecules are likely 
taking vertical orientations that occupied minimum areas while maintaining hydrophilic 
groups in aqueous phase. If the hydrophilic groups are widely separated in the molecule, 
such as parabens and steroids, the solute cannot take the minimum surface areas and, at 
the same time, keep the hydrophilic groups in water. The long axes of those molecules 
would form angles with the normal of oil/water interface to reach the minimum of total 
free energy. 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Shaoxin Feng 2009 
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Chapter 7 
NMR Studies on Inter-molecular Interactions in Micelles and Micellar Diffusivity 
 
7.1.   INTRODUCTION 
Several spectroscopy-based methods, such as UV/vis, fluorescence, NMR, etc., have 
been used to determine the location of solubilizates in micelles (Sabate et al., 2001; 
Vermathen et al., 2000; Bromberg and Temchenko, 1999; Lebedeva et al., 2007; Ueno 
and Asano, 1997; Hawrylak and Marangoni, 1999). The thermodynamic-model-based 
approach of the present work has advantages in quantitative predictions of fractions of 
drugs located in different regions of micelles and micelle/water partitioning coefficients 
of model drugs. On the other hand, the method lacks detailed information of micellar 
solubilization, such as locations of specific functional groups in micelles, because the 
thermodynamic analysis treats one whole molecule as an elemental unit. The 
spectroscopic techniques could provide qualitative information such as the 
microenvironment of a functional group and explicit interactions between different 
function groups.  
 
In Chapters 3~5 we have employed the thermodynamic-model-based method to 
determine the location of drugs in micelles and predict the partitioning of drugs between 
micelles and water phase. In this chapter, we will use 2-D and PGSE NMR techniques to 
study the microstructures of micelles solubilizing drugs. The inter-molecular interactions 
between surfactants and drugs are expected to be determining factors in the locations and 
orientations of drug molecules in micelles. For example, if the drugs were located at 
micelle surface, interactions between drugs and headgroups of surfactants would be 
expected. Specifically, the 2-D NMR techniques, including NOESY (Nuclear Overhauser 
Effect SpectroscopY) and ROESY (Rotating-frame nuclear Overhauser Effect 
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SpectroscopY), were employed to measure the interactions between surfactants and drugs 
in micellar aggregates. PGSE NMR technique can provide information on the 
translational diffusivities of particles which are correlated to the particle sizes. Here the 
PGSE NMR technique was mainly employed to detect the changes of micelle size with 
different drug concentrations and in the presence and absence of salts. The information of 
micellar size was used to test the validity of some assumptions in the thermodynamic 
model in Chapter 3~5. These studies provide complementary information on 
solubilization mechanism of micelle systems. 
 
7.2.   MATERIALS AND METHODS 
7.2.1.   MATERIALS 
Progesterone (>99%), diazepam, temazepam, methylparaben (>99%), ethylparaben 
(>99%), butylparaben (>99%), sodium dodecyl sulfate (>99%), 
dodecyltrimethylammonium bromide (>99%) and dodecyle -D-maltoside (>98%) were 
obtained from Sigma-Aldrich (St. Louis, MO). 11-hydroxyprogesterone (>95%) was 
from Janssen Chimica (New Brunswick, NJ). D2O (>99.9% isotopic purity) was 
purchased from Sigma-Aldrich. Three millimeter NMR tubes with a 500MHz rating were 
purchased from Norell (Landisville, NJ).  
 
7.2.2.   METHODS 
7.2.2.1.   2D NMR (NOESY and ROESY) Methods 
NOESY (Nuclear Overhauser Effect SpectroscopY) and ROESY (Rotating-frame nuclear 
Overhauser Effect SpectroscopY) were used to detect the inter-molecular interactions 
when the spatial distance between two protons is shorter than 5Å. NOESY measures the 
dipolar coupling between nuclear spins and is suitable for „small‟ (MW<1000) and „large‟ 
(MW>2000) molecules for which NOEs (nuclear Overhauser effect) are positive and 
negative respectively, but may fail for mid-sized molecules (Claridge, 1999). ROESY 
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observed transient NOEs in the rotating frame and is especially useful where the NOESY 
cross-peak signals are weak because the NOEs are near the transition between positive 
and negative. ROESY cross-peaks are always positive, but ROESY signal can also be 
interfered by other effects, such as TOCSY (TOtal Correlation SpectroscopY) transfer 
and COSY(COrelation SpectroscopY)-type cross-peak (Claridge, 1999). 
 
Figure 7.1 shows the pulse sequences used in NOESY and ROESY experiments. The 
sequence of NOESY consists of three 90
o
 pulses. The evolution time, d2, would be 
systematically incremented to provide chemical shift information along the 2
nd
 dimension 
(F1 domain). The mixing time, mix, is the duration for the spin-spin cross relaxation to 
occur and is kept constant in the experiments. The ROESY sequence includes a 90
o
 pulse 
following by a varied evolution time, d2, and a fixed mixing time, max, when an 
alternating-phase spin-lock is applied to reduce TOCSY transfer (Hwang, 1992).  
 
NOESY experiments were performed on a Varian Inova 400MHz NMR spectrometer 
(S/N S010883) equipped with a Highland Performa II gradient probe (S/N P003732). The 
acquisition and processing of the spectra were carried out using VNMR 6.1c software 
(Varian). D2O was used as solvent for all the NMR experiments. The mixing time in 
NOESY measurements was 0.5~1.0s, and the relaxation delay, d1, was 6s. The 
experiments were acquired with 16 scans and 1024 complex data points for each of the 
200 evolution delay time (d2). The spectral width was 4060Hz. 
 
ROESY experiments were carried out on a Varian VNMR 500MHz NMR spectrometer 
(S/N 41312). The acquisition and processing of the spectra were carried out using 
VNMRJ 2.2c software (Varian). The mixing time in ROESY measurement was 0.2~0.3s. 
The relaxation delay, d1, was set to 3s and a homospoil gradient spoil sequence was 
employed prior to the d1 delay to achieve a less oscillatory steady-state for 2-D 
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Figure 7.1, The schematics of pulse sequences used in NOESY and ROESY experiments.  
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experiment (Varian Instrumental Manual, 2001). The experiments were acquired with 32 
scans and 2048 complex data points for each of the 224 evolution delay time (d2). The 
spectral width was 5000Hz. 
 
7.2.2.2.   2-D NMR Sample Preparations 
Near-saturated concentrations of model drugs were employed in surfactant solutions with 
D2O as solvent. The systems containing drugs and surfactant solutions were rotated at 
room temperature for 2 days to ensure complete dissolution. For the 400 MHz NMR 
instrument, about 0.75mL sample solutions were placed into 5mm NMR tubes. For the 
500 MHz NMR instrument, about 0.25mL sample solutions were placed into 3mm NMR 
tubes. 
 
7.2.2.3.   PGSE NMR Method 
Pulsed gradient spin echo (PGSE) NMR technique as a means of measuring diffusivity 
was first developed by Stejskal and Tanner (Stejskal and Tanner, 1965) based on the 
concept of nuclear spin echo brought by Hahn (Hahn, 1950) and Carr and Purcell (Carr 
and Purcell, 1954). Two magnetic field gradient pulses are employed, and they are 
essential for correlating the translational motion of nuclei to the NMR signal intensity. 
There are two commonly used pulse sequences: nonstimulated and stimulated PGSE 
pulse sequences, which are shown in Figure 7.2. Nonstimulated PGSE pulse sequence 
uses a 90
o
 pulse to start dephasing the magnetization followed by a 180
o
 pulse to rephrase 
the magnetization and realize an echoed signal. The stimulated pulse sequences utilize 
three successive 90
o
 pulses to bring about the same effect. In Figure 7.2, d0~d5 are 
acquisition delays. The spin echo condition requires: d0=d3 and d2=d4.  
 
Stimulated spin echoes are often employed in system which has a short T2 relaxation time 
and a slow diffusivity. For the micelle system, the diffusivity of micelle is much slower 
than that of monomer and the spin-spin coupling relaxation time (T2) of nuclei in micelle 
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Figure 7.2, Schematics of nonstimulated and stimulated PGSE NMR sequences used in 
diffusivity measurements. The shaded bars represent the magnetic field gradient (along z 
direction) pulses with duration, , and intensity, g.  
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is also much shorter than that of monomer due to the molecular motional restriction in 
micelles.  
 
For stimulated PGSE experiment, the equation used to determine the diffusivity can be 
written as: 
  3exp 2220   gDII           (7.1) 
where I and I0 are the measured NMR signal intensities in the presence and absence of 
magnetic field gradient; D is the diffusivity;  is the gyromagnetic ratio (which is equal to 
2.67515x10
8
s
-1
T
-1
 for proton);  and g are the duration and intensity of the magnetic field 
gradient pulse along z direction;  is the diffusion time between two magnetic field 
gradients in the pulse sequence which is equal to 3905902 dpwdpwd   (see 
Figure 7.2; pw90 is the length of a 90
o
 pulse). In the experiment,  and  are kept 
constant. By changing gradient strength, g, a series of signal intensity I are measured. 
Since the ln(I/I0) and g
2
 have good linear relationship, the slope is used to calculate the 
diffusion coefficient D. 
 
The diffusivity measurements were carried out on a Varian Inova 400MHz Fourier 
Transform NMR spectrometer (S/N S010883) equipped with a Highland Performa II 
gradiet probe (S/N P003732). Thin-walled 3mm glass sample tubes were used in order to 
keep the sample within the linear region of the gradient coil. Compared to 5mm tube, the 
3mm sample tube could also shorten the time to reach thermal equilibrium and inhibit the 
thermal convection that could affect the measured diffusivity (Antalek, 2002). The 
temperature of the measurements was controlled at 27.0±0.1
o
C. The samples were 
equilibrated inside the NMR probe for at least 15 minutes prior to the data collection. The 
trapezoidal gradient shape was utilized instead of the standard rectangular gradient in 
order to minimize the effects of eddy currents on diffusivity measurements (Price and 
Kuchel, 1991). 
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The instrument was calibrated using a standard solution containing 15mg/mL SDS in 
D2O. The literature values of the diffusivities of dodecyl sulfate at 15mg/mL 
concentration are 0.976x10
-10
m
2
/s at 25
o
C (Landman et al., 1984) and 1.70x10
-10
m
2
/s at 
45
o
C (Miller et al., 1994). The interpolated diffusion coefficient at 27
o
C based on 
Arrhenius relationship was 1.05x10
-10
m
2
/s. After the calibration our measured diffusivity 
of the standard was (1.05±0.01)x10
-10
m
2
/s. The diffusivity of the standard was measured 
both before and after each set of experiments. The intraday deviation of the diffusivities 
of standards was less than 1%. The advantage of using 15mg/mL SDS as the standard 
solution was the diffusivity value of the standard was close to the diffusivity of the 
samples while conventional standards, such as D2O or dioxane, had values which were 
one order of magnitude higher than that of samples. 
 
In our experiments, a value of 200ms was used for the delay time d5 which was the 
dominant term for the diffusion time, . Delay time d2(=d4) was 10~20ms and d0(=d3) 
was 0.4ms. Pre-sequence time delay d1 should be 5 times greater than T1 of species of 
interest so as to permit the magnetizations to return to their equilibrium positions. A delay 
time of 5s was chosen for d1. The length of 90
o
 pulse, pw90, ranged from 15.3 to 16.0s 
when the transmitter power (tpwr) was set to 57 dB. The duration of the magnetic field 
gradient pulses, , was set to 5ms, and the strength of the gradient pulses, g, was varied 
from 5 to 27 Gauss/cm in 10 steps in most cases. The squares of gradient strengths, g
2
, 
were chosen to be equally spaced between the minimum and maximum values. The 
minimum field gradient strength was set to 5 Gauss/cm instead of zero due to the poor 
performance at gradient strengths near zero, specifically significant phase distortion of 
spectra. The maximum gradient strength was varied between 22 and 30 Gauss/cm based 
on the gradient strength needed to cause an attenuation of NMR signal by about 90%. A 
trapezoidal shape of magnetic field gradient pulse was employed: a gradient ramp with 
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duration of 0.2ms was applied at the beginning and end of each gradient pulse in order to 
minimize the eddy current effect on signal fluctuation. Other parameters and their 
corresponding values included a sweep width of 6000 Hz, 16384 points for Fourier 
transform and 8~64 transients depending on the signal strength. 
 
There were multiple NMR bands associated to each molecule, the drug or surfactant, in 
the system. Each band could be used to detect the diffusivity of the corresponding 
molecule. To improve the accuracy of the measurements, three bands were chosen for 
each molecule to detect the diffusivity separately. Since the measurement of each sample 
was repeated three times, the final determined diffusivity was an average of 3×3=9 
measurements. The chosen NMR bands in diffusivity determinations for model drug and 
surfactant molecules are listed in Table 7.1. The chemical shifts of SDS, DTAB and 
butylparaben were in good agreements with the reported values in D2O media (Hawrylak 
and Marangoni,1999; Suratkar and Mahapatra, 2000; Panicker, 2008). 
 
7.2.2.4.   PGSE NMR Sample Preparations 
A known amount of model drugs was dissolved into surfactant solutions with D2O as 
solvent to make near-saturated solutions of the drugs. The drug-surfactant solution 
systems were rotated for 2 days to ensure complete dissolution of the solid drugs. To 
prepare solutions with lower drug concentrations, the above samples were diluted 1.5~3 
times with blank surfactant solutions (with same surfactant concentration). When salts 
were present, NaCl was weighed and added into surfactant solutions to make 0.15N 
concentration of NaCl. About 0.25mL sample solutions were place into 3mm NMR tube 
for diffusivity measurements. 
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Table 7.1, List of NMR bands of model drugs and surfactants used in diffusivity 
measurements. 
Drug/Surfactant 
Chemical shifts of NMR bands used 
in diffusivity measurements (ppm) 
Progesterone 5.8, 2.2, 0.7 
Diazepam 7.5, 7.2, 3.5 
Methylparaben 7.9, 6.9, 3.9 
Butylparaben 7.9, 6.9, 1.0 
SDS 4.1, 1.3, 0.9 
DTAB 3.2, 1.3, 0.9 
DM 3.5~3.9, 1.3, 0.9 
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7.3   RESULTS AND DISCUSSION 
7.3.1.   Two-dimensional NMR 
7.3.1.1.   2-D NMR for Steroids in Micelles 
NOESY and ROESY NMR techniques were used as a means to study the locus of 
solubilization of model drugs in micelles. Figure 7.3 shows the ROESY spectrum for 
3.5mg/mL 11-hydroxyprogesterone in 15mg/mL SDS solutions. The corresponding 1-D 
spectrum is shown at both the top and left sides of the 2-D spectrum. There are several 
peaks identified as belonging to the steroid, such as 0.7, 2.0~2.7, 5.7ppm; one 
characteristic peak belonging to SDS, 0.9ppm; and at least three overlapped peaks having 
contributions from both the surfactant and drug, such as 1.3, 1.7, 4.0ppm. Many 
cross-peaks are present corresponding to short distance (<5Å) between two hydrogen 
atoms. Unfortunately, all the cross-peaks could be explained by intra-molecular 
interactions (surfactant-surfactant or drug-drug) and no evidence of inter-molecular 
interactions between surfactant and drug molecules was observed. Shown in Figure 7.4 is 
the ROESY spectrum for 1.9mg/mL 11-hydroxyprogesterone in 20mg/mL DTAB 
solutions. Based on the 1-D spectrum, the peaks at 0.7, 2.0~2.7, 4.0, 5.7ppm are 
exclusively assigned to the drug; the peaks at 0.9, 3.2, 3.4ppm are assigned to DTAB and 
the peaks at 1.3, 1.8ppm are assigned to both the drug and surfactant due to the overlaps. 
Similar to 11-hydroxyprogesterone-SDS systems, all observed cross-peaks correspond 
to intra-molecular interactions and no inter-molecular interaction between drug and 
surfactant molecules is evident. These results do not imply that the surfactant fails to 
solubilize the drug. The data in Section 3.3.1 clearly does illustrate the power of SDS to 
solubilize 11-hydroxyprogesterone.  
 
The ROESY experiments were carried out on 11-hydroxyprogesterone (0.5mg/mL) in 
20mg/mL DM solutions. The results are not shown. No cross-peak corresponding to 
inter-molecular interactions between drug and surfactant was observed. It is partly due to  
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Figure 7.3, ROESY of 3.5mg/mL 11-hydroxyprogesterone in 15mg/mL SDS. 
 
Figure 7.4, ROESY of 1.9mg/mL 11-hydroxyprogesterone in 20mg/mL DTAB 
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the low drug concentration compared to the concentration of surfactant. As a result, the 
intra-molecular interactions of drug molecules may not be sufficiently detectable and 
only the cross-peaks between protons of surfactant molecules were observed.  
 
Both ROESY and NOESY techniques were applied to 15mg/mL SDS solutions 
containing 2.6mg/mL progesterone with the results not shown here. The mixing time for 
ROESY experiment was 0.2s while the mixing time for NOESY experiments varied from 
0.2 to 1.0s. But in all the 2-D spectra, no cross-peak related to inter-molecular 
interactions between drug and surfactant was seen.  
 
In all the studied steroid-in-micelle systems, no evidence of interactions between steroid 
and surfactant molecules was observed. The possible reasons include: (1) In some 
systems, there are broad overlaps between characteristic peaks of the drug and surfactant. 
For example, in 11-hydroxyprogesterone/SDS systems, there is only one peak 
exclusively assigned to surfactant (0.9ppm), which corresponds to the protons at the 
terminal methyl group of alkyl tail of SDS. As a consequence of 0.9ppm being the sole 
unambiguous peak, the outlined NMR methods will only detect an interaction between 
drug and the end of hydrophobic tail of SDS molecules. (2) The qualities of 2-D spectra 
were poor due to a significant t1-noise and the signal/noise ratio was significantly 
lowered. (3) The rotational movement of drug molecules in micelles can be sufficiently 
rapid that the distance between two protons of drug and surfactant cannot remain below 
5Å on the NMR timescale. In Chapter 6 it was speculated that the steroids have larger 
degree of freedom at oil/water interface compared to benzodiazepines and parabens. This 
factor may contribute to the difficulties of detecting interactions between drugs and 
surfactants for SDS-steroid systems. 
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7.3.1.2.   2-D NMR for Parabens in Micelles 
Figure 7.5 shows the ROESY spectrum of 4.9mg/mL methylparaben in 15mg/mL SDS 
solutions. The NMR bands at 0.9, 1.2, 1.6 and 4.0ppm are assigned to the methyl group, 
hydrocarbon chain (including 9 carbons adjacent to methyl group), -protons and 
-protons of the SDS. Methylparaben has characteristic peaks at 3.8ppm (methyl group), 
6.9 and 7.9ppm (aromatic ring). The following cross-peaks corresponding to 
inter-molecular interactions between the drug and surfactant were observed: 0.9↔3.8ppm, 
1.2↔3.8/6.9/7.9ppm, 1.6↔7.9ppm, 4.0↔7.9ppm (labeled by arrows in Fig. 7.5). A 
schematic representation, Figure 7.6, demonstrates how the interactions could be used to 
determine the location and orientation of drug molecules in micelles. The short distance 
between aromatic ring of methylparaben and - and -protons of SDS indicates the 
location of the aromatic ring in the vicinity of the head groups of the surfactant, and 
therefore the micelle surface. The interactions between methyl group of methylparaben 
and the terminal methyl group of the hydrophobic tail of SDS suggests the methyl group 
of methylparaben is pointing towards the micelle core. From the configuration derived 
from the inter-molecular interactions, the hydroxyl group of methylparaben must be 
pointing to the aqueous environment. To prove the observed interactions happened in the 
micelles but not in the solution state, such as from dimer complexes, the 2-D NMR 
spectrum was measured at surfactant concentration lower than the CMC. The spectrum of 
1.0mg/mL methylparaben in 1.0mg/mL SDS solutions shows only cross-peaks 
corresponding to intra-molecular interactions and no cross-peak between the drug and 
surfactant (the spectrum is not shown). 
 
Figure 7.7 shows the ROESY spectrum of 6.7mg/mL methylparaben in 20mg/mL DTAB 
solutions. There is no overlap between NMR bands of methylparaben and those of DTAB. 
The characteristic peaks of DTAB include 0.9ppm (methyl group at the end of  
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Figure 7.5, ROESY of 4.9mg/mL methylparaben in 15mg/mL SDS. The interested 
cross-peaks are labeled using arrows. 
 
 
 
Figure 7.6, A schematic of inter-molecular interactions between methylparaben and SDS 
molecules detected by ROESY experiments (Fig. 7.5). 
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the hydrocarbon tail), 1.1~1.2ppm (hydrocarbon chain consisting of 9 carbons adjacent to 
methyl group), 1.6ppm (-protons), 3.2ppm (methyl groups at the head group), and 
3.8ppm (-protons). The following cross-peaks between functional groups of 
methylparaben and DTAB were observed: 0.9↔3.8ppm, 1.1~1.2↔3.8/6.9/7.9ppm, 
3.2↔6.9/7.9ppm (labeled using arrows in Fig. 7.7). Figure 7.8 is a schematic 
representation illustrating the specific interactions between methylparaben and DTAB in 
micelles. The aromatic ring of the drug is close to the head group of DTAB molecules 
while the methyl group of methylparaben is close to the end of hydrophobic tail of the 
surfactant.  These observations are consistent with the conclusion that the aromatic ring 
and hydroxyl group of methylparaben are located at micelle surface while the methyl 
group of the drug points towards the micelle core.  
 
Shown in Figure 7.9 is the NOESY spectrum of 3.7mg/mL methylparaben in 20mg/mL 
DM solutions. DM has characteristic bands at 0.9ppm (methyl group of the hydrophobic 
tail), 1.3ppm (hydrocarbon chain including 9 carbons adjacent to terminal methyl group), 
1.6ppm (-protons), 3.3~3.9, 4.3 and 5.3ppm (head group). Obviously, the broad band, 
3.3~3.9ppm, of the head group overlaps with the sharp peak (3.8ppm) corresponding to 
the methyl group of methylparaben. No conclusive information can be obtained for 
interactions with the methyl group of methylparaben. The cross-peaks between 
6.9/7.9ppm and 0.9/1.3/1.6/3.3~3.9ppm were observed which indicate the interactions 
between the aromatic ring of methylparaben and both the head group and hydrocarbon 
chain (including the terminal methyl group) of the surfactant. A schematic figure 
demonstrating the inter-molecular interactions is shown in Figure 7.10. These results 
suggest the drug and surfactant molecules may have more compact packing in DM 
micelles compared to that in ionic micelles. The ROESY experiments were carried out on 
the same system (methylparaben/DM system, results are not shown). No cross-peaks 
between the drug and surfactant were seen. This lack of response may be because the  
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Figure 7.7, ROESY of 6.7mg/mL methylparaben in 20mg/mL DTAB. The interested 
cross-peaks are labeled using arrows. 
 
Figure 7.8, A schematic of inter-molecular interactions between methylparaben and 
DTAB molecules detected by ROESY experiments (Fig. 7.7). 
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Figure 7.9, NOESY of 3.7mg/mL methylparaben in 20mg/mL DM. The interested 
cross-peaks are labeled using arrows. 
 
 
Figure 7.10, A schematic of inter-molecular interactions between methylparaben and DM 
molecules detected by NOESY experiments (Fig. 7.9). 
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cross-peak was significantly weakened by the much shorter spin-spin relaxation time 
(T2=0.01~0.04s) for protons in DM micelles compared to the mixing time used in 
ROESY experiments (tmix=0.3s). 
 
Figure 7.11 is the ROESY spectrum of 3.7mg/mL ethylparaben in 15mg/mL SDS 
solutions. Ethylparaben has characteristic bands at 7.8 and 6.9ppm (aromatic ring), 
4.3ppm (-CH2- group), and 1.3ppm (methyl group). Compared to NMR bands of SDS, 
4.0, 1.6, 1.2 and 0.8ppm, the methyl group band of the drug (1.3ppm) is very close to the 
peak of the hydrocarbon chain of SDS (1.2ppm) and is near the methyl group band of 
SDS (0.8ppm). When a small cross-peak (such as inter-molecular interactions) arises 
where two bands exhibit close chemical shifts, the signal is often difficult to be 
distinguished because of the t1-noise (along y-axis of Fig. 7.11) in a region close to the 
diagonal peaks of the 2-D spectrum. Therefore the interaction between methyl group of 
ethylparaben and alkyl chain of SDS is difficult to detect. On the other hand, from the 
off-diagonal cross-peaks, the following interactions between the drug and surfactant 
could be observed: the aromatic ring of ethylparaben with the alkyl chain of SDS 
(7.8/6.9ppm↔1.2ppm); the aromatic ring of the drug with the -protons of SDS 
(7.8/6.9ppm↔4.0ppm). A schematic representation of the detected inter-molecular 
interactions between ethylparaben and SDS molecules is shown in Fig. 7.12. The results 
indicate the aromatic ring of ethylparaben is located between the head group and alkyl 
chain of the surfactant. The orientation of the model drug cannot be determined from the 
ROESY experiment. 
 
Shown in Figure 7.13 is the ROESY spectrum of 5.8mg/mL ethylparaben in 20mg/mL 
DTAB solutions. Inter-molecular interactions included: the aromatic ring of ethylparaben 
with the hydrocarbon chain of DTAB (7.8/6.9ppm↔1.2ppm); the aromatic ring of the 
drug with the methyl groups in head group of DTAB (7.8/6.9ppm↔3.1ppm). The  
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Figure 7.11, ROESY of 3.7mg/mL ethylparaben in 15mg/mL SDS. The interested 
cross-peaks are labeled using arrows. 
 
 
Figure 7.12, A schematic of inter-molecular interactions between ethylparaben and SDS 
molecules detected by ROESY experiments (Fig. 7.11). 
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Figure 7.13, ROESY of 5.8mg/mL ethylparaben in 20mg/mL DTAB. The interested 
cross-peaks are labeled using arrows. 
 
 
Figure 7.14, A schematic of inter-molecular interactions between ethylparaben and DTAB 
molecules detected by ROESY experiments (Fig. 7.13).  
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inter-molecular interactions are demonstrated in Figure 7.14.  The aromatic ring of 
ethylparaben is close to both the head group and alkyl chain of the surfactant molecule 
which suggest the aromatic ring of the drug is near the surface of the DTAB micelles. 
Similar to that observed in ethylparaben/SDS system the 2-D NMR technique could not 
detect significant interaction between the methyl group of ethylparaben and the 
hydrophobic tail of DTAB. No conclusions concerning molecular orientation could be 
made.  
 
Figure 7.15 is the ROESY spectrum of 5.0mg/mL butylparaben in 15mg/mL SDS 
solutions. Butylparaben has characteristic peaks at 7.8 & 6.9ppm (aromatic ring), 4.2ppm 
(-protons), 1.7ppm (-protons), 1.4ppm (-protons), and 0.9ppm (methyl group). The 
short spacing between the NMR bands of alkyl chain of butylparaben and the peaks of 
alkyl chain of SDS (4.0, 1.6, 1.2 and 0.8ppm) prevents unambiguous identification of 
interactions between alkyl chains of the drug and surfactant. On the other hand the 
cross-peaks between the aromatic ring of butylparaben (7.8/6.9ppm) and the alkyl chain 
(1.2ppm) or -protons (4.0ppm) of SDS were observed. The corresponding interactions 
are illustrated in Figure 7.16 which suggests the aromatic ring of butylparaben is located 
between the head group and alkyl chain of the surfactant and therefore is in the vicinity of 
the micelle surface.  
 
For all three parabens, the aromatic rings of the drug are shown to be close to micelle 
surface. When methylparaben is solubilized in ionic surfactant systems (SDS and DTAB), 
the methyl group of the drug is spatially close to the terminal methyl group of 
hydrophobic tail of the surfactant. The orientation of model solute could be determined: 
methyl group of methylparaben penetrats into the micelle core and the hydroxyl group of 
methylparaben must be on the micelle surface contacting water molecules. The location 
of methyl groups of ethylparaben and butylparaben in micelle could not be defined so  
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Figure 7.15, ROESY of 5.0mg/mL butylparaben in 15mg/mL SDS. The interested 
cross-peaks are labeled using arrows. 
 
 
Figure 7.16, A schematic of inter-molecular interactions between butylparaben and SDS 
molecules detected by ROESY experiments (Fig. 7.15).  
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easily because the corresponding NMR peaks are close to the peaks of hydrophobic tail 
of surfactants. A weak cross-peak between two NMR bands that are near to each other in 
chemical shift is usually overwhelmed by the t1 noise in the 2-D NMR spectrum. In 
nonionic surfactant system, the interactions between the aromatic rings of methylparaben 
and all characteristic peaks of DM were observed. It may be due to the compact 
molecular packing in DM micelle. 
 
7.3.1.3.   2-D NMR for Benzodiazepines in Micelles 
Figure 7.17 shows the ROESY spectrum of 3.8mg/mL diazepam in 15mg/mL SDS 
solutions. The NMR bands assigned to diazepam have 7.6ppm (-8H, -9H), 7.5/7.4ppm 
(benzene ring connected to C-5), 7.1ppm (-6H), 4.6/3.8ppm (-CH2-), and 3.4ppm (-CH3). 
As marked with arrows in the figure, the observed cross-peaks between the drug and 
surfactant include 7.5↔1.2ppm, 7.5↔4.0ppm, 7.4↔1.2ppm, and 7.1↔1.2ppm. The 
corresponding intermolecular interactions are illustrated in Figure 7.18. The benzene ring 
connected to C-5 of diazepam is close to both the -protons and alkyl chain of SDS 
molecule. The proton at C-6 position of diazepam is near the alkyl chain of SDS 
molecule in the micelles. These interactions indicate that part of diazepam molecule, e.g. 
the benzene ring at C-5, is near the head group of surfactant and therefore close to the 
micelle surface. 
 
Shown in Figure 7.19 is the ROESY spectrum of 4.4mg/mL temazepam in 15mg/mL 
SDS. The characteristic peaks for temazepam have 7.6ppm (-8H, -9H), 7.5/7.4ppm 
(benzene ring connected to C-5), 7.1ppm (-6H), 3.4ppm (-CH3). The observed 
cross-peaks are: 7.5↔1.2ppm, 7.5↔3.9ppm, 7.4↔1.2ppm, 7.4↔3.9ppm and 
7.1↔1.2ppm (labeled using arrows in Fig. 7.19). The corresponding intermolecular 
interactions between temazepam and SDS molecules are shown in Figure 7.20. The 
benzene ring at C-5 position of temazepam is close to both the -protons and alkyl chain  
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Figure 7.17, ROESY of 3.8mg/mL diazepam in 15mg/mL SDS. The interested 
cross-peaks are labeled using arrows. 
 
Figure 7.18, A schematic of inter-molecular interactions between diazepam and SDS 
molecules detected by ROESY experiments (Fig. 7.17).  
5 
6 
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Figure 7.19, ROESY of 4.4mg/mL temazepam in 15mg/mL SDS. The interested 
cross-peaks are labeled using arrows. 
 
Figure 7.20, A schematic of inter-molecular interactions between temazepam and SDS 
molecules detected by ROESY experiments (Fig. 7.19).  
5 
6 
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of surfactant. The proton at C-6 position of temazepam is near alkyl chain of SDS 
molecule. These drug-surfactant interactions suggest part of temazepam molecules is 
close to the micelle surface, e.g. the benzene ring at C-5 position. 
 
Figure 7.21 shows the ROESY spectrum of 1.6mg/mL temazepam in 20mg/mL DTAB 
solutions. The detected inter-molecular interactions include: the benzene ring at C-5 
position of temazepam with the alkyl chain of DTAB (7.6/7.5↔1.3ppm); the benzene 
ring at C-5 of temazepam with the methyl groups at head group of DTAB (7.6↔3.1ppm); 
the proton at C-6 of temazepam with the alkyl chain of DTAB (7.2↔1.3ppm). Figure 
7.22 shows the schematic representation of inter-molecular interactions between the drug 
and surfactant molecules. The benzene ring at C-5 of temazepam is near micelle surface 
due to the short distance between the benzene ring and head group of DTAB. The 
measured intermolecular interactions are not sufficient to determine the orientation of 
temazepam in the micelles. 
 
ROESY spectrum of 0.7mg/mL temazepam in 20mg/mL DM solutions was measured 
with the results not shown here. No cross-peak corresponding to inter-molecular 
interaction was observed. The relatively low concentration of drug compared to the 
surfactant concentration and the short spin-spin relaxation time (T2) of DM compared to 
the mixing time are two reasons for the failure of detecting inter-molecular interactions in 
the system. 
 
In conclusion, when benzodiazepines are solubilized in ionic surfactant systems (SDS 
and DTAB), 2-D NMR method can detect the interactions between the benzene ring at 
C-5 position of benzodiazepines and both the head groups (-protons of SDS or methyl 
groups at head group of DTAB) and alkyl chain of surfactant molecules. The results 
indicate the benzene ring at C-5 of the drug molecules are in the vicinity of the micelle  
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Figure 7.21, ROESY of 1.6mg/mL temazepam in 20mg/mL DTAB. The interested 
cross-peaks are labeled using arrows. 
 
Figure 7.22, A schematic of inter-molecular interactions between temazepam and DTAB 
molecules detected by ROESY experiments (Fig. 7.21).  
5 
6 
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surface. Since some other functional groups of benzodiazepines, e.g. carbonyl and/or 
hydroxyl groups, are more hydrophilic than the benzene ring, it is very likely those 
hydrophilic groups are located at the micelle surface and contact with water molecules. 
 
7.3.2.   Pulse Gradient Spin-Echo (PGSE) NMR 
PGSE NMR technique was employed to measure the diffusivity of drug or surfactant 
molecule in solutions. The diffusivity was correlated to particle size through 
Stokes-Einstein relation assuming the particle had a spherical shape: 
     
r
Tk
D B
 6
                (7.2) 
where D is the diffusivity; kB is the Boltzmann‟s constant (1.38×10
-23
 J/K);  is the 
viscosity of media; and r is the radius of the particle. Fortunately, the model micelles had 
a spherical shape (Yalkowski and Zografi, 1972) which satisfied the requirement of 
Stokes-Einstein relation. Since kB, T and  are all constant or near constant in our study, 
the micelle size could be detected by measuring the diffusivity of the micelle.  
 
For both the drug and surfactant, the measured diffusivities are comprised of two 
components, monomers and micelles. The total diffusivity could be expressed as: 
     micellemonomermonomermonomertotal DfDfD )1(         (7.3) 
where Dtotal, Dmonomer, Dmicelle are measured diffusivity, diffusivity of the monomer and 
diffusivity of the micelle, respectively; fmonomer is the mole fraction of the drug or 
surfactant in monomer state in solutions. Only under conditions fmonomer<<1 and 
fmonomerDmonomer<<Dtotal, the measured total diffusivity would reflect the diffusivity of 
micelle. 
 
The micelle size was measured as a function of drug concentration in order to detect the 
extent to which the micelle size may change when drugs were solubilized.  
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7.3.2.1.   Drugs Solubilized in SDS Micelles 
Progesterone, diazepam and butylparaben were chosen as representatives of the three 
model drug series. The concentration of SDS was fixed at 15mg/mL. The measured 
diffusivities of drug molecules as a function of drug concentration are shown in Figure 
7.23. Rearranging Eq. (7.3), the diffusivity of the micelle can be expressed as: 
monomer
monomermonomertotal
micelle
f
DfD
D



1
          (7.4) 
The diffusivity of progesterone monomer in D2O has been reported as (5.68±0.07)×10
-6
 
cm
2
/s (Land, 2005). The diffusivity of the diazepam or butylparaben monomer was 
estimated based on approximate relationship:  
31
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where Ddrug and Dprogestereone are the diffusivities of the drug and progesterone monomers 
in D2O; Vprogesterone and Vdrug are molar volumes of the drug and progesterone. The molar 
volumes of the model drugs could be obtained from Table 5.1. The validity of Eq.(7.5) 
was tested by comparing the calculated diffusivity of methylparaben in D2O (7.6×10
-6
 
cm
2
/s) to that of the measured value (7.4×10
-6
 cm
2
/s). Applying Eq. (7.5), the diffusivities 
of diazepam and butylparaben monomers in D2O were 6.2×10
-6
 and 6.8×10
-6
 cm
2
/s, 
respectively.  
 
The mole fraction of drug monomers as a function of total drug concentration could be 
estimated from the solubilization results in Chapter 3 (Table 3.2~3.4 and Fig. 3.14, 3.17 
and 3.20). The fmonomer values are 0.0027 for progesterone, 0.010 for diazepam and 0.033 
for butylparaben. Substituting the values of Dmonomer and fmonomer into Eq. (7.4), the 
measured diffusivities of SDS micelles are 6.8, 6.6 and 6.5×10
-7
 cm
2
/s when progesterone, 
diazepam and butylparaben were used as the solubilizates. Using the average value of the 
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diffusivities, 6.6×10
-7
 cm
2
/s, and viscosity of D2O at 27
o
C (1.05cP) (Cho et al., 1999) in 
Eq. (7.2), the radius of SDS micelle is determined to be 32Å.  
 
As shown in Fig. 7.23, for all three model drugs, the diffusivities of micelle exhibit no 
statistically significant changes in radius with varying drug concentration, indicating the 
micelle size remains constant even when solubilizing drugs. The results support the 
co-adsorption model of the drug and surfactant at micelle surface where micelle size 
remains constant. 
 
In Figure 7.23, the effect of added electrolyte on the micelle size is also presented. In the 
presence of 0.15M NaCl in 15mg/mL SDS solutions, the total diffusivities of 
progesterone and diazepam are significantly larger than the diffusivities in the absence of 
salt. The mole fractions of drug monomers could be determined from the solubilization 
results in Chapter 3 (Table 3.5, Fig. 3.24). The fmonomer values are 0.0040 for progesterone 
and 0.012 for diazepam. Eq. (7.4) was employed to determine the diffusivities of SDS 
micelles to be 7.7×10
-7
 (progesterone as solute) and 7.3×10
-7
 cm
2
/s (diazepam as solute). 
Using Eq. (7.2), the micelle size is estimated to be 28Å, a value slightly smaller than the 
32Å found in the absence of NaCl.  
 
In may also be noted in Figure 7.23 that in the presence of 0.15M NaCl, the micelle size 
is not significantly changed with increasing drug concentration.  
 
7.3.2.2.   Drugs Solubilized in DTAB Micelles 
Progesterone, diazepam and butylparaben were solubilized in 20mg/mL DTAB solutions. 
The diffusivities of drug molecules were measured as a function of drug concentration 
with results shown in Figure 7.24 and 7.25. Based on early studies on solubilization of  
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Figure 7.23, Diffusivities of progesterone, diazepam and butylparaben as a function of 
drug concentration in 15mg/mL SDS solutions in the absence and presence of 0.15M 
NaCl. 
 
Figure 7.24, Diffusivities of progesterone and diazepam as a function of drug 
concentration in 20mg/mL DTAB solutions in the absence and presence of 0.15M NaCl. 
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Figure 7.25, Diffusivities of butylparaben as a function of drug concentration in 
20mg/mL DTAB solutions.  
 209 
progesterone and diazepam in DTAB solutions (Table 3.2~3.3, Fig. 3.15 and 3.18), the 
mole fractions of drug monomers, fmonomer, are 0.0055 for progesterone and 0.033 for 
diazepam. The calculated diffusivities of DTAB micelles from Eq. (7.4) are 7.7×10
-7
 
cm
2
/s (progesterone as solute) and 7.9×10
-7
 cm
2
/s (diazepam as solute). The 
hydrodynamic radius of DTAB micelle is calculated from Eq. (7.2) to be 27Å. 
 
From Fig. 7.24, with increasing concentration of progesterone, the micelle size of DTAB 
was observed to decrease slightly, but significantly, due to the increase in diffusivity of 
the micelle. The student‟s t-test gives a two-tailed p-value of <0.01 (0.007) between the 
diffusivities at low (0.47mg/mL) and high (1.42mg/mL) concentrations of progesterone 
(using unequal variances because the measured diffusivity of a substance has a larger 
standard deviation at lower concentration of the substance). For diazepam, the radius of 
DTAB micelle has no significant change with increasing drug concentration. Both of the 
results suggested the solubilized drug may replace surfactant molecules during the 
solubilization process to keep micelle size constant or even decrease micelle size.  
 
In our early solubilization studies (Chap. 3), it was observed that additon of butylparaben 
to DTAB solution could make the solutions cloudy indicating the disturbance of DTAB 
micelle structures. Here we investigated the size of newly formed assemblies by 
measuring the corresponding diffusivity. Figure 7.25 shows the diffusivity of 
butylparaben is dramatically decreased with increasing drug concentration in the DTAB 
solutions. When the concentration of butylparaben is increased from 2mg/mL to 6mg/mL, 
the diffusivity of butylparaben is decreased by 43%. The corresponding micelle size and 
micelle volume would increase by approximately 43% and 190%, respectively. The 
significant grow of micelle size may have resulted in phase transition of the system and 
the cloudy appearance of butylparaben in DTAB mixture. 
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The effect of added electrolyte on DTAB micelle size is shown in Fig. 7.24. In the 
presence of 0.15M NaCl in 20mg/mL DTAB solutions, the diffusivities of progesterone 
and diazepam were measured as a function of drug concentration. To estimate the 
contribution of drug monomers to total measured diffusivity, the mole fraction, fmonomer, 
was determined using the early solubilization results in the presence of salt (Table 3.5 and 
Fig. 3.25). The mole fraction of progesterone monomers is 0.0061 and the mole fraction 
of diazepam monomers is 0.032. The diffusivities of DTAB micelles are calculated from 
Eq. (7.4) to be 9.2×10
-7
 cm
2
/s (progesterone as solute) and 8.4×10
-7
 cm
2
/s (diazepam as 
solute). Using the average value of micelle diffusivities in Eq. (7.2), the estimated 
hydrodynamic radius of the DTAB micelle in the presence of 0.15M NaCl is 24Å which 
is smaller than the radius of the DTAB micelle in the absence of NaCl (27Å). 
 
7.3.2.3.   Drugs Solubilized in DM Micelles 
Figure 7.26 shows the diffusivities of dodecyl -D-maltoside (20mg/mL) as a function of 
concentration of model drugs, progesterone and diazepam. Due to the low solubilization 
capacity of DM micelles, the concentration of solubilized drugs is much lower than the 
surfactant concentration, resulting in weak NMR signals. The diffusivity measurements 
of drug molecules using those weak NMR signals exhibited large relative error (>10%) 
and were not used in micellar size determination. As an alternative, diffusivity of the DM 
micelle was determined by employing DM-associated NMR signals. 
 
To estimate the diffusivity of the DM micelle using Eq. (7.4), the diffusivity of DM 
monomers was required. It may be inappropriate to extrapolate the diffusivity of DM 
monomer from the diffusion coefficient of progesterone using Eq. (7.5) because DM has 
a long chain structure while the structure of progesterone is bulky. The structural 
similarity between DM and SDS molecules enabled us to estimate the diffusivity of DM  
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Figure 7.26, Diffusivities of DM as a function of drug concentration in 20mg/mL DM 
solutions in the absence and presence of 0.15M NaCl. Two model drugs, progesterone 
and diazepam, were used. 
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monomer based on diffusion coefficient of dodecyl sulfate monomer. The measured 
Dmonomer of dodecyl sulfate ion is 4.6×10
-6
 cm
2
/s at SDS concentration below the CMC. 
The McGowan volumes of dodecyl sulfate and DM are calculated to be 361 and 
651Å³/molecule (McGowan, 1978), respectively. Employing Eq.(7.5), the estimated 
diffusivity of DM monomer is 3.8×10
-6
 cm
2
/s. consequently, the diffusivity of DM 
micelle in the absence of drug is 6.0×10
-7
 cm
2
/s. The hydrodynamic radius of DM micelle 
is calculated from Stokes-Einstein relation to be 35Å. 
 
From Fig. 7.26, the diffusivity of micelles is significantly decreased in the presence of 
either progesterone or diazepam. When drug concentrations are raised to 0.5mg/mL for 
progesterone and 0.6mg/mL for diazepam, the diffusivities of DM micelles are decreased 
by 18% and 15%, respectively, that corresponds to increases of the micelle size by 18% 
(progesterone as solute) and 15% (diazepam as solute). The volume changes of DM 
micelles due to the solubilization of model drugs would be more dramatic: 64% 
(progesterone) and 52% (diazepam) increases. Assuming the drugs were simply added to 
DM micelles, the volumes of the micelles should be increased by only ~2.5% for 
progesterone and ~3% for diazepam. The measured volume changes of DM micelles are 
significantly larger than those based on the simple addition model, suggesting the 
aggregation number of DM micelle must be increased dramatically even in the presence 
of small amount of solubilized drug molecules.  
 
The effect of adding 0.15M NaCl on the measured diffusivities of DM molecule as a 
function of concentration of model drugs, progesterone and diazepam, is shown also in 
Figure 7.26. In the absence of drug, the diffusivity of DM molecule in the presence of 
salts is not significantly different from that in the absence of salts, suggesting the micelle 
size does not change with added salts. The additions of 0.6mg/mL progesterone and 
0.8mg/mL diazepam result in a decrease in the diffusivities of DM by 31% and 29%, 
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respectively. Similar to drug in DM micelle systems in the absence of salt, the micelle 
volumes are dramatically increased by 125% (progesterone as solute) and 115% 
(diazepam as solute) when solubilizing <4% (w/w) model drugs in micelles. Under these 
conditions, the aggregation number of DM micelle must be increased significantly with 
increasing drug concentration. Our early studies in Section 5.3.4.2 used the 
surface-localized thermodynamic model to demonstrate the solubilizations were not very 
sensitive to the aggregation number of DM micelles. 
 
7.3.2.4.   Support for Competition of the Drug and Surfactant at the Micelle 
Surface 
In the interfacial tension experiments in the bulk state outlined in Chapter 4, competition 
between the drugs and surfactants for the dodecane/water clearly occurred.  It is 
interesting to speculate whether the co-adsorption of drug and surfactant in the micelle 
might be described as a competition for micelle interface.  If we hypothesize that the 
drugs are competing with surfactants at the micelle surface, the micelle size must not 
increase upon drug solubilization.  Under the condition of constant micelle size, the 
drug molecule could replace surfactant molecule at micelle surface instead of simply 
adding to the micelle. The studies in Sections 7.3.2.1 and 7.3.2.2 showed the radii of SDS 
and DTAB micelles are not significantly increased with the increasing concentration of 
solubilizates, e.g. progesterone and diazepam, both in the absence and presence of 0.15N 
NaCl. In the case of progesterone in DTAB system (in the absence of NaCl), the micelles 
size is even significantly decreased with increasing drug concentration. These results 
would be consistent with the hypothesis that the added drugs to micelles may be 
replacing surfactant molecules due to the limited surface area of a micelle. Additional 
work would be necessary before a definitive conclusion of competition over 
co-adsorption could be drawn.  
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7.3.2.5.   Possible Self-Association of Drug Molecules 
Previously, we alluded to the assumption that the drug molecules do not self-associate in 
bulk solution. To test this assumption, we measured the diffusivities of the drug as a 
function of drug concentration. The results are shown in Figure 7.27. If the drug could 
self-associate at a certain drug concentration, the diffusivity of methylparaben as a 
function of drug concentration would exhibit a breakpoint connecting a constant 
diffusivity region and a descending curve with increasing drug concentration. The results 
in Figure 7.27 show that the diffusivity of methylparaben is independent of the drug 
concentration up to the aqueous solubility. The absolute diffusivity value of 
methylparaben could also rule out the formation of dimer or oligomer because the 
diffusivity of dimer or oligomer should be lower than 6.0×10
-6
 cm
2
/s according to Eq. 
(7.5). The measured diffusivity is, in fact, higher at 7.3±0.1×10
-6
 cm
2
/s. Based on above 
analyses it may be concluded that methylparaben does not self-associate in aqueous 
solutions. 
 
7.4.   CONCLUSION 
The two-dimensional NMR techniques including ROESY and NOESY were employed to 
probe the inter-molecular interactions between the drug and surfactant molecules in the 
micelles. In steroids/surfactants systems, the overlaps of NMR bands between solute 
molecules and hydrocarbon chains of surfactants (not including terminal methyl group) 
hindered the possible intermolecular interactions.  
 
When parabens were solubilized in SDS and DTAB micelles, the interactions between 
aromatic rings of parabens and alkyl chains of surfactants as well as -protons of SDS or 
methyl groups at head group of DTAB were clearly detected which indicated the aromatic 
rings of parabens were close to micelle surface. For methylparaben in SDS and DTAB 
systems, the methyl groups of the drug was found to be spatially close to the terminal 
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Figure 7.27, Diffusion coefficients of methylparaben in D2O as a function of drug 
concentration. 
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methyl groups of alkyl chains of surfactants. Then the orientation of methylparaben in 
SDS/DTAB micelles was determined: the phenol group was likely located at micelle 
surface and the methyl group penetrated inside the micelles. For ethylparaben and 
butylparaben solubilized in SDS and DTAB micelle systems, the methyl groups of the 
drugs had chemical shifts close to that of methyl group in alkyl chain of surfactant which 
made the detection of corresponding cross-peaks difficult due to the big t1-noise. In 
methylparaben/DM system, the interactions between aromatic ring of the drug and many 
NMR bands of DM including head group, hydrocarbon chain and even the terminal 
methyl group of hydrophobic tail of DM. The nonspecific interactions may be due to the 
compact molecular packing in the nonionic micelles.  
 
In benzodiazepine/surfactant systems, the interactions between benzene ring at C-5 
position of benzodiazepines and both alkyl chain and head group (-prontons in SDS or 
methyl groups at N-1 position of DTAB) of ionic surfactants were observed which 
suggested part of benzodiazepine molecule was located in the vicinity of the micelle 
surface. When benzodiazepines were solubilized in DM micelles, the relatively low 
solubilization capacity of the nonionic micelles resulted in a drug concentration much 
less than surfactant concentration. Therefore the cross-peaks between drug and surfactant, 
whose intensities were proportional to drug and surfactant concentrations, were too weak 
to be detected. 
 
In all drug/surfactant systems where inter-molecular interactions were detected, there 
were some evidences that show part of solubilized drug was close to micelle surface. This 
finding supported our micellar surface solubilization picture based on the thermodynamic 
analyses in Chapter 3~5.  
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The PGSE NMR method was utilized to measure the diffusivity and size of the micelles 
in the presence of different drugs. The sizes of SDS micelles had no statistically 
significant change with increasing concentration of progesterone, diazepam or 
butylparaben. The phenomena are consistent with the hypothesis that added drug 
molecules may replace surfactant molecules in micelles to keep the micelle size constant 
in agreement with the existence of drug-surfactant competition for micelle surface. The 
sizes of DTAB micelles were either slightly decreased or unchanged with increasing 
concentration of progesterone or diazepam which also supported the co-adsorption of the 
drug and surfactant at the micelle surface. When butylparaben was added to DTAB 
solutions, the micelle size was significantly increased by up to 43%. The cloudy 
appearance of the solutions suggests a broad distribution of micelle sizes. For nonionic 
DM micelles, the solubilization of small amount of hydrophobic drug resulted in 
significant increase in micelle size and aggregation number.  
 
The salt effect on micelle size was studied. The hydrodynamic radii of SDS and DTAB 
micelles were decreased in the presence of 0.15M NaCl while the hydrodynamic radii of 
DM micelles were not affected by salts. The sizes of SDS and DTAB micelles showed no 
significant change with increasing concentration of progesterone or diazepam in the 
presence of salts. The results indicate the co-adsorption of the drug and surfactant at 
micelle surface would happen even in the presence of salts. On the other hand, the sizes 
of DM micelles were significantly increased with added progesterone or diazepam in the 
presence of salts. It may be due to the decrease in Laplace pressure by the solubilized 
drug at micelle surface that let the surfactant move to micelle surface more easily. 
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Chapter 8 
Conclusions and Future Work 
 
In summary, the following experimental results have been obtained: 
 
 For three series of model drugs in three micelle systems, the measured micelle/water 
partitioning coefficients were much larger than hydrocarbon/water partitioning 
coefficients, which indicated the core region of micelle was insufficient to solubilize 
the model hydrophobic drugs. 
 Hydrocarbon/water interfacial tension could be significantly decreased in the 
presence of hydrophobic drugs, while the model drugs exhibited little or no surface 
activity at oil/air or water/air interface. The hydrophobic drugs could compete with 
surfactant molecules for the oil/water interface and the competition could be 
quantitatively simulated using thermodynamic model. 
 A surface-localized thermodynamic model that considered the surfactant-drug 
co-adsorption at the micelle surface was successfully applied to predict the 
micelle/water partitioning coefficients of three series of model drugs in three micelle 
systems. The critical parameters in calculating micelle/water partitioning included 
the radii of micelles, surface activities of model drugs at oil/water interface 
( interfacewaterG ) and surface pressure at the micelle surface. 
 The surface-localized thermodynamic model successfully explained the salt effect on 
micellar solubilization, drug concentration dependency for micelle/water partitioning 
(solubilization isotherm), and surfactant CMC depression by solutes. 
 Molecular simulations combined with experiments on drug adsorption at oil/water 
interface were employed to determine the orientation of drug at oil/water interface. 
The molecular orientations were strongly dependent on the distribution of 
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hydrophilic functional groups of model drugs. 
 2-D NMR (ROESY and NOESY) technique was able to detect some drug-surfactant 
interactions but also had limitations when strong overlaps of NMR peaks or low drug 
loading occurred. 
 The measured diffusivities of micelles using PGSE NMR method showed 
insensitivity of micelle size (for ionic surfactants) to the solute concentration, which 
supported the drug-surfactant co-adsorption in micelles. 
 
The overall goal of this dissertation is to probe the mechanism of drug solubilization in 
micelle systems. The work presented here provides a starting point for future studies that 
are laid out as followings: 
 
 The surface-localized model could be extended to more complex mixed-micelle 
systems that are physiologically relevant, e.g. phospholipids/bile salts mixtures. The 
competitions between hydrophobic drugs and two surfactants for oil/water interface 
are expected. 
 The surface adsorption of model drugs at oil/water interface could mimic biological 
membrane/water partitioning. Therefore, the permeability of drug through biological 
membrane may be correlated to the surface activities of the drug at 
hydrocarbon/water interface.  
 The present work is mainly dealing with surfactants that have small headgroups. The 
micelle surface (oil/water interface) is the dominant locations for drugs. In practical 
applications, many nonionic surfactants have much larger headgroups that usually 
contain PEGylated chains, e.g. Tween80, VitaminE TPGS, CremophorEL, Solutol, 
etc. These bulky headgroups will introduce at least one more location for drug 
solubilization. A model that considers multi-locations will be proposed to predict the 
drug solubilization. 
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The progress on the mechanistic understanding and quantitative predictions on drug 
solubilization in micelle systems will provide a guideline for selecting solubilizing 
ingredients and speed up the drug formulation process. 
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APPENDICES 
 
Appendix 1.   Liquid-liquid Interfacial Adsorption by Two-dimensional Solution 
Model  
Based on 2-D solution model, the chemical potential of a component of the interface can 
be expressed according to Butler‟s equation (Butler, 1932): 
       
  isisisisi afxRT   ln0,          (A1.1) 
where i is the chemical potential of component i, which could be water, drugs or 
surfactants; superscript s stands for surface; superscript 0 stands for standard state; x is 
the mole fraction based concentration; f is the activity coefficient;  is the interfacial 
tension; and a is the partial molar interfacial area occupied by a molecule of component i. 
In the bulk phase the chemical potential could be written as: 
       
 lililili fxRT ln0,              (A1.2) 
where superscript l stands for bulk liquid. When the interface and bulk phase reach 
equilibrium the chemical potentials will be same: 
       li
s
i                 (A1.3) 
In the absence of surface active species, the following relationship holds for solvent 
water: 
       water
l
water
s
water a0
0,0,              (A1.4) 
where 0 is the interfacial tension in the absence of surface active agents and awater is the 
interfacial area occupied by a water molecule.  
 
If the activity coefficients at the interface, sif , are assumed to be unity for all molecules 
and lif  are assumed to be unity for neutral molecules, the above equations yield 
following relationships: 
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                 (A1.5c) 
where subscripts “water”, “drug” and “surfact” represent water, drug and surfactant; 
interfacewaterG  is transfer free energy from bulk water to interface 
i
l
i
s
ii aG 0
0,0,
,interfacewater    ;  is the surface pressure defined as interfacial tension 
difference between in the absence and presence of surfactant:   0 . In Eq.(A1.5a), 
the mole fraction of bulk water, lwaterx , is chosen as 1 because 
l
drug
l
surfact xx ,  are both 
assumed to be much less than 1. 
 
The total mole fractions of components occupying the surface will be equal to 1: 
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The Eq.(A1.5a)~(A1.5c) are substituted into the appropriate equation (A1.6) in order to 
solve for surface pressure . The final equation will have one of the following forms 
under selected conditions: 
 
1) Only one type of ionic surfactant, e.g. SDS or DTAB, is present, Eq. (A1.6) becomes: 
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2) Only one kind of nonionic surfactant or neutral drug is present, Eq. (A1.6) becomes: 
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where subscript i could be surfactant or drug.  
 
3) Both ionic surfactant and neutral drug are present, Eq. (A1.6) becomes: 
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4) Both nonionic surfactant and neutral drug are present, Eq. (A1.6) becomes: 
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The oil/water surface tension in the presence of one or two surface active components 
could be calculated by   0  using the surface pressure solved from Eq. 
(A1.7)~(A1.10). 
 
Another important property of surface adsorption is the surface pressure as a function of 
interfacial area per surfactant molecule, known as the -A relationship. For ionic 
surfactant in the absence of drug, according to 2-D solution model, the interfacial area per 
surfactant (A) can be calculated as follows: 
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Rearranging Eq. (A1.6), 12  ssurfact
s
water xx , to 2)1(
s
water
s
surfact xx  . Substituting the 
expression for ssurfactx  in Eq. (A1.5a) to Eq. (A1.11) the equivalent form of -A 
relationship is obtained: 
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The above equation could be transformed to - relationship:  
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For nonionic surfactant in the absence of drug, the -A relationship is derived based on 
same principle: 
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Appendix 2.   Surface-localized Thermodynamic Model 
In Mukerjee‟s two-state model, solubility of drugs in the micelle system was expressed as 
a sum of contributions from two locations (Gumkowski, 1986). 
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where Km/w and Kh/w are micelle/water and hydrocarbon/water partitioning coefficients of 
drugs based on mole fraction; Xw and Xcore are mole fraction-based concentrations of drug 
in aqueous phase and micellar core; P is Laplace pressure which is equal to 2/r for 
spherical micelle ( is interfacial tension on micelle surface and r is radius of the micelle); 
V is partial molar volume of drug; f is relative adsorption potential of the drug to account 
for the effect of headgroups on adsorption;  is surface excess of the drug in 
hydrocarbon/water interface and is defined by the Gibbs isotherm: 
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A is micelle/water interfacial area per surfactant molecule and could be estimated by: 
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where r is the radius of micelles and Naggr is the aggregation number.  
 
In the surface-localized model, the micelle/water partitioning coefficient could be 
expressed as: 
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The intermediate step, the 2
nd
 line of Eq. (A2.4), is equivalent to Mukerjee‟s two-state 
model, Eq. (A2.1). An assumption used in the model is the micelle surface is subjected to 
Laplace pressure. The assumption was implicitly employed in Mukerjee‟s two-state 
model but was not clearly stated. In our studied systems, the contributions of the micellar 
core to solubilization were assumed to be negligible and the micelle/water partitioning 
coefficient was expressed using the solubilization by micellar surface only. See Chapter 3 
for experimental evidence to support this assumption.  
 
A2.1.   Dilute Solute Condition 
The term Xw in Eq. (5.4) could be expressed by rearranging the Gibbs isotherm as: 
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At infinite dilution of drug, the Eq. (A1.8) for neutral drug adsorbed at liquid-liquid 
interface can be simplified using 0,0  w
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Substituting above equation to (A2.5), the term Xw is expressed in terms of free energy 
of transfer: 
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Relative adsorption potential f is defined as surface density of drugs in the presence of 
surfactants divided by surface density of drugs in the absence of surfactants: 
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where   and  are the surface density at dodecane/water interface in the absence and 
presence of surfactants; sx is the mole fraction at the interface. 
 
The mole fractions of the various components at the surface are related to the mole 
fractions in bulk liquid by Eq. (A1.5a, b, c). Using the equation set combined with 
infinite dilution condition ( 0, drugdrug  ) and relationship Eq. (A1.6), the first term of 
Eq. (A2.8) could be simplified for nonionic surfactants: 
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Applying the equations (A1.5b), the second term in Eq. (A2.8) becomes: 
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Substituting the equations (A2.9) and (A2.10) into Eq. (A2.8), the relative adsorption 
potential becomes: 
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Eq. (A2.11) is valid for nonionic surfactant. For ionic surfactant, such as SDS and DTAB, 
the relative adsorption potential could be written as: 
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Substituting Eq. (A1.14)/(A1.12) and Eq. (A2.11)/(A2.12) into Eq. (A2.4), the 
micelle/water partitioning coefficient could be calculated as follows: 
For nonionic surfactants: 
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For ionic surfactants: 
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The Eq. (A2.13) and (A2.14) are the operational equations employed to predict 
micelle/water partitioning coefficients.  
 
A2.2.   Non-dilute Solute Condition 
When concentration of solute is finite, the definition of micelle/water partition coefficient 
is: 
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Eq. (A1.5a, b, c) are modified to be applied to highly curved micelle surface: 
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(A2.16c) 
 
Eq. (A2.16a, b, c) have the same forms with Eq. (A1.5a, b, c) with the differences in the 
free energies of transfer from water to interface for drugs and surfactants. The 
interfacewater
G  represents the transfer free energy from bulk water to highly curved 
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micelle surface. Because the drugs are subjected to Laplace pressure at micelle surface, 
the transfer free energy for drug is expressed as: 
PVGG drugdrug    interface,waterinterface,water        (A2.17) 
 
Since the PV term is positive, the free energy of transfer from water to micelle surface, 
drugG interface,water , has less negative value than that for flat surface. Therefore, the drug is 
less surface active at micelle surface compared to flat oil/water interface.  
 
For ionic surfactant, the surfactG interfacewater  can be determined using pure surfactant 
system in the absence of drugs. An equation similar to Eq. (A1.7) is obtained by 
substituting Eq. (A2.16a) and (A2.16c) into Eq. (A1.6): 
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  (A2.18) 
The surface pressure, , at the micelle surface can be estimated according to Section 5.3.2. 
The monomer concentration in bulk water, lsurfactx , is equal to CMC. Activity coefficient 
l
surfactf  can be calculated using Eq. (4.3) and interfacial areas occupied by water and 
surfactants are shown in Section 4.3.3.2. The only unknown parameter is 
surfactG interface,water  which could be determined by solving Eq. (A2.18). 
 
Using same principle, the surfactG interface,water  term for nonionic surfactant can be 
calculated using the following equation: 
    1expexpexp
  interface,water















 








RT
a
RT
G
x
RT
a surfactsurfactl
surfact
water

 (A2.19) 
 
 
 231 
When both ionic surfactant and neutral drug are present, the equations (A2.16a, b, c) are 
substituted into Eq. (1.6): 
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When both nonionic surfactant and neutral drug are present, the following equation is 
obtained by substituting Eq. (A2.16a, b, c) into Eq. (1.6): 
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In Eq. (A2.20) or (A2.21), there is only one unknown parameter, the surface pressure (). 
The equation is numerically solved for the surface pressure.  
 
Now all the parameters in Eq. (2.16a, b, c) are known, the micelle/water partition 
coefficient is calculated by substituting Eq. (2.16b, c) into Eq. (2.15): 
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For ionic surfactant: 
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(A2.22) 
For nonionic surfactant: 
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(A2.23) 
 
The assumptions used for above derivations include: 
(1) The solute and surfactant are ideally competing with each other for the micelle 
surface in the absence of specific interactions between the solute and surfactant 
molecules. 
(2) The radius of micelles is not changed with addition of solutes to micelles. 
(3) The transfer free energy of solute molecule from water to micelle surface is 
independent of solute concentration. 
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A2.3.   The Effect of Finite Solute Concentration on CMC of Surfactants Using 
Laplace Pressure Concept 
The CMC of micelle would be a function of the transfer free energy of surfactant 
molecule from bulk water to micelle surface. The following relationship holds: 
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where CMC and CMC0 are the critical micelle concentrations in the presence and absence 
of solutes; interfacewaterG  and 0 interface,waterG  are the transfer free energies of the 
surfactant from water to micelle surface in the presence and absence of solute.  
 
The change in the transfer free energy is mainly due to the change in Laplace pressure 
acting on surfactant molecule.  
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where P and P0 are the Laplace pressures in the micelles in the presence and absence of 
solute; 0  is the surface pressure at micelle surface in the absence of solute with the 
values for the model surfactants shown in Table 5.4;   is the surface pressure at micelle 
surface in the presence of model drugs and can be calculated in Section A2.2. 
 
Substituting Eq. (A2.25) into Eq. (A2.24), the ratio CMC/CMC0 is expressed as: 
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Because of the usage of results in Section A2.2, the three assumptions used in that section 
are applied to the current question. There is one more assumption that the surfactant 
molecules are subject to Laplace pressure.  
Copyright © Shaoxin Feng 2009 
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